≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Thrombocytopenia, unspecified

DOID EFO Endpoint Browser PheWeb

D3_THROMBOCYTOPENIANAS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D69.6
  • Hospital discharge: ICD-9 — 2875
  • Hospital discharge: ICD-8 — 28719|2872
  • Cause of death: ICD-10 — D69.6
  • Cause of death: ICD-9 — 2875
  • Cause of death: ICD-8 — 28719|2872

2 out of 7 registries used, show all original rules.

3071

4. Check minimum number of events

None

3071

5. Include endpoints

None

3071

6. Filter based on genotype QC (FinnGen only)

2962

Control definitions (FinnGen only)

Control exclude
D3_COAGDEF_PURPUR_HAEMORRHAGIC

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D69
Name in latin
Thrombocytopenia NAS

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 20979 9790 11000
Only index persons 17647 8393 9254
Unadjusted period prevalence (%)
Whole population 0.29 0.28 0.31
Only index persons 0.33 0.31 0.35
Median age at first event (years)
Whole population 60.24 59.26 61.06
Only index persons 59.45 57.70 61.04

-FinnGen-

Key figures

All Female Male
Number of individuals 2962 1375 1587
Unadjusted period prevalence (%) 0.62 0.49 0.73
Median age at first event (years) 62.76 58.01 66.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3071
Matched controls
30705
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D70.82
ICD-10 Finland
Drug-induced neutropenia
21.5
307.7
300
154
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
7644.4
307.7
625
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.0
307.7
551
658
WW500
NOMESCO Finland
Blood transfusion
14.4
307.7
636
546
D70.89
ICD-10 Finland
Neutropenic splenomegaly
22.8
307.7
270
129
XW000
NOMESCO Finland
Bone marrow biopsy
23.6
307.7
943
567
D64.9
ICD-10 Finland
Anaemia, unspecified
5.3
307.7
876
2144
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
16264.3
307.7
2914
35
L03AA02
ATC
filgrastim; parenteral
9.0
240.2
311
379
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
10.4
232.8
269
282
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.8
228.3
384
630
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
223.0
816
2576
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
79.1
200.3
107
14
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
195.7
708
2200
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
12.3
185.4
188
162
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
15.2
181.0
161
111
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
875.5
170.6
166
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.0
168.0
314
568
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
11.7
156.5
163
146
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
27.3
143.4
98
37
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
140.3
1885
11642
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
10.1
138.1
160
167
R50.9
ICD-10 Finland
Fever, unspecified
3.0
137.9
768
3057
JN6AD
NOMESCO Finland
CT of torso and neck
8.9
136.9
175
208
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
25.4
136.8
96
39
JN4AD
NOMESCO Finland
Body CT examination
3.3
134.9
623
2223
28719
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia NUD
+∞
133.3
127
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
133.2
504
1586
L03AA14
ATC
lipegfilgrastim; parenteral
8.7
125.0
161
193
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.8
123.8
104
64
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
13.8
120.7
113
85
ZX120
NOMESCO Finland
Intravenous
3.5
120.2
484
1579
L03AA13
ATC
pegfilgrastim; parenteral
4.9
117.6
274
600
JN4BD
NOMESCO Finland
Extensive body CT
3.2
115.7
528
1858
H02AB06
ATC
prednisolone; systemic
2.4
115.1
1744
10990
YNB10
NOMESCO Finland
Collection of stem cells for transplant
55.3
114.5
65
12
M04AA01
ATC
allopurinol; systemic
2.9
114.3
676
2753
H02AB02
ATC
dexamethasone; systemic
3.1
114.1
554
2021
WW300
NOMESCO Finland
Transfer of autologic stem cells
28.2
114.0
77
28
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
9.0
112.9
142
165
D69.5
ICD-10 Finland
Secondary thrombocytopenia
380.8
111.1
111
*
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
12.3
99.8
100
84
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.5
96.4
194
373
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
96.3
343
1027
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
94.2
759
3568
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
25.0
93.6
66
27
Z51.5
ICD-10 Finland
Palliative care
3.0
91.3
460
1701
A04AA02
ATC
granisetron; systemic, transdermal
3.5
91.0
335
1024
D68.8
ICD-10 Finland
Other specified coagulation defects
27.0
89.0
61
23
B02BX05
ATC
eltrombopag; oral
+∞
87.9
84
*
D69.4
ICD-10 Finland
Other primary thrombocytopenia
+∞
87.9
84
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
19.8
87.9
68
35
A04AA01
ATC
ondansetron; systemic, rectal
3.2
86.9
390
1347
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.0
85.8
190
397
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
84.1
1199
7100
C83.1
ICD-10 Finland
Mantle cell lymphoma
18.5
83.8
67
37
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
83.7
837
4301
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.6
83.0
299
900
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
35.2
82.4
52
15
J01MA12
ATC
levofloxacin; systemic
2.3
81.9
754
3735
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
44.3
80.6
48
11
C03CA01
ATC
furosemide; systemic
2.1
77.9
1174
7050
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
77.1
1076
6274
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
7.3
75.5
112
158
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
18.5
72.5
58
32
A02BC02
ATC
pantoprazole; systemic
2.1
71.5
2226
17082
ZX108
NOMESCO Finland
Inhalation
11.1
67.8
72
66
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
67.6
834
4603
1517, ,
Kela drug reimbursment
+∞
66.9
64
*
3039, ,
Kela drug reimbursment
+∞
66.9
64
*
6BA02, ,
NOMESCO Finland
22.6
66.9
49
22
N02AA05
ATC
oxycodone; systemic
2.2
65.7
737
3915
B03XA02
ATC
darbepoetin alfa; parenteral
5.0
65.5
146
306
WZC00
NOMESCO Finland
Treatment plan or consultation
1.9
64.7
1271
8237
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
62.9
261
855
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
11.4
61.4
64
57
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
16.9
60.0
50
30
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
58.9
193
543
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
58.4
977
5957
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.2
57.8
246
817
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
9.3
57.0
69
76
TGC00
NOMESCO Finland
Bronchial lavation
4.4
56.8
148
352
L04AD01
ATC
ciclosporin; systemic
5.7
55.7
106
193
ZXE00
NOMESCO Finland
One hour or less
1.8
55.2
1249
8351
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
54.2
514
2534
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
9.0
53.2
66
75
L01CB01
ATC
etoposide; systemic
10.5
52.7
58
56
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
9.1
52.0
64
72
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
22.6
51.8
38
17
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
50.6
442
2103
R18
ICD-10 Finland
Ascites
4.9
50.4
113
238
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
14.7
50.2
45
31
1XC02, ,
NOMESCO Finland
9.0
50.2
62
70
2875A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia, unspecified
+∞
50.1
48
*
127
Kela drug reimbursment
Transplant complication
5.6
48.3
93
171
H02AB09
ATC
hydrocortisone; systemic
4.2
47.1
127
310
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.5
46.5
91
170
B01AB10
ATC
tinzaparin; parenteral
2.3
45.1
404
1936
A05AA02
ATC
ursodeoxycholic acid; oral
5.6
45.0
86
157
ZXD05
NOMESCO Finland
Urgent procedure
1.8
44.8
965
6268
L04AA06
ATC
mycophenolic acid; systemic
4.8
44.5
102
219
R04.0
ICD-10 Finland
Epistaxis
2.5
44.3
316
1372
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
43.7
684
4021
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.0
43.6
202
703
PJA10
NOMESCO Finland
Exploration of lymph nodes
5.9
43.5
78
134
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
43.2
826
5167
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
43.1
425
2115
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
62.2
42.3
49
8
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
5.7
42.1
79
142
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
12.2
41.9
42
35
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.6
41.9
101
226
ED1AA
NOMESCO Finland
Mandibular X-ray examination
8.1
41.8
56
70
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
13.1
41.7
40
31
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
14.2
41.6
38
27
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.6
41.3
142
412
XX3DW
NOMESCO Finland
Time consuming IT work
2.2
41.3
401
1983
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.5
41.2
101
229
A07AA11
ATC
rifaximin; oral
12.6
40.9
40
32
L04AX01
ATC
azathioprine; systemic
3.2
40.9
171
561
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
40.7
166
536
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
40.7
280
1194
AA1AD
NOMESCO Finland
CT of head and brain
1.7
40.3
983
6574
JMA10
NOMESCO Finland
Transabdominal total splenectomy
9.5
39.8
47
50
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
8.2
39.7
53
66
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
7.3
39.4
58
81
D69.1
ICD-10 Finland
Qualitative platelet defects
138.5
38.8
41
*
C03DA01
ATC
spironolactone; oral
2.0
38.5
449
2376
B01AB05
ATC
enoxaparin; parenteral
1.7
38.4
983
6642
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.6
37.9
91
203
ZX112
NOMESCO Finland
Subcutaneous
4.0
37.8
109
280
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.0
37.2
109
283
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
9.5
37.1
44
47
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.0
36.9
105
267
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
35.6
340
1666
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
11.0
34.7
37
34
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
34.6
409
2170
B02AA02
ATC
tranexamic acid; systemic
2.0
34.1
412
2202
WZC30
NOMESCO Finland
Teaching
1.8
34.0
565
3355
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
4.9
34.0
75
156
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.0
33.7
155
537
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
33.0
301
1446
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
33.0
167
610
H02AB07
ATC
prednisone; oral
1.9
32.9
445
2471
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.6
32.9
62
112
D64.8
ICD-10 Finland
Other specified anaemias
4.0
32.7
94
241
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
32.5
628
3895
2873A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]
+∞
32.3
31
*
D69.0
ICD-10 Finland
Allergic purpura
34.6
31.9
41
12
TK800
NOMESCO Finland
Hemodialysis
3.8
31.9
97
259
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
7.2
31.8
47
66
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.0
31.8
142
484
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
10.7
31.3
34
32
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.8
31.3
71
151
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
30.8
249
1137
122
Kela drug reimbursment
Aplastic anaemia
86.0
30.8
34
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.8
30.6
164
617
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
30.5
323
1643
N02AX02
ATC
tramadol; systemic, rectal
1.6
30.5
1295
9774
B02BX04
ATC
romiplostim; parenteral
+∞
30.3
29
*
A07AA09
ATC
vancomycin; oral
4.4
30.2
75
172
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
7.0
30.1
46
67
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
30.1
782
5245
Z94.4
ICD-10 Finland
Liver transplant status
10.4
29.8
33
32
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
29.4
1224
9173
R4110
NOMESCO Finland
Physiotherapy
1.6
29.2
851
5868
K92.1
ICD-10 Finland
Melaena
2.4
29.2
208
899
K70.4
ICD-10 Finland
Alcoholic hepatic failure
9.3
29.2
35
38
TPX15
NOMESCO Finland
Removal of vascular injection port
8.9
28.9
36
41
L04AD02
ATC
tacrolimus; systemic
5.5
28.8
56
104
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
10.8
28.7
31
29
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
28.6
438
2525
UJF32
NOMESCO Finland
Coloscopy
1.6
28.5
808
5527
K72.9
ICD-10 Finland
Hepatic failure, unspecified
7.4
28.4
41
56
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.2
28.4
116
375
Z3231
NOMESCO Finland
Registered nurse
1.6
28.3
837
5784
3038, ,
Kela drug reimbursment
+∞
28.2
27
*
1516, ,
Kela drug reimbursment
+∞
28.2
27
*
SPAT1088
SPAT
Blood transfusion
7.7
28.0
39
51
K70.1
ICD-10 Finland
Alcoholic hepatitis
7.7
28.0
39
51
J01DB01
ATC
cefalexin; oral
1.7
28.0
2448
21537
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
9.5
28.0
33
35
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
27.9
237
1105
J01MA14
ATC
moxifloxacin; systemic
2.1
27.7
301
1544
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
7.6
27.6
39
52
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
11.2
27.6
29
26
D73.1
ICD-10 Finland
Hypersplenism
47.6
27.4
33
7
WW200
NOMESCO Finland
Immunization
3.2
27.4
108
342
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
53.8
27.2
32
6
1524, ,
Kela drug reimbursment
+∞
27.1
26
*
3052, ,
Kela drug reimbursment
+∞
27.1
26
*
D61.3
ICD-10 Finland
Idiopathic aplastic anaemia
+∞
27.1
26
*
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
6.3
27.0
45
72
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
27.0
275
1377
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.9
26.9
80
210
A06AD11
ATC
lactulose; oral
1.8
26.9
493
2997
A41.8
ICD-10 Finland
Other specified sepsis
3.5
26.7
93
272
J05AB11
ATC
valaciclovir; oral
1.8
26.7
440
2592
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
26.4
489
2982
WPA13
NOMESCO Finland
Palliative consultation
7.6
26.3
37
49
Z2221
NOMESCO Finland
Medical doctor
1.6
26.3
794
5498
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.3
26.2
216
994
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.5
26.0
50
92
N05CF01
ATC
zopiclone; oral
1.6
25.9
948
6859
A46
ICD-10 Finland
Erysipelas
1.8
25.8
479
2919
A02BC01
ATC
omeprazole; systemic
1.6
25.6
805
5622
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
9.5
25.3
30
32
JN4CD
NOMESCO Finland
Very extensive body CT
2.7
25.2
141
543
B02BX08
ATC
avatrombopag; systemic
+∞
25.0
24
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
6.4
24.8
41
65
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.7
24.3
56
121
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
4.6
24.3
57
125
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
24.2
1035
7715
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
5.4
24.0
47
88
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.1
23.5
49
97
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
47.0
23.3
28
6
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
7.3
23.3
34
47
WX402
NOMESCO Finland
General anaesthesia
1.6
23.2
660
4485
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
5.4
23.2
46
87
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
7.4
22.9
33
45
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
7.2
22.9
34
48
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.8
22.8
116
425
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.3
22.7
84
256
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
27.5
22.2
30
11
212
Kela drug reimbursment
Gout
3.2
22.2
87
275
WX892
NOMESCO Finland
Monitored bed care
2.0
22.1
258
1356
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
5.0
21.8
47
96
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
21.8
232
1179
WX002
NOMESCO Finland
Sedation and analgesia
1.6
21.6
571
3806
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
21.2
531
3491
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
4.7
21.0
48
103
TAB00
NOMESCO Finland
Lumbar puncture
2.4
21.0
149
643
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
16.7
20.9
33
20
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
5.4
20.9
41
77
ZX131
NOMESCO Finland
Intrathecal
60.4
20.9
24
*
A10AB05
ATC
insulin aspart; parenteral
2.0
20.7
253
1349
J01MA02
ATC
ciprofloxacin; systemic
1.5
20.7
1142
8891
TGD00
NOMESCO Finland
Needle biopsy of lung
6.4
20.5
34
54
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
8.2
20.5
27
33
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.4
20.5
75
227
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
20.4
112
427
J01FF01
ATC
clindamycin; systemic
1.5
20.4
769
5546
N03AX14
ATC
levetiracetam; systemic
2.8
20.3
106
394
D68.9
ICD-10 Finland
Coagulation defect, unspecified
48.3
20.1
24
5
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
5.1
20.0
42
84
L01BB02
ATC
mercaptopurine; oral
4.4
19.9
49
112
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.0
19.8
56
142
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
19.8
255
1385
K29.6
ICD-10 Finland
Other gastritis
4.1
19.5
54
135
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
4.6
19.4
46
102
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
14.7
19.4
32
22
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
15.6
19.2
31
20
J02AC03
ATC
voriconazole; systemic
15.6
19.2
31
20
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
19.2
153
694
L01AX03
ATC
temozolomide; systemic
5.6
19.1
36
65
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
19.1
110
430
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
20.2
19.0
28
14
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.1
19.0
78
254
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
34.5
18.9
24
7
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
18.8
131
561
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
18.7
168
800
JJC00
NOMESCO Finland
Allogenic transplantation of liver
17.2
18.7
29
17
ZX121
NOMESCO Finland
Central venous catheter
7.4
18.6
27
37
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
18.6
2039
17813
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
4.4
18.5
46
106
B01AA03
ATC
warfarin; systemic
1.5
18.5
584
4044
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.1
18.5
50
123
K92.0
ICD-10 Finland
Haematemesis
2.8
18.3
92
335
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.0
18.3
51
128
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.4
18.2
64
189
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
5.3
18.0
36
69
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
52.8
17.9
21
*
P01BA02
ATC
hydroxychloroquine; oral
1.9
17.8
226
1221
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
17.8
993
7694
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.5
17.5
61
179
M35.1
ICD-10 Finland
Other overlap syndromes
6.6
17.5
28
43
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.5
17.3
59
171
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
17.3
148
692
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
17.2
790
5896
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.7
17.1
93
353
N03AX16
ATC
[U] pregabalin
1.5
17.0
626
4470
WF002
NOMESCO Finland
Radical radiotherapy
2.0
17.0
189
976
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
16.9
170
845
Z3226
NOMESCO Finland
Physiotherapist
1.6
16.9
515
3530
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
16.9
1446
12020
J01CA04
ATC
amoxicillin; systemic
1.5
16.6
2342
21148
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.9
16.5
207
1113
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
7.3
16.5
24
33
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
16.4
179
918
B99
ICPC
Blood/lymph/spleen disease other
6.1
16.4
28
46
Z31.5
ICD-10 Finland
Genetic counselling
2.2
16.3
142
668
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
16.3
662
4818
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
16.2
405
2651
N02BE01
ATC
paracetamol; systemic, rectal
1.5
16.2
2613
24152
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
3.2
16.0
64
205
WVA20
NOMESCO Finland
Medicine administration
2.5
16.0
99
401
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
5.6
16.0
30
54
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.9
16.0
76
269
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
21.1
16.0
23
11
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
16.0
196
1047
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.0
15.9
69
232
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
2.3
15.9
122
545
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
15.9
184
963
A03
ICPC
Fever
1.6
15.7
467
3180
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
15.7
238
1360
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.4
15.7
106
448
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
85.5
15.6
17
*
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
15.6
253
1476
L04AX03
ATC
methotrexate; systemic
1.8
15.5
267
1584
WX872
NOMESCO Finland
Intensive care
2.0
15.5
163
825
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.9
15.3
188
1005
C91.4
ICD-10 Finland
Hairy-cell leukaemia
28.7
15.2
20
7
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.4
15.0
54
162
WZC15, ,
NOMESCO Finland
4.2
15.0
39
93
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.7
15.0
300
1853
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
15.0
144
704
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
5.0
15.0
32
65
R31
ICD-10 Finland
Unspecified haematuria
1.6
15.0
329
2084
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
10.9
15.0
28
26
E0000UV, ,
ATC
1.4
14.9
1142
9264
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
14.9
531
3755
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
6.8
14.9
23
34
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.6
14.8
86
338
WPB10
NOMESCO Finland
Making a convalescent care decision
5.5
14.8
28
51
C90.0
ICD-10 Finland
Multiple myeloma
3.5
14.7
50
145
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.7
14.5
78
295
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
150.7
14.5
15
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
14.5
294
1825
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
36.2
14.4
18
5
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
36.2
14.4
18
5
WX882
NOMESCO Finland
High dependency care
2.4
14.3
101
435
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
4.2
14.3
37
88
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
27.3
14.3
19
7
A04AA55
ATC
palonosetron, combinations; systemic
2.3
14.3
104
455
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
4.1
14.2
39
97
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.8
14.2
43
115
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
14.2
279
1716
R60.0
ICD-10 Finland
Localized oedema
1.6
14.2
370
2443
K76.9
ICD-10 Finland
Liver disease, unspecified
3.4
14.1
49
144
R11
ICD-10 Finland
Nausea and vomiting
1.7
14.1
249
1487
R53
ICD-10 Finland
Malaise and fatigue
1.4
14.0
709
5357
N19
ICD-10 Finland
Unspecified kidney failure
2.1
13.9
130
629
K72.1
ICD-10 Finland
Chronic hepatic failure
15.8
13.9
22
14
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.6
13.9
78
302
130
Kela drug reimbursment
Malignant tumour
1.7
13.9
274
1687
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
13.8
356
2343
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
13.6
13.7
23
17
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
13.6
307
1955
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
6.5
13.6
22
34
28710
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia essentialis (Morbus Werlhof)
+∞
13.5
13
*
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.8
13.5
196
1104
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.4
13.5
90
378
B82
ICPC
Anaemia other/unspecified
2.3
13.5
101
447
Z2446
NOMESCO Finland
Social worker
1.8
13.5
191
1069
WF004
NOMESCO Finland
Palliative radiotherapy
2.6
13.4
78
307
J05AB01
ATC
aciclovir; systemic
1.4
13.4
578
4235
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
16.3
13.4
21
13
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
13.4
101
449
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
13.4
268
1657
B34.9
ICD-10 Finland
Viral infection, unspecified
2.4
13.4
87
362
M31.1
ICD-10 Finland
Thrombotic microangiopathy
25.8
13.4
18
7
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
25.8
13.4
18
7
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
13.3
1009
8136
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
21.2
13.3
19
9
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
13.3
447
3119
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
3.7
13.3
42
116
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
13.3
173
943
C07AB07
ATC
bisoprolol; oral
1.3
13.3
1398
11839
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
13.1
127
624
M10.9
ICD-10 Finland
Gout, unspecified
1.7
13.1
227
1349
WW409
NOMESCO Finland
Other aferesis
12.2
13.1
23
19
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
3.9
13.1
38
99
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
13.0
438
3057
306
Kela drug reimbursment
Erythropoietin and darbepoetin
6.1
12.9
22
36
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
12.9
175
967
D68.0
ICD-10 Finland
Von Willebrand disease
50.2
12.8
15
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.0
12.8
129
644
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.8
12.7
62
223
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.4
12.7
44
129
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.2
12.7
49
154
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
5.1
12.7
26
51
XX2RW, ,
NOMESCO Finland
3.1
12.7
52
170
N03AX18
ATC
lacosamide; systemic
4.4
12.6
31
71
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
70.1
12.6
14
*
I81
ICD-10 Finland
Portal vein thrombosis
5.5
12.6
24
44
ZX080
NOMESCO Finland
Image guided radiotherapy
2.6
12.6
71
276
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.6
12.4
70
272
B28
ICPC
Limited function/disability (B)
5.6
12.4
23
41
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
5.0
12.4
26
52
C07AG02
ATC
carvedilol; oral
1.8
12.4
178
1001
K29.7
ICD-10 Finland
Gastritis, unspecified
2.2
12.4
108
510
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.2
12.4
106
497
K08.3
ICD-10 Finland
Retained dental root
1.7
12.1
224
1354
A28
ICPC
Limited function/disability NOS
1.4
12.0
530
3893
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
12.0
444
3154
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
9.3
12.0
24
26
I50.0
ICD-10 Finland
Congestive heart failure
1.7
12.0
234
1437
S97
ICPC
Chronic ulcer skin
1.8
12.0
192
1116
R06.0
ICD-10 Finland
Dyspnoea
1.4
12.0
765
5989
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.1
12.0
108
517
N05BA04
ATC
oxazepam; oral
1.4
11.9
687
5286
E87.5
ICD-10 Finland
Hyperkalaemia
2.6
11.9
68
266
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.9
11.9
53
182
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
10.5
11.7
22
21
A06AH03
ATC
naloxegol; oral
2.9
11.7
54
189
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.7
11.7
228
1399
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
11.6
616
4673
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
11.6
369
2542
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
19.0
11.6
17
9
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.8
11.5
183
1060
N18.8
ICD-10 Finland
Other chronic renal failure
2.4
11.5
78
331
K74.3
ICD-10 Finland
Primary biliary cirrhosis
5.0
11.5
24
48
B73
ICPC
Leukaemia
13.6
11.4
19
14
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.5
11.3
67
267
SPAT1262
SPAT
Handing over of treatment supplies
1.4
11.3
483
3525
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.0
11.3
128
666
B01AB04
ATC
dalteparin; parenteral
1.9
11.3
137
730
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.3
11.2
82
360
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
17.1
11.2
17
10
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
4.7
11.2
25
53
WW402
NOMESCO Finland
Leucoferesis
25.1
11.1
15
6
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
20.1
11.1
16
8
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
11.1
868
6996
A79
ICPC
Malignancy NOS
2.8
11.1
54
195
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
8.1
11.1
24
30
SPAT1255
SPAT
Intravenous administration of medicine
1.7
11.0
190
1129
AB2
HP
AVR bio, stent
4.4
11.0
27
62
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
4.5
10.9
26
58
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
10.9
513
3807
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
43.5
10.9
13
*
UKC02
NOMESCO Finland
Cystoscopy
1.4
10.9
474
3469
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.9
10.9
144
789
K76.7
ICD-10 Finland
Hepatorenal syndrome
11.9
10.8
19
16
K70.0
ICD-10 Finland
Alcoholic fatty liver
4.0
10.7
30
76
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.3
10.6
80
356
P01AB01
ATC
metronidazole; oral, rectal
1.3
10.6
1002
8281
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
10.5
170
992
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
110.4
10.4
11
*
J05AX18
ATC
letermovir; oral
110.4
10.4
11
*
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
5.4
10.4
20
37
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.9
10.4
30
78
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
10.4
502
3743
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
10.4
109
553
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
7.7
10.4
23
30
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
10.3
1148
9691
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.2
10.3
40
127
J02AC04
ATC
posaconazole; systemic
18.8
10.3
15
8
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
9.6
10.2
20
21
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
9.6
10.2
20
21
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
23.4
10.2
14
6
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
23.4
10.2
14
6
H02AB04
ATC
methylprednisolone; systemic
1.5
10.2
360
2530
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
10.1
73
319
TKC20
NOMESCO Finland
Catheterisation of bladder
1.7
10.1
199
1224
UJF92
NOMESCO Finland
Capsular endoscopy
2.4
10.1
65
270
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
4.5
10.0
24
54
R06
ICPC
Nose bleed/epistaxis
2.3
10.0
76
340
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
3.0
10.0
43
145
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
14.6
10.0
16
11
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.7
10.0
51
189
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
10.0
319
2198
A10AE04
ATC
insulin glargine; parenteral
1.5
10.0
273
1820
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.6
9.9
58
230
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.3
9.9
72
316
6753
FHL
Transabdominal splenectomy
16.7
9.9
15
9
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.8
9.9
49
179
TK810
NOMESCO Finland
Hemofiltration
4.3
9.8
25
59
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.4
9.8
67
286
AAA10
NOMESCO Finland
Biopsy through craniotomy
26.1
9.8
13
5
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
26.1
9.8
13
5
WX730
NOMESCO Finland
Conventional respirator
2.7
9.8
51
191
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
9.8
208
1306
I48.1
ICD-10 Finland
Persistent atrial fibrillation
1.8
9.8
133
737
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.5
9.7
61
251
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.6
9.7
206
1294
390
Kela drug reimbursment
Ibrutinib
13.4
9.7
16
12
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.9
9.6
110
575
L04AA01
ATC
[U] ciclosporin
3.1
9.6
39
127
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
2.5
9.6
60
246
B03XA01
ATC
erythropoietin; parenteral
3.4
9.6
33
97
R06AE07
ATC
cetirizine; oral
1.3
9.6
1102
9317
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
4.4
9.5
23
52
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.0
9.5
40
133
H05AA02
ATC
teriparatide; parenteral
4.8
9.5
21
44
WNF00
NOMESCO Finland
Infection source and contact determination
4.6
9.5
22
48
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
9.1
9.5
19
21
D69.8
ICD-10 Finland
Other specified haemorrhagic conditions
15.1
9.5
15
10
120
Kela drug reimbursment
Hypogammaglobulinaemia
15.1
9.5
15
10
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
9.4
157
923
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
3.2
9.4
36
113
126
Kela drug reimbursment
Chronic coagulation defects
+∞
9.4
9
*
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.1
9.4
89
436
K76.6
ICD-10 Finland
Portal hypertension
21.7
9.3
13
6
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
4.9
9.3
20
41
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.3
1130
9610
318
Kela drug reimbursment
Teriparatide
4.5
9.3
22
49
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
2.9
9.3
42
146
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.1
9.3
87
424
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.1
9.2
38
125
L01XX05
ATC
hydroxycarbamide; oral
2.9
9.2
42
147
QDA10
NOMESCO Finland
Incision of skin of lower limb
3.7
9.1
28
76
I50
ICD-10 Finland
Heart failure
2.0
9.1
93
467
ZXA10
NOMESCO Finland
Bilateral
1.4
9.1
472
3554
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.3
9.1
70
315
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
9.1
122
673
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
5.0
9.1
19
38
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.8
9.1
140
806
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.7
9.1
168
1018
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
2.7
9.0
48
182
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.0
9.0
97
497
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
3.3
9.0
33
101
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
18.6
8.9
13
7
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
24.1
8.9
12
5
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.3
8.9
32
97
W19
ICD-10 Finland
Unspecified fall
1.5
8.9
266
1809
L01BC06
ATC
capecitabine; oral
1.9
8.8
107
571
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.2
8.8
71
326
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.9
8.8
39
134
SPAT1263
SPAT
Sampling
1.3
8.8
1083
9209
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.8
8.8
126
710
R4190
NOMESCO Finland
Nutritional therapy
1.9
8.7
112
609
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
8.7
404
2984
N06AX11
ATC
mirtazapine; oral
1.3
8.7
873
7231
N02AA01
ATC
morphine; systemic, rectal
2.3
8.7
61
264
A98.5
ICD-10 Finland
Haemorrhagic fever with renal syndrome
2.4
8.7
57
240
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
2.9
8.6
40
141
I95.9
ICD-10 Finland
Hypotension, unspecified
2.4
8.6
55
228
A10AC01
ATC
insulin (human); parenteral
1.6
8.6
200
1283
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
7.6
8.6
19
25
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.3
8.6
64
284
B18.2
ICD-10 Finland
Chronic viral hepatitis C
3.3
8.6
31
94
S18
ICPC
Laceration/cut
1.3
8.6
1296
11281
ZX100
NOMESCO Finland
Oral
2.7
8.6
44
164
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
2.3
8.5
59
254
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.7
8.5
43
159
E83.50
ICD-10 Finland
Hypercalcemia
2.7
8.5
43
159
ZX114
NOMESCO Finland
Intramuscular
2.7
8.5
43
159
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
8.5
125
710
3AC01, ,
NOMESCO Finland
3.2
8.5
33
105
WW500, ,
SPAT
27.6
8.5
11
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.7
8.5
151
906
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.7
8.5
142
838
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
7.3
8.4
19
26
A02BC05
ATC
esomeprazole; systemic
1.3
8.4
1039
8827
A04AD12
ATC
aprepitant; systemic
2.4
8.4
54
225
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
8.4
27
76
1512
Kela drug reimbursment
Ibrutinib
12.8
8.4
14
11
L01AA01
ATC
cyclophosphamide; systemic
4.7
8.3
19
41
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
8.3
8
*
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
8.3
8
*
A91
ICPC
Abnormal result investigation NOS
1.7
8.3
151
911
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
9.5
8.3
16
17
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.1
8.2
72
342
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.2
8.2
32
102
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
8.2
274
1905
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
3.0
8.2
35
118
B02.9
ICD-10 Finland
Zoster without complication
1.6
8.2
186
1189
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
4.8
8.1
18
38
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
8.1
343
4622
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
8.1
993
8422
Z85.6
ICD-10 Finland
Personal history of leukaemia
33.4
8.1
10
*
D70
ICD-10 Finland
Agranulocytosis
33.4
8.1
10
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.2
8.1
63
286
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
11.7
8.1
14
12
L01EL01
ATC
ibrutinib; oral
22.1
8.0
11
5
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
22.1
8.0
11
5
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
22.1
8.0
11
5
K65.0
ICD-10 Finland
Acute peritonitis
2.9
8.0
36
125
TQW80
NOMESCO Finland
Local dermatologic skincare
2.1
8.0
73
353
J01AA02
ATC
doxycycline; systemic
1.3
8.0
2119
19588
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
8.0
146
883
B04
ICPC
Blood symptom/complaint
3.9
8.0
23
60
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
8.0
775
6386
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
7.2
7.9
18
25
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
7.9
456
3490
C09AA05
ATC
ramipril; oral
1.3
7.9
677
5485
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.7
7.9
146
885
R55
ICD-10 Finland
Syncope and collapse
1.5
7.9
295
2096
M05BA04
ATC
alendronic acid; oral
1.5
7.9
213
1416
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
6.6
7.9
19
29
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
4.6
7.9
18
39
D07AC01
ATC
betamethasone; topical
1.3
7.8
939
7935
RK320, ,
NOMESCO Finland
3.5
7.8
26
75
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
7.8
231
1567
D75.2
ICD-10 Finland
Essential thrombocytosis
3.9
7.7
22
57
SPAT1301
SPAT
No procedures
1.3
7.7
810
6738
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
3.4
7.7
26
76
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.4
7.7
49
204
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.1
7.6
68
326
C95.9
ICD-10 Finland
Leukaemia, unspecified
18.4
7.6
11
6
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
18.4
7.6
11
6
L95.8
ICD-10 Finland
Other vasculitis limited to skin
8.0
7.6
16
20
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
25.1
7.6
10
*
AA1
HP
Conventional CABG
2.2
7.5
58
262
N30.0
ICD-10 Finland
Acute cystitis
1.4
7.5
412
3127
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
6.2
7.5
19
31
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
3.8
7.5
22
58
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.7
7.5
129
768
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.4
544
4310
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
7.4
107
605
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
7.4
70
343
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.8
7.4
35
125
M05BX04
ATC
denosumab; parenteral
1.6
7.4
159
1002
I85
ICD-10 Finland
Oesophageal varices
80.3
7.4
8
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
3.5
7.4
24
68
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.2
7.4
60
277
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
7.4
474
3685
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
3.4
7.4
25
73
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.4
7.4
304
2199
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
7.7
7.4
16
21
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
7.4
657
5346
ZXA00
NOMESCO Finland
Right side
1.3
7.4
670
5466
S16
ICPC
Bruise/contusion
1.9
7.4
84
441
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.6
7.3
41
160
J47
ICD-10 Finland
Bronchiectasis
2.3
7.3
55
246
E87.6
ICD-10 Finland
Hypokalaemia
1.8
7.3
96
528
28799
ICD-8 Finland
Purpura and other haemorrhagic conditions, Other and unspecified
+∞
7.3
7
*
B72
ICPC
Hodgkin Lymphoma
10.9
7.3
13
12
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
7.3
1072
9255
Z00.8
ICD-10 Finland
Other general examinations
1.5
7.3
194
1287
N17.8
ICD-10 Finland
Other acute renal failure
2.6
7.3
40
155
D97
ICPC
Liver disease NOS
4.1
7.3
19
46
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.2
7.3
28
89
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.1
7.2
65
313
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
7.2
212
1438
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.5
7.2
43
174
B83
ICPC
Purpura/coagulation defect
30.1
7.1
9
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.9
7.1
87
467
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
3.4
7.1
25
75
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
4.1
7.1
19
47
Z01.7
ICD-10 Finland
Laboratory examination
1.4
7.1
412
3157
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
7.0
313
2295
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
7.0
179
1175
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
8.8
7.0
14
16
J12.8
ICD-10 Finland
Other viral pneumonia
3.0
7.0
29
96
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
1.9
7.0
80
420
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.2
7.0
59
277
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.6
7.0
164
1057
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
7.0
7.0
16
23
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
7.0
629
5122
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.0
7.0
74
379
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.3
7.0
48
207
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.6
7.0
37
141
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.0
7.0
69
345
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.9
7.0
86
464
A11CC03
ATC
alfacalcidol; systemic
2.0
6.9
68
339
D70.81
ICD-10 Finland
Neutropenia congenital
13.8
6.9
11
8
A02BA03
ATC
famotidine; systemic
1.8
6.9
95
531
WF003
NOMESCO Finland
Adjuvant radiotherapy
1.9
6.9
84
452
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
1.7
6.9
121
726
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
10.9
6.8
12
11
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
2.4
6.8
45
191
L01XX52
ATC
venetoclax; oral
9.3
6.8
13
14
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
6.1
6.8
17
28
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.1
6.8
63
308
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
6.8
217
1498
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
6.7
411
3170
A07AA02
ATC
nystatin; oral
1.6
6.7
141
885
C07AA05
ATC
propranolol; systemic
1.3
6.7
461
3619
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.7
348
2619
O28.0
ICD-10 Finland
Abnormal haematological finding on antenatal screening of mother
22.6
6.7
9
*
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
2.4
6.6
45
193
JAH01
NOMESCO Finland
Laparoscopy
1.8
6.6
99
567
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.2
6.6
50
225
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
1.7
6.6
107
628
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.2
6.6
55
258
C08CA05
ATC
nifedipine; systemic
1.6
6.6
152
977
K83.0
ICD-10 Finland
Cholangitis
2.3
6.6
45
194
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.6
6.5
134
836
RK110, ,
NOMESCO Finland
3.4
6.5
23
69
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
3.0
6.5
28
95
SPAT1229
SPAT
Assessment of need for aid
1.5
6.5
193
1310
RD210, ,
NOMESCO Finland
2.2
6.5
49
220
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.5
6.5
40
164
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
6.5
131
815
R05
ICD-10 Finland
Cough
1.3
6.5
536
4314
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.1
6.5
26
85
C83.71
ICD-10 Finland
Burkitt's tumour
70.0
6.4
7
*
D59.5
ICD-10 Finland
Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
70.0
6.4
7
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
3.4
6.4
22
65
N05BA06
ATC
lorazepam; systemic, sublingual
1.6
6.4
130
810
B81
ICPC
Anaemia vit B12/folate deficiency
1.7
6.4
100
581
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.4
6.4
42
178
SPAT1260
SPAT
Consultation of another employee
1.3
6.4
427
3339
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
6.4
262
1896
SPAT1211
SPAT
Application of soft bandage
1.5
6.3
218
1529
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
2.5
6.3
37
149
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
18.0
6.3
9
5
D65
ICD-10 Finland
Disseminated intravascular coagulation [defibrination syndrome]
+∞
6.2
6
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
26.7
6.2
8
*
D02AX
ATC
Other emollients and protectives
1.9
6.2
74
395
J96.0
ICD-10 Finland
Acute respiratory failure
2.4
6.2
40
168
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.6
6.2
35
138
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.6
6.2
130
817
XX9XE
NOMESCO Finland
Other ultrasound examination
3.1
6.2
24
77
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.3
6.2
42
181
L01BA01
ATC
methotrexate; systemic
1.8
6.1
84
469
WF099
NOMESCO Finland
Other radiotherapy
3.4
6.1
21
62
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.7
6.1
113
687
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
2.8
6.1
28
99
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.7
6.1
31
116
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
1.6
6.1
138
884
R4180
NOMESCO Finland
Podiatric therapy
2.4
6.0
38
158
M32
ICD-10 Finland
Systemic lupus erythematosus
10.0
6.0
11
11
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.4
6.0
225
1600
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
1.9
6.0
70
371
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.5
6.0
37
152
RS220, ,
NOMESCO Finland
2.5
6.0
37
152
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
1.9
6.0
67
350
J94.8
ICD-10 Finland
Other specified pleural conditions
2.2
6.0
45
202
A04
ICPC
Weakness/tiredness general
1.3
6.0
405
3169
H26.3
ICD-10 Finland
Drug-induced cataract
3.5
6.0
20
58
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
5.2
6.0
17
33

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Thrombocytopenia, unspecified
D69.6 [45581327]
4.0e+00
5.3e+00
1.0e+50
1.0e+50
1.0e+50
8.0e+00
6.6e+00
cases:1.30%
controls:0.02%
cases:3.38%
controls:0.02%
cases:3.93%
controls:0.00%
cases:96.45%
controls:0.00%
cases:36.15%
controls:0.00%
cases:38.27%
controls:0.02%
cases:20.72%
controls:0.04%
38
7
2884
29140
99
5
2828
29187
115
0
2812
29192
2823
0
104
29192
1034
0
1826
29105
966
6
1558
27941
393
8
1504
22769
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
1.2e+00
2.2e+00
4.2e+00
6.1e+00
5.0e+00
2.8e+00
1.6e+00
cases:7.39%
controls:2.43%
cases:10.18%
controls:1.24%
cases:9.26%
controls:0.15%
cases:6.97%
controls:0.02%
cases:14.41%
controls:0.11%
cases:15.21%
controls:1.12%
cases:15.29%
controls:3.45%
216
707
2706
28440
298
362
2629
28830
271
44
2656
29148
204
5
2723
29187
412
32
2448
29073
384
312
2140
27635
290
785
1607
21992
Diffuse lymphoma with large B cells
C83.31 [2000501224]
2.1e+00
3.6e+00
4.6e+00
—
5.1e+00
4.0e+00
3.6e+00
cases:1.27%
controls:0.15%
cases:3.59%
controls:0.10%
cases:3.96%
controls:0.04%
—
—
cases:4.41%
controls:0.03%
cases:4.68%
controls:0.09%
cases:4.43%
controls:0.13%
37
44
2885
29103
105
30
2822
29162
116
12
2811
29180
—
126
8
2734
29097
118
25
2406
27922
84
30
1813
22747
Simple antiboidy therapy of methastized malignancy
WD405 [2001310688]
2.2e+00
3.5e+00
4.2e+00
1.0e+50
4.4e+00
3.5e+00
2.8e+00
cases:1.54%
controls:0.17%
cases:4.10%
controls:0.13%
cases:3.55%
controls:0.05%
cases:0.68%
controls:0.00%
cases:3.22%
controls:0.04%
cases:4.91%
controls:0.15%
cases:3.22%
controls:0.20%
45
49
2877
29098
120
38
2807
29154
104
16
2823
29176
20
0
2907
29192
92
12
2768
29093
124
42
2400
27905
61
45
1836
22732
filgrastim; parenteral
L03AA02 [21603851]
1.9e+00
3.3e+00
4.6e+00
—
3.8e+00
4.0e+00
2.8e+00
cases:1.47%
controls:0.23%
cases:2.87%
controls:0.11%
cases:2.29%
controls:0.02%
—
—
cases:1.36%
controls:0.03%
cases:4.64%
controls:0.09%
cases:2.37%
controls:0.14%
43
67
2879
29080
84
31
2843
29161
67
7
2860
29185
—
39
9
2821
29096
117
24
2407
27923
45
32
1852
22745
Reticulocyte production index
31111-8 [3000012]
1.9e+00
3.0e+00
4.7e+00
1.0e+50
5.0e+00
3.4e+00
1.9e+00
cases:1.44%
controls:0.23%
cases:2.66%
controls:0.13%
cases:1.78%
controls:0.02%
cases:1.33%
controls:0.00%
cases:2.52%
controls:0.02%
cases:3.61%
controls:0.13%
cases:2.90%
controls:0.44%
42
66
2880
29081
78
39
2849
29153
52
5
2875
29187
39
0
2888
29192
72
5
2788
29100
91
36
2433
27911
55
101
1842
22676
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
2.6e+00
3.6e+00
4.2e+00
—
4.3e+00
3.4e+00
1.6e+00
cases:2.81%
controls:0.21%
cases:6.66%
controls:0.19%
cases:5.26%
controls:0.09%
—
—
cases:4.83%
controls:0.07%
cases:6.14%
controls:0.21%
cases:1.63%
controls:0.35%
82
62
2840
29085
195
56
2732
29136
154
25
2773
29167
—
138
21
2722
29084
155
59
2369
27888
31
79
1866
22698
Hematology
82 [38004501]
1.8e+00
2.3e+00
3.4e+00
—
4.8e+00
4.1e+00
3.1e+00
cases:5.75%
controls:1.03%
cases:7.07%
controls:0.73%
cases:6.15%
controls:0.22%
—
—
cases:21.78%
controls:0.22%
cases:29.52%
controls:0.72%
cases:23.51%
controls:1.31%
168
300
2754
28847
207
214
2720
28978
180
64
2747
29128
—
623
64
2237
29041
745
202
1779
27745
446
299
1451
22478
pegfilgrastim; parenteral
L03AA13 [21603856]
2.1e+00
3.4e+00
4.5e+00
—
4.1e+00
3.0e+00
1.4e+00
cases:2.26%
controls:0.28%
cases:4.34%
controls:0.15%
cases:3.35%
controls:0.04%
—
—
cases:2.13%
controls:0.04%
cases:3.01%
controls:0.16%
cases:1.21%
controls:0.29%
66
81
2856
29066
127
43
2800
29149
98
11
2829
29181
—
61
11
2799
29094
76
44
2448
27903
23
66
1874
22711
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
1.7e+00
2.8e+00
3.9e+00
1.0e+50
4.9e+00
3.3e+00
1.9e+00
cases:1.47%
controls:0.28%
cases:2.19%
controls:0.13%
cases:1.81%
controls:0.04%
cases:1.47%
controls:0.00%
cases:3.85%
controls:0.03%
cases:3.92%
controls:0.15%
cases:2.69%
controls:0.42%
43
83
2879
29064
64
39
2863
29153
53
11
2874
29181
43
0
2884
29192
110
9
2750
29096
99
43
2425
27904
51
96
1846
22681
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.7e+00
2.8e+00
3.5e+00
1.0e+50
4.9e+00
3.2e+00
2.0e+00
cases:1.30%
controls:0.24%
cases:1.88%
controls:0.11%
cases:1.02%
controls:0.03%
cases:0.44%
controls:0.00%
cases:3.85%
controls:0.03%
cases:3.57%
controls:0.15%
cases:2.64%
controls:0.35%
38
71
2884
29076
55
33
2872
29159
30
9
2897
29183
13
0
2914
29192
110
9
2750
29096
90
43
2434
27904
50
80
1847
22697
Blood transfusion
WW500 [2001310603]
2.0e+00
3.5e+00
5.2e+00
1.0e+50
—
4.4e+00
2.8e+00
cases:1.78%
controls:0.24%
cases:4.10%
controls:0.12%
cases:3.11%
controls:0.02%
cases:8.78%
controls:0.00%
—
—
cases:8.80%
controls:0.12%
cases:4.06%
controls:0.25%
52
70
2870
29077
120
36
2807
29156
91
5
2836
29187
257
0
2670
29192
—
222
34
2302
27913
77
58
1820
22719
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.5e+00
2.7e+00
3.3e+00
1.0e+50
4.9e+00
3.2e+00
2.3e+00
cases:1.61%
controls:0.37%
cases:2.43%
controls:0.16%
cases:1.54%
controls:0.06%
cases:0.44%
controls:0.00%
cases:4.93%
controls:0.04%
cases:5.35%
controls:0.23%
cases:4.27%
controls:0.47%
47
108
2875
29039
71
47
2856
29145
45
17
2882
29175
13
0
2914
29192
141
11
2719
29094
135
63
2389
27884
81
106
1816
22671
lipegfilgrastim; parenteral
L03AA14 [43534819]
1.8e+00
3.8e+00
4.9e+00
—
—
4.7e+00
2.7e+00
cases:0.89%
controls:0.15%
cases:2.84%
controls:0.07%
cases:2.77%
controls:0.02%
—
—
—
—
cases:2.61%
controls:0.03%
cases:0.63%
controls:0.04%
26
44
2896
29103
83
19
2844
29173
81
6
2846
29186
—
—
66
7
2458
27940
12
10
1885
22767
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
1.4e+00
3.1e+00
3.7e+00
—
4.1e+00
3.4e+00
2.1e+00
cases:2.53%
controls:0.62%
cases:4.75%
controls:0.23%
cases:2.60%
controls:0.07%
—
—
cases:2.83%
controls:0.05%
cases:8.20%
controls:0.30%
cases:5.75%
controls:0.73%
74
181
2848
28966
139
68
2788
29124
76
20
2851
29172
—
81
14
2779
29091
207
83
2317
27864
109
166
1788
22611
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
1.3e+00
2.6e+00
3.9e+00
—
4.5e+00
2.9e+00
2.5e+00
cases:2.12%
controls:0.56%
cases:2.02%
controls:0.16%
cases:1.50%
controls:0.03%
—
—
cases:1.54%
controls:0.02%
cases:2.50%
controls:0.14%
cases:3.06%
controls:0.25%
62
164
2860
28983
59
46
2868
29146
44
9
2883
29183
—
44
5
2816
29100
63
39
2461
27908
58
58
1839
22719
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.3e+00
2.3e+00
4.3e+00
—
5.2e+00
2.8e+00
1.6e+00
cases:5.37%
controls:1.56%
cases:8.10%
controls:0.91%
cases:7.14%
controls:0.10%
—
—
cases:11.71%
controls:0.08%
cases:12.76%
controls:0.86%
cases:12.18%
controls:2.70%
157
456
2765
28691
237
267
2690
28925
209
29
2718
29163
—
335
22
2525
29083
322
241
2202
27706
231
615
1666
22162
Follicular lymphoma grade II
C82.1 [45532946]
2.5e+00
2.6e+00
3.5e+00
1.0e+50
3.4e+00
2.8e+00
2.7e+00
cases:0.79%
controls:0.07%
cases:0.82%
controls:0.06%
cases:0.75%
controls:0.02%
cases:0.55%
controls:0.00%
cases:0.73%
controls:0.02%
cases:0.91%
controls:0.05%
cases:1.05%
controls:0.07%
23
19
2899
29128
24
18
2903
29174
22
7
2905
29185
16
0
2911
29192
21
7
2839
29098
23
15
2501
27932
20
17
1877
22760
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
1.3e+00
2.6e+00
4.7e+00
1.0e+50
4.9e+00
2.4e+00
1.6e+00
cases:3.94%
controls:1.15%
cases:5.47%
controls:0.44%
cases:3.21%
controls:0.03%
cases:0.65%
controls:0.00%
cases:4.48%
controls:0.03%
cases:4.83%
controls:0.44%
cases:5.75%
controls:1.22%
115
334
2807
28813
160
129
2767
29063
94
9
2833
29183
19
0
2908
29192
128
10
2732
29095
122
122
2402
27825
109
279
1788
22498
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
1.4e+00
2.6e+00
3.5e+00
1.0e+50
4.8e+00
3.1e+00
2.1e+00
cases:1.27%
controls:0.33%
cases:1.74%
controls:0.13%
cases:0.79%
controls:0.02%
cases:0.41%
controls:0.00%
cases:2.06%
controls:0.02%
cases:3.33%
controls:0.16%
cases:2.69%
controls:0.35%
37
96
2885
29051
51
38
2876
29154
23
7
2904
29185
12
0
2915
29192
59
5
2801
29100
84
45
2440
27902
51
80
1846
22697
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
1.4e+00
2.5e+00
4.0e+00
—
4.7e+00
2.8e+00
1.8e+00
cases:3.94%
controls:1.01%
cases:4.95%
controls:0.42%
cases:3.93%
controls:0.07%
—
—
cases:4.86%
controls:0.04%
cases:6.62%
controls:0.42%
cases:7.54%
controls:1.31%
115
294
2807
28853
145
123
2782
29069
115
21
2812
29171
—
139
13
2721
29092
167
117
2357
27830
143
298
1754
22479
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 [3030692]
1.6e+00
2.6e+00
3.2e+00
1.0e+50
4.3e+00
3.1e+00
2.4e+00
cases:1.16%
controls:0.24%
cases:1.37%
controls:0.10%
cases:0.61%
controls:0.02%
cases:0.34%
controls:0.00%
cases:1.22%
controls:0.02%
cases:2.50%
controls:0.11%
cases:2.06%
controls:0.19%
34
69
2888
29078
40
29
2887
29163
18
7
2909
29185
10
0
2917
29192
35
5
2825
29100
63
31
2461
27916
39
43
1858
22734
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
8.9e-01
1.7e+00
2.9e+00
5.3e+00
3.3e+00
1.9e+00
1.1e+00
cases:10.54%
controls:4.62%
cases:13.05%
controls:2.64%
cases:9.12%
controls:0.54%
cases:5.36%
controls:0.03%
cases:10.70%
controls:0.44%
cases:16.09%
controls:2.70%
cases:18.45%
controls:6.75%
308
1346
2614
27801
382
772
2545
28420
267
158
2660
29034
157
8
2770
29184
306
127
2554
28978
406
754
2118
27193
350
1538
1547
21239
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]
1.5e+00
2.5e+00
3.6e+00
1.0e+50
4.2e+00
3.2e+00
2.2e+00
cases:0.96%
controls:0.21%
cases:1.20%
controls:0.10%
cases:0.65%
controls:0.02%
cases:0.31%
controls:0.00%
cases:1.33%
controls:0.02%
cases:2.69%
controls:0.11%
cases:2.27%
controls:0.26%
28
61
2894
29086
35
30
2892
29162
19
5
2908
29187
9
0
2918
29192
38
6
2822
29099
68
31
2456
27916
43
59
1854
22718
Differential panel, method unspecified - Blood
69738-3 [42870588]
8.5e-01
1.6e+00
2.9e+00
5.3e+00
3.4e+00
1.9e+00
1.2e+00
cases:17.25%
controls:8.14%
cases:19.95%
controls:4.81%
cases:15.48%
controls:0.98%
cases:10.35%
controls:0.06%
cases:20.73%
controls:0.86%
cases:26.19%
controls:4.98%
cases:28.10%
controls:10.27%
504
2374
2418
26773
584
1403
2343
27789
453
285
2474
28907
303
17
2624
29175
593
249
2267
28856
661
1391
1863
26556
533
2340
1364
20437
Internal Medicine
11 [38004456]
5.2e-01
1.1e+00
2.2e+00
7.1e+00
3.1e+00
1.9e+00
1.1e+00
cases:32.61%
controls:22.40%
cases:22.62%
controls:8.92%
cases:11.72%
controls:1.40%
cases:42.88%
controls:0.06%
cases:25.00%
controls:1.43%
cases:39.03%
controls:8.97%
cases:43.28%
controls:20.81%
953
6528
1969
22619
662
2603
2265
26589
343
408
2584
28784
1255
18
1672
29174
715
415
2145
28690
985
2507
1539
25440
821
4739
1076
18038
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
1.3e+00
2.4e+00
3.6e+00
1.0e+50
4.7e+00
3.0e+00
1.9e+00
cases:1.47%
controls:0.43%
cases:1.88%
controls:0.17%
cases:0.96%
controls:0.03%
cases:0.41%
controls:0.00%
cases:2.31%
controls:0.02%
cases:3.84%
controls:0.19%
cases:3.53%
controls:0.52%
43
124
2879
29023
55
51
2872
29141
28
8
2899
29184
12
0
2915
29192
66
6
2794
29099
97
54
2427
27893
67
119
1830
22658
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
1.1e+00
1.8e+00
3.4e+00
1.0e+50
5.1e+00
3.3e+00
2.3e+00
cases:1.57%
controls:0.54%
cases:1.57%
controls:0.27%
cases:1.26%
controls:0.04%
cases:1.37%
controls:0.00%
cases:4.30%
controls:0.03%
cases:4.16%
controls:0.16%
cases:4.43%
controls:0.47%
46
157
2876
28990
46
79
2881
29113
37
13
2890
29179
40
0
2887
29192
123
8
2737
29097
105
46
2419
27901
84
106
1813
22671
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
1.3e+00
2.4e+00
3.6e+00
1.0e+50
4.8e+00
2.9e+00
1.9e+00
cases:1.47%
controls:0.41%
cases:1.88%
controls:0.17%
cases:0.96%
controls:0.03%
cases:0.48%
controls:0.00%
cases:2.45%
controls:0.02%
cases:3.76%
controls:0.22%
cases:3.64%
controls:0.58%
43
119
2879
29028
55
51
2872
29141
28
8
2899
29184
14
0
2913
29192
70
6
2790
29099
95
61
2429
27886
69
133
1828
22644
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
1.0e+00
2.3e+00
3.4e+00
1.0e+50
5.0e+00
3.2e+00
1.9e+00
cases:0.99%
controls:0.36%
cases:1.40%
controls:0.14%
cases:0.72%
controls:0.02%
cases:0.20%
controls:0.00%
cases:2.41%
controls:0.02%
cases:2.42%
controls:0.10%
cases:1.90%
controls:0.30%
29
106
2893
29041
41
42
2886
29150
21
7
2906
29185
6
0
2921
29192
69
5
2791
29100
61
27
2463
27920
36
69
1861
22708
Leukocyte morphology finding [Identifier] in Blood
11156-7 [3008757]
1.6e+00
2.3e+00
3.4e+00
1.0e+50
4.7e+00
3.0e+00
1.9e+00
cases:1.06%
controls:0.23%
cases:0.96%
controls:0.10%
cases:0.68%
controls:0.02%
cases:0.75%
controls:0.00%
cases:2.13%
controls:0.02%
cases:2.26%
controls:0.12%
cases:1.63%
controls:0.24%
31
66
2891
29081
28
29
2899
29163
20
7
2907
29185
22
0
2905
29192
61
6
2799
29099
57
33
2467
27914
31
55
1866
22722
Monocytes/Leukocytes in Blood
26485-3 [3019069]
7.4e-01
1.5e+00
2.8e+00
5.2e+00
3.4e+00
1.9e+00
1.2e+00
cases:21.70%
controls:11.66%
cases:25.18%
controls:6.82%
cases:19.41%
controls:1.38%
cases:12.23%
controls:0.08%
cases:25.49%
controls:1.15%
cases:32.61%
controls:7.05%
cases:36.48%
controls:15.16%
634
3399
2288
25748
737
1991
2190
27201
568
403
2359
28789
358
23
2569
29169
729
334
2131
28771
823
1971
1701
25976
692
3453
1205
19324
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
6.2e-01
1.7e+00
3.3e+00
4.2e+00
3.9e+00
2.0e+00
9.7e-01
cases:6.50%
controls:3.60%
cases:6.08%
controls:1.23%
cases:4.07%
controls:0.16%
cases:1.16%
controls:0.02%
cases:5.24%
controls:0.11%
cases:7.81%
controls:1.16%
cases:11.39%
controls:4.63%
190
1050
2732
28097
178
358
2749
28834
119
47
2808
29145
34
5
2893
29187
150
32
2710
29073
197
324
2327
27623
216
1054
1681
21723
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
7.1e-01
1.5e+00
2.9e+00
5.2e+00
3.4e+00
1.8e+00
1.1e+00
cases:21.70%
controls:12.02%
cases:25.42%
controls:7.01%
cases:19.68%
controls:1.39%
cases:12.37%
controls:0.08%
cases:25.66%
controls:1.16%
cases:32.69%
controls:7.24%
cases:36.43%
controls:15.71%
634
3504
2288
25643
744
2045
2183
27147
576
407
2351
28785
362
22
2565
29170
734
339
2126
28766
825
2023
1699
25924
691
3578
1206
19199
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
7.3e-01
1.5e+00
2.8e+00
5.2e+00
3.4e+00
1.9e+00
1.2e+00
cases:21.49%
controls:11.63%
cases:25.18%
controls:6.82%
cases:19.23%
controls:1.38%
cases:11.99%
controls:0.08%
cases:25.28%
controls:1.15%
cases:32.53%
controls:7.04%
cases:36.37%
controls:15.14%
628
3391
2294
25756
737
1990
2190
27202
563
403
2364
28789
351
23
2576
29169
723
336
2137
28769
821
1967
1703
25980
690
3448
1207
19329
Basophils/Leukocytes in Blood
30180-4 [3022096]
7.3e-01
1.5e+00
2.8e+00
5.1e+00
3.4e+00
1.8e+00
1.2e+00
cases:21.32%
controls:11.58%
cases:24.97%
controls:6.81%
cases:19.03%
controls:1.38%
cases:11.96%
controls:0.08%
cases:25.03%
controls:1.16%
cases:32.29%
controls:7.02%
cases:36.32%
controls:15.16%
623
3376
2299
25771
731
1988
2196
27204
557
404
2370
28788
350
23
2577
29169
716
337
2144
28768
815
1963
1709
25984
689
3454
1208
19323
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
9.7e-01
2.2e+00
3.2e+00
1.0e+50
5.1e+00
3.1e+00
1.9e+00
cases:0.96%
controls:0.36%
cases:1.23%
controls:0.14%
cases:0.58%
controls:0.02%
cases:0.27%
controls:0.00%
cases:2.62%
controls:0.02%
cases:2.30%
controls:0.10%
cases:1.85%
controls:0.29%
28
106
2894
29041
36
42
2891
29150
17
7
2910
29185
8
0
2919
29192
75
5
2785
29100
58
29
2466
27918
35
66
1862
22711
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
1.7e+00
3.0e+00
4.2e+00
—
3.2e+00
2.5e+00
1.5e+00
cases:2.81%
controls:0.50%
cases:5.43%
controls:0.28%
cases:2.08%
controls:0.03%
—
—
cases:1.01%
controls:0.04%
cases:2.89%
controls:0.23%
cases:1.85%
controls:0.41%
82
146
2840
29001
159
82
2768
29110
61
9
2866
29183
—
29
12
2831
29093
73
65
2451
27882
35
93
1862
22684
Medical Oncology
90 [38004507]
8.0e-01
1.8e+00
2.7e+00
4.9e+00
2.7e+00
1.9e+00
1.3e+00
cases:9.34%
controls:4.42%
cases:16.06%
controls:3.04%
cases:14.59%
controls:1.11%
cases:11.89%
controls:0.10%
cases:14.09%
controls:1.07%
cases:17.04%
controls:2.92%
cases:15.55%
controls:4.72%
273
1287
2649
27860
470
888
2457
28304
427
324
2500
28868
348
28
2579
29164
403
310
2457
28795
430
816
2094
27131
295
1075
1602
21702
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 [21493690]
1.7e+00
3.3e+00
3.2e+00
—
1.0e+50
4.4e+00
3.6e+00
cases:0.72%
controls:0.13%
cases:1.33%
controls:0.05%
cases:0.41%
controls:0.02%
—
—
cases:0.52%
controls:0.00%
cases:3.49%
controls:0.05%
cases:3.85%
controls:0.11%
21
38
2901
29109
39
14
2888
29178
12
5
2915
29187
—
15
0
2845
29105
88
13
2436
27934
73
25
1824
22752
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
1.2e+00
1.9e+00
4.1e+00
—
5.0e+00
2.4e+00
1.6e+00
cases:2.87%
controls:0.91%
cases:3.31%
controls:0.49%
cases:2.87%
controls:0.05%
—
—
cases:5.77%
controls:0.04%
cases:4.36%
controls:0.41%
cases:6.06%
controls:1.34%
84
265
2838
28882
97
144
2830
29048
84
15
2843
29177
—
165
12
2695
29093
110
114
2414
27833
115
305
1782
22472
Cystostatic therapy of methastized malignancy
WD105 [2001310678]
2.0e+00
2.8e+00
3.3e+00
—
2.9e+00
3.0e+00
2.0e+00
cases:1.98%
controls:0.27%
cases:3.62%
controls:0.22%
cases:2.49%
controls:0.09%
—
—
cases:1.61%
controls:0.09%
cases:4.00%
controls:0.20%
cases:2.37%
controls:0.34%
58
79
2864
29068
106
65
2821
29127
73
27
2854
29165
—
46
25
2814
29080
101
57
2423
27890
45
78
1852
22699
Multidisciplinary treatment meeting
WZC20 [2001310890]
1.2e+00
2.6e+00
3.9e+00
1.0e+50
3.9e+00
2.6e+00
1.7e+00
cases:1.95%
controls:0.58%
cases:3.59%
controls:0.28%
cases:1.50%
controls:0.03%
cases:0.34%
controls:0.00%
cases:1.36%
controls:0.03%
cases:3.61%
controls:0.26%
cases:2.74%
controls:0.49%
57
168
2865
28979
105
81
2822
29111
44
9
2883
29183
10
0
2917
29192
39
8
2821
29097
91
74
2433
27873
52
112
1845
22665
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
1.3e+00
2.3e+00
3.7e+00
—
4.1e+00
2.6e+00
2.0e+00
cases:5.00%
controls:1.42%
cases:6.56%
controls:0.69%
cases:4.24%
controls:0.11%
—
—
cases:5.59%
controls:0.10%
cases:8.99%
controls:0.71%
cases:11.39%
controls:1.75%
146
413
2776
28734
192
202
2735
28990
124
33
2803
29159
—
160
28
2700
29077
227
198
2297
27749
216
399
1681
22378
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
5.6e-01
1.4e+00
2.7e+00
5.3e+00
3.1e+00
1.8e+00
9.6e-01
cases:20.05%
controls:12.56%
cases:23.51%
controls:7.02%
cases:19.13%
controls:1.49%
cases:10.73%
controls:0.06%
cases:23.92%
controls:1.35%
cases:30.82%
controls:6.70%
cases:33.53%
controls:16.20%
586
3660
2336
25487
688
2050
2239
27142
560
436
2367
28756
314
17
2613
29175
684
393
2176
28712
778
1873
1746
26074
636
3691
1261
19086
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
6.6e-01
1.4e+00
2.7e+00
5.1e+00
3.2e+00
1.7e+00
1.1e+00
cases:20.50%
controls:11.73%
cases:23.40%
controls:6.81%
cases:17.12%
controls:1.33%
cases:10.56%
controls:0.08%
cases:22.34%
controls:1.15%
cases:30.55%
controls:7.10%
cases:35.58%
controls:15.29%
599
3418
2323
25729
685
1989
2242
27203
501
388
2426
28804
309
22
2618
29170
639
334
2221
28771
771
1985
1753
25962
675
3483
1222
19294
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
1.3e+00
2.2e+00
3.6e+00
—
4.3e+00
2.7e+00
1.9e+00
cases:7.80%
controls:2.36%
cases:11.14%
controls:1.37%
cases:9.09%
controls:0.28%
—
—
cases:12.87%
controls:0.20%
cases:16.84%
controls:1.30%
cases:18.24%
controls:3.24%
228
687
2694
28460
326
401
2601
28791
266
81
2661
29111
—
368
59
2492
29046
425
362
2099
27585
346
737
1551
22040
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
6.1e-01
1.4e+00
2.7e+00
5.3e+00
3.0e+00
1.8e+00
1.0e+00
cases:23.82%
controls:14.58%
cases:29.31%
controls:9.01%
cases:25.56%
controls:2.24%
cases:18.93%
controls:0.12%
cases:29.83%
controls:2.00%
cases:37.12%
controls:9.08%
cases:39.85%
controls:18.90%
696
4249
2226
24898
858
2630
2069
26562
748
655
2179
28537
554
34
2373
29158
853
582
2007
28523
937
2537
1587
25410
756
4305
1141
18472
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
1.0e+00
2.2e+00
3.6e+00
1.0e+50
4.8e+00
2.8e+00
1.5e+00
cases:1.30%
controls:0.48%
cases:1.50%
controls:0.17%
cases:0.61%
controls:0.02%
cases:0.38%
controls:0.00%
cases:2.52%
controls:0.02%
cases:2.26%
controls:0.14%
cases:2.16%
controls:0.51%
38
140
2884
29007
44
50
2883
29142
18
5
2909
29187
11
0
2916
29192
72
6
2788
29099
57
38
2467
27909
41
117
1856
22660
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
1.1e+00
2.2e+00
4.3e+00
1.0e+50
4.6e+00
2.3e+00
1.4e+00
cases:5.51%
controls:1.94%
cases:6.35%
controls:0.73%
cases:4.24%
controls:0.06%
cases:0.96%
controls:0.00%
cases:5.91%
controls:0.07%
cases:6.46%
controls:0.68%
cases:8.01%
controls:2.09%
161
566
2761
28581
186
213
2741
28979
124
18
2803
29174
28
0
2899
29192
169
19
2691
29086
163
189
2361
27758
152
477
1745
22300
CD3 cells/Lymphocytes in Blood
90304-7 [1175426]
1.7e+00
3.1e+00
3.2e+00
—
—
4.4e+00
3.6e+00
cases:0.72%
controls:0.13%
cases:1.37%
controls:0.07%
cases:0.41%
controls:0.02%
—
—
—
—
cases:3.49%
controls:0.05%
cases:4.01%
controls:0.12%
21
39
2901
29108
40
19
2887
29173
12
5
2915
29187
—
—
88
13
2436
27934
76
27
1821
22750
Monocytes [#/volume] in Blood
26484-6 [3001604]
6.7e-01
1.5e+00
2.7e+00
5.0e+00
3.1e+00
1.8e+00
1.1e+00
cases:21.46%
controls:12.26%
cases:25.59%
controls:7.38%
cases:18.41%
controls:1.47%
cases:10.45%
controls:0.08%
cases:22.10%
controls:1.25%
cases:33.20%
controls:7.54%
cases:37.64%
controls:16.58%
627
3573
2295
25574
749
2154
2178
27038
539
429
2388
28763
306
24
2621
29168
632
364
2228
28741
838
2107
1686
25840
714
3776
1183
19001
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
6.5e-01
1.4e+00
2.7e+00
5.0e+00
3.1e+00
1.8e+00
1.1e+00
cases:21.94%
controls:12.81%
cases:25.76%
controls:7.62%
cases:19.00%
controls:1.51%
cases:10.93%
controls:0.08%
cases:22.90%
controls:1.27%
cases:33.60%
controls:7.78%
cases:37.69%
controls:17.07%
641
3735
2281
25412
754
2224
2173
26968
556
440
2371
28752
320
24
2607
29168
655
370
2205
28735
848
2175
1676
25772
715
3887
1182
18890
Basophils [#/volume] in Blood
26444-0 [3006315]
6.7e-01
1.5e+00
2.7e+00
5.0e+00
3.1e+00
1.8e+00
1.1e+00
cases:21.49%
controls:12.31%
cases:25.62%
controls:7.40%
cases:18.28%
controls:1.48%
cases:10.52%
controls:0.08%
cases:22.06%
controls:1.25%
cases:33.28%
controls:7.58%
cases:37.69%
controls:16.66%
628
3588
2294
25559
750
2159
2177
27033
535
431
2392
28761
308
24
2619
29168
631
364
2229
28741
840
2117
1684
25830
715
3794
1182
18983
Eosinophils [#/volume] in Blood
26449-9 [3013115]
6.6e-01
1.5e+00
2.7e+00
5.0e+00
3.1e+00
1.8e+00
1.1e+00
cases:22.18%
controls:12.87%
cases:26.38%
controls:7.67%
cases:19.10%
controls:1.57%
cases:11.48%
controls:0.09%
cases:23.29%
controls:1.34%
cases:34.03%
controls:7.85%
cases:38.22%
controls:17.23%
648
3751
2274
25396
772
2238
2155
26954
559
459
2368
28733
336
26
2591
29166
666
390
2194
28715
859
2194
1665
25753
725
3924
1172
18853
Demanding antibody therapy of methastized malignancy
WD415 [2001310689]
2.2e+00
3.3e+00
3.9e+00
—
—
4.0e+00
2.4e+00
cases:1.06%
controls:0.12%
cases:1.98%
controls:0.07%
cases:1.13%
controls:0.02%
—
—
—
—
cases:2.22%
controls:0.04%
cases:1.05%
controls:0.10%
31
34
2891
29113
58
21
2869
29171
33
7
2894
29185
—
—
56
12
2468
27935
20
22
1877
22755
Thorax X-ray examination
GD1AA [2001303617]
5.5e-01
1.3e+00
2.4e+00
6.0e+00
2.7e+00
1.6e+00
9.6e-01
cases:16.74%
controls:10.40%
cases:13.94%
controls:4.04%
cases:4.95%
controls:0.49%
cases:9.22%
controls:0.02%
cases:5.63%
controls:0.40%
cases:16.72%
controls:3.77%
cases:23.72%
controls:10.66%
489
3031
2433
26116
408
1179
2519
28013
145
144
2782
29048
270
7
2657
29185
161
117
2699
28988
422
1054
2102
26893
450
2429
1447
20348
Anaemia, unspecified
D64.9 [45600610]
1.0e+00
2.2e+00
3.9e+00
—
4.7e+00
2.7e+00
1.2e+00
cases:3.83%
controls:1.44%
cases:5.33%
controls:0.65%
cases:3.62%
controls:0.08%
—
—
cases:7.73%
controls:0.08%
cases:9.55%
controls:0.69%
cases:6.48%
controls:2.15%
112
419
2810
28728
156
189
2771
29003
106
23
2821
29169
—
221
23
2639
29082
241
192
2283
27755
123
489
1774
22288
CD3 cells [#/volume] in Blood
8122-4 [3011412]
1.6e+00
3.0e+00
3.4e+00
—
—
4.1e+00
3.4e+00
cases:1.03%
controls:0.21%
cases:1.47%
controls:0.07%
cases:0.51%
controls:0.02%
—
—
—
—
cases:3.92%
controls:0.07%
cases:4.16%
controls:0.14%
30
61
2892
29086
43
21
2884
29171
15
5
2912
29187
—
—
99
19
2425
27928
79
32
1818
22745
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
4.3e-01
1.2e+00
2.8e+00
5.1e+00
3.2e+00
1.8e+00
1.0e+00
cases:9.21%
controls:6.17%
cases:9.12%
controls:3.06%
cases:5.94%
controls:0.39%
cases:4.13%
controls:0.03%
cases:8.46%
controls:0.38%
cases:13.39%
controls:2.57%
cases:17.34%
controls:6.86%
269
1799
2653
27348
267
894
2660
28298
174
113
2753
29079
121
8
2806
29184
242
112
2618
28993
338
717
2186
27230
329
1563
1568
21214
pH of Serum or Plasma
2753-2 [3018418]
5.9e-01
1.4e+00
2.7e+00
5.1e+00
3.0e+00
1.6e+00
8.8e-01
cases:11.67%
controls:6.83%
cases:14.01%
controls:3.91%
cases:8.30%
controls:0.61%
cases:3.38%
controls:0.02%
cases:11.26%
controls:0.60%
cases:15.41%
controls:3.49%
cases:20.24%
controls:9.50%
341
1991
2581
27156
410
1140
2517
28052
243
179
2684
29013
99
6
2828
29186
322
176
2538
28929
389
976
2135
26971
384
2164
1513
20613
Segmented neutrophils/Leukocytes in Blood
26505-8 [3017354]
1.5e+00
1.8e+00
3.1e+00
1.0e+50
4.4e+00
2.8e+00
1.6e+00
cases:0.72%
controls:0.16%
cases:0.61%
controls:0.11%
cases:0.61%
controls:0.03%
cases:0.96%
controls:0.00%
cases:1.99%
controls:0.02%
cases:1.94%
controls:0.11%
cases:1.32%
controls:0.27%
21
46
2901
29101
18
31
2909
29161
18
8
2909
29184
28
0
2899
29192
57
7
2803
29098
49
32
2475
27915
25
62
1872
22715
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
1.1e+00
1.4e+00
2.9e+00
1.0e+50
4.7e+00
3.0e+00
2.0e+00
cases:1.54%
controls:0.50%
cases:0.99%
controls:0.25%
cases:0.61%
controls:0.03%
cases:0.65%
controls:0.00%
cases:2.62%
controls:0.02%
cases:2.81%
controls:0.14%
cases:3.11%
controls:0.42%
45
146
2877
29001
29
73
2898
29119
18
10
2909
29182
19
0
2908
29192
75
7
2785
29098
71
40
2453
27907
59
95
1838
22682
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
8.7e-01
1.4e+00
3.1e+00
—
4.7e+00
3.0e+00
2.1e+00
cases:1.40%
controls:0.59%
cases:1.09%
controls:0.26%
cases:0.79%
controls:0.03%
—
—
cases:2.87%
controls:0.03%
cases:3.21%
controls:0.17%
cases:3.48%
controls:0.46%
41
172
2881
28975
32
76
2895
29116
23
10
2904
29182
—
82
8
2778
29097
81
47
2443
27900
66
105
1831
22672
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
1.0e+00
1.6e+00
4.2e+00
—
4.7e+00
2.2e+00
1.4e+00
cases:1.27%
controls:0.46%
cases:0.92%
controls:0.18%
cases:1.13%
controls:0.02%
—
—
cases:1.89%
controls:0.02%
cases:1.74%
controls:0.20%
cases:2.32%
controls:0.58%
37
135
2885
29012
27
53
2900
29139
33
5
2894
29187
—
54
5
2806
29100
44
56
2480
27891
44
131
1853
22646
Drug-induced neutropenia
D70.82 [2000501376]
3.0e+00
4.6e+00
—
1.0e+50
—
4.8e+00
2.6e+00
cases:1.13%
controls:0.05%
cases:2.36%
controls:0.02%
—
—
cases:5.50%
controls:0.00%
—
—
cases:4.48%
controls:0.04%
cases:1.32%
controls:0.10%
33
16
2889
29131
69
7
2858
29185
—
161
0
2766
29192
—
113
11
2411
27936
25
22
1872
22755
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
9.6e-01
2.2e+00
4.1e+00
1.0e+50
4.2e+00
2.3e+00
1.3e+00
cases:6.13%
controls:2.43%
cases:7.58%
controls:0.94%
cases:3.66%
controls:0.07%
cases:0.68%
controls:0.00%
cases:6.22%
controls:0.10%
cases:7.69%
controls:0.85%
cases:9.86%
controls:2.90%
179
708
2743
28439
222
275
2705
28917
107
19
2820
29173
20
0
2907
29192
178
29
2682
29076
194
238
2330
27709
187
661
1710
22116
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20607-8 [3020073]
2.4e+00
4.0e+00
—
—
—
4.8e+00
3.7e+00
cases:0.51%
controls:0.05%
cases:0.96%
controls:0.02%
—
—
—
—
—
—
cases:2.61%
controls:0.02%
cases:2.37%
controls:0.06%
15
14
2907
29133
28
5
2899
29187
—
—
—
66
6
2458
27941
45
14
1852
22763
Simple therapy of methastized malignancy with biomodifiers
WD305 [2001310685]
2.1e+00
2.9e+00
3.6e+00
1.0e+50
—
3.6e+00
2.5e+00
cases:0.68%
controls:0.08%
cases:1.13%
controls:0.06%
cases:0.65%
controls:0.02%
cases:1.20%
controls:0.00%
—
—
cases:2.65%
controls:0.07%
cases:1.21%
controls:0.10%
20
24
2902
29123
33
18
2894
29174
19
5
2908
29187
35
0
2892
29192
—
67
20
2457
27927
23
22
1874
22755
Hemoglobin [Entitic mass] in Reticulocytes
42810-2 [3029080]
2.0e+00
3.0e+00
4.4e+00
1.0e+50
—
3.3e+00
2.0e+00
cases:1.44%
controls:0.20%
cases:2.32%
controls:0.12%
cases:1.98%
controls:0.02%
cases:1.57%
controls:0.00%
—
—
cases:3.17%
controls:0.12%
cases:2.69%
controls:0.36%
42
58
2880
29089
68
34
2859
29158
58
7
2869
29185
46
0
2881
29192
—
80
34
2444
27913
51
82
1846
22695
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
1.8e+00
2.8e+00
2.9e+00
—
—
3.7e+00
3.4e+00
cases:0.99%
controls:0.16%
cases:1.40%
controls:0.09%
cases:0.38%
controls:0.02%
—
—
—
—
cases:3.57%
controls:0.09%
cases:4.06%
controls:0.14%
29
47
2893
29100
41
25
2886
29167
11
6
2916
29186
—
—
90
25
2434
27922
77
32
1820
22745
Inpatient Hospital
21 [8717]
3.3e-01
9.3e-01
2.1e+00
6.5e+00
2.7e+00
1.3e+00
7.8e-01
cases:39.70%
controls:32.22%
cases:22.58%
controls:10.34%
cases:10.73%
controls:1.44%
cases:24.60%
controls:0.05%
cases:16.85%
controls:1.39%
cases:28.61%
controls:9.47%
cases:39.64%
controls:23.12%
1160
9391
1762
19756
661
3018
2266
26174
314
419
2613
28773
720
15
2207
29177
482
405
2378
28700
722
2646
1802
25301
752
5265
1145
17512
Erythropoietin (EPO) [Units/volume] in Serum or Plasma
15061-5 [3024172]
9.5e-01
1.4e+00
3.3e+00
1.0e+50
4.5e+00
2.9e+00
1.5e+00
cases:0.75%
controls:0.29%
cases:0.48%
controls:0.12%
cases:0.48%
controls:0.02%
cases:0.24%
controls:0.00%
cases:1.50%
controls:0.02%
cases:2.30%
controls:0.13%
cases:1.95%
controls:0.46%
22
85
2900
29062
14
36
2913
29156
14
5
2913
29187
7
0
2920
29192
43
5
2817
29100
58
36
2466
27911
37
105
1860
22672
Immunohistochemistry procedure
117617002 [4035726]
1.1e+00
2.4e+00
3.4e+00
—
3.9e+00
2.1e+00
1.5e+00
cases:4.52%
controls:1.57%
cases:6.53%
controls:0.62%
cases:1.71%
controls:0.06%
—
—
cases:2.24%
controls:0.04%
cases:3.76%
controls:0.45%
cases:5.01%
controls:1.18%
132
458
2790
28689
191
182
2736
29010
50
17
2877
29175
—
64
13
2796
29092
95
127
2429
27820
95
268
1802
22509
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
1.3e+00
2.1e+00
3.2e+00
—
4.2e+00
2.3e+00
1.3e+00
cases:4.55%
controls:1.31%
cases:7.28%
controls:0.95%
cases:4.92%
controls:0.20%
—
—
cases:8.85%
controls:0.15%
cases:10.50%
controls:1.14%
cases:9.54%
controls:2.70%
133
381
2789
28766
213
277
2714
28915
144
59
2783
29133
—
253
44
2607
29061
265
318
2259
27629
181
614
1716
22163
Outpatient Hospital
22 [8756]
3.0e-01
9.4e-01
2.1e+00
6.1e+00
2.7e+00
1.4e+00
8.3e-01
cases:31.45%
controls:25.32%
cases:16.71%
controls:7.25%
cases:7.31%
controls:0.94%
cases:11.86%
controls:0.03%
cases:10.45%
controls:0.82%
cases:21.28%
controls:5.96%
cases:32.00%
controls:17.04%
919
7379
2003
21768
489
2115
2438
27077
214
273
2713
28919
347
9
2580
29183
299
238
2561
28867
537
1667
1987
26280
607
3881
1290
18896
CD19 cells/cells in Blood
8117-4 [3016228]
2.4e+00
3.6e+00
—
—
—
4.7e+00
3.6e+00
cases:0.55%
controls:0.05%
cases:1.02%
controls:0.03%
—
—
—
—
—
—
cases:2.73%
controls:0.03%
cases:2.74%
controls:0.08%
16
15
2906
29132
30
8
2897
29184
—
—
—
69
7
2455
27940
52
18
1845
22759
CD8 cells/Lymphocytes in Specimen
80222-3 [21494814]
2.4e+00
3.6e+00
—
—
—
4.7e+00
3.6e+00
cases:0.55%
controls:0.05%
cases:1.02%
controls:0.03%
—
—
—
—
—
—
cases:2.73%
controls:0.03%
cases:2.74%
controls:0.08%
16
15
2906
29132
30
8
2897
29184
—
—
—
69
7
2455
27940
52
18
1845
22759
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
1.3e+00
2.1e+00
3.2e+00
—
4.1e+00
2.3e+00
1.4e+00
cases:3.94%
controls:1.14%
cases:6.42%
controls:0.87%
cases:4.24%
controls:0.18%
—
—
cases:8.18%
controls:0.15%
cases:9.90%
controls:1.07%
cases:9.17%
controls:2.51%
115
331
2807
28816
188
255
2739
28937
124
54
2803
29138
—
234
43
2626
29062
250
300
2274
27647
174
572
1723
22205
Mantle cell lymphoma
C83.1 [45542646]
2.2e+00
3.8e+00
—
1.0e+50
—
4.1e+00
4.2e+00
cases:0.34%
controls:0.04%
cases:1.78%
controls:0.04%
—
—
cases:1.67%
controls:0.00%
—
—
cases:2.02%
controls:0.04%
cases:2.32%
controls:0.04%
10
11
2912
29136
52
12
2875
29180
—
49
0
2878
29192
—
51
10
2473
27937
44
8
1853
22769
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
1.1e+00
2.4e+00
3.6e+00
—
3.8e+00
2.0e+00
1.4e+00
cases:3.97%
controls:1.34%
cases:5.64%
controls:0.57%
cases:3.28%
controls:0.09%
—
—
cases:3.50%
controls:0.08%
cases:3.65%
controls:0.53%
cases:6.38%
controls:1.70%
116
392
2806
28755
165
165
2762
29027
96
26
2831
29166
—
100
23
2760
29082
92
148
2432
27799
121
388
1776
22389
Emergency Room Visit
ER [9203]
3.4e-01
9.8e-01
2.1e+00
6.5e+00
2.2e+00
1.3e+00
8.0e-01
cases:42.61%
controls:34.63%
cases:26.41%
controls:11.87%
cases:11.51%
controls:1.59%
cases:29.52%
controls:0.06%
cases:12.20%
controls:1.47%
cases:31.70%
controls:11.33%
cases:48.50%
controls:29.83%
1245
10094
1677
19053
773
3465
2154
25727
337
463
2590
28729
864
18
2063
29174
349
427
2511
28678
800
3167
1724
24780
920
6794
977
15983
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
4.3e-01
1.2e+00
2.4e+00
5.1e+00
2.9e+00
1.4e+00
7.8e-01
cases:16.56%
controls:11.45%
cases:18.41%
controls:6.45%
cases:10.73%
controls:1.03%
cases:5.64%
controls:0.04%
cases:15.00%
controls:0.96%
cases:20.17%
controls:5.76%
cases:26.62%
controls:14.29%
484
3337
2438
25810
539
1884
2388
27308
314
302
2613
28890
165
11
2762
29181
429
279
2431
28826
509
1610
2015
26337
505
3255
1392
19522
Extensive body CT
JN4BD [2001310899]
1.0e+00
2.2e+00
3.1e+00
—
3.1e+00
2.6e+00
2.1e+00
cases:4.31%
controls:1.56%
cases:4.85%
controls:0.55%
cases:1.33%
controls:0.06%
—
—
cases:1.50%
controls:0.07%
cases:5.63%
controls:0.43%
cases:5.96%
controls:0.76%
126
454
2796
28693
142
162
2785
29030
39
17
2888
29175
—
43
21
2817
29084
142
121
2382
27826
113
173
1784
22604
Bacterial infection, unspecified
A49.9 [45590816]
9.8e-01
2.1e+00
3.5e+00
—
3.9e+00
2.4e+00
1.1e+00
cases:3.11%
controls:1.19%
cases:4.00%
controls:0.49%
cases:2.15%
controls:0.07%
—
—
cases:3.46%
controls:0.07%
cases:6.38%
controls:0.59%
cases:5.22%
controls:1.72%
91
347
2831
28800
117
144
2810
29048
63
19
2864
29173
—
99
21
2761
29084
161
164
2363
27783
99
392
1798
22385
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
1.2e+00
2.1e+00
3.2e+00
—
4.1e+00
2.3e+00
1.3e+00
cases:4.18%
controls:1.26%
cases:6.90%
controls:0.93%
cases:4.44%
controls:0.20%
—
—
cases:7.87%
controls:0.14%
cases:9.59%
controls:1.10%
cases:8.96%
controls:2.61%
122
367
2800
28780
202
272
2725
28920
130
58
2797
29134
—
225
41
2635
29064
242
307
2282
27640
170
594
1727
22183
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
9.0e-01
2.1e+00
3.3e+00
1.0e+50
4.7e+00
2.3e+00
8.8e-01
cases:1.61%
controls:0.66%
cases:1.98%
controls:0.25%
cases:1.33%
controls:0.05%
cases:0.41%
controls:0.00%
cases:2.83%
controls:0.03%
cases:3.01%
controls:0.31%
cases:2.95%
controls:1.24%
47
192
2875
28955
58
73
2869
29119
39
15
2888
29177
12
0
2915
29192
81
8
2779
29097
76
87
2448
27860
56
283
1841
22494
Thrombin time
3243-3 [3036489]
8.5e-01
1.2e+00
3.0e+00
—
4.5e+00
2.7e+00
1.8e+00
cases:1.54%
controls:0.66%
cases:1.02%
controls:0.30%
cases:0.68%
controls:0.03%
—
—
cases:2.66%
controls:0.03%
cases:2.77%
controls:0.19%
cases:3.74%
controls:0.62%
45
193
2877
28954
30
89
2897
29103
20
10
2907
29182
—
76
9
2784
29096
70
54
2454
27893
71
141
1826
22636
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
7.4e-01
2.0e+00
4.1e+00
—
4.3e+00
1.9e+00
1.0e+00
cases:6.06%
controls:2.97%
cases:7.79%
controls:1.16%
cases:5.23%
controls:0.10%
—
—
cases:7.27%
controls:0.11%
cases:6.81%
controls:1.04%
cases:9.65%
controls:3.61%
177
867
2745
28280
228
340
2699
28852
153
28
2774
29164
—
208
31
2652
29074
172
290
2352
27657
183
822
1714
21955
Chemotherapy session for neoplasm
Z51.1 [45595526]
1.4e+00
3.5e+00
4.2e+00
—
3.4e+00
3.0e+00
1.7e+00
cases:0.27%
controls:0.07%
cases:1.13%
controls:0.03%
cases:1.09%
controls:0.02%
—
—
cases:0.52%
controls:0.02%
cases:0.75%
controls:0.04%
cases:0.37%
controls:0.07%
8
19
2914
29128
33
10
2894
29182
32
5
2895
29187
—
15
5
2845
29100
19
11
2505
27936
7
16
1890
22761
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
9.2e-01
2.2e+00
3.4e+00
—
3.9e+00
2.0e+00
1.5e+00
cases:1.27%
controls:0.51%
cases:1.71%
controls:0.20%
cases:1.23%
controls:0.04%
—
—
cases:1.57%
controls:0.03%
cases:1.66%
controls:0.22%
cases:2.74%
controls:0.61%
37
148
2885
28999
50
58
2877
29134
36
12
2891
29180
—
45
9
2815
29096
42
61
2482
27886
52
139
1845
22638
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
1.9e+00
2.9e+00
4.3e+00
1.0e+50
—
2.8e+00
2.0e+00
cases:2.43%
controls:0.37%
cases:3.18%
controls:0.18%
cases:2.56%
controls:0.03%
cases:1.91%
controls:0.00%
—
—
cases:3.33%
controls:0.20%
cases:4.01%
controls:0.56%
71
108
2851
29039
93
52
2834
29140
75
10
2852
29182
56
0
2871
29192
—
84
57
2440
27890
76
127
1821
22650
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
9.1e-01
2.2e+00
3.5e+00
—
3.9e+00
2.0e+00
1.5e+00
cases:1.27%
controls:0.51%
cases:1.81%
controls:0.21%
cases:1.33%
controls:0.04%
—
—
cases:1.61%
controls:0.03%
cases:1.78%
controls:0.24%
cases:2.85%
controls:0.66%
37
150
2885
28997
53
60
2874
29132
39
12
2888
29180
—
46
10
2814
29095
45
66
2479
27881
54
150
1843
22627
Normoblasts [#/volume] in Blood
715-3 [3021589]
5.6e-01
1.1e+00
2.5e+00
5.0e+00
2.6e+00
1.3e+00
9.1e-01
cases:17.42%
controls:10.73%
cases:21.11%
controls:8.47%
cases:18.62%
controls:1.89%
cases:14.72%
controls:0.12%
cases:21.15%
controls:1.90%
cases:26.15%
controls:8.97%
cases:31.42%
controls:15.57%
509
3127
2413
26020
618
2472
2309
26720
545
552
2382
28640
431
35
2496
29157
605
553
2255
28552
660
2508
1864
25439
596
3546
1301
19231
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
1.0e+00
2.1e+00
3.6e+00
—
3.9e+00
2.1e+00
1.2e+00
cases:4.62%
controls:1.72%
cases:6.53%
controls:0.83%
cases:4.89%
controls:0.14%
—
—
cases:5.73%
controls:0.13%
cases:6.81%
controls:0.88%
cases:6.96%
controls:2.26%
135
502
2787
28645
191
243
2736
28949
143
41
2784
29151
—
164
37
2696
29068
172
246
2352
27701
132
514
1765
22263
Bone marrow Pathology biopsy report
33721-2 [3045142]
2.6e+00
4.0e+00
—
1.0e+50
1.0e+50
4.3e+00
3.1e+00
cases:1.81%
controls:0.14%
cases:3.76%
controls:0.07%
—
—
cases:0.99%
controls:0.00%
cases:4.30%
controls:0.00%
cases:4.56%
controls:0.07%
cases:3.27%
controls:0.16%
53
41
2869
29106
110
21
2817
29171
—
29
0
2898
29192
123
0
2737
29105
115
19
2409
27928
62
36
1835
22741
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
9.1e-01
2.1e+00
3.5e+00
—
3.8e+00
2.0e+00
1.5e+00
cases:1.37%
controls:0.56%
cases:1.84%
controls:0.22%
cases:1.37%
controls:0.04%
—
—
cases:1.71%
controls:0.04%
cases:1.78%
controls:0.25%
cases:2.90%
controls:0.69%
40
162
2882
28985
54
64
2873
29128
40
12
2887
29180
—
49
11
2811
29094
45
69
2479
27878
55
157
1842
22620
Blasts/Leukocytes in Blood
26446-5 [3025159]
1.2e+00
2.0e+00
3.1e+00
—
4.0e+00
2.2e+00
1.3e+00
cases:3.63%
controls:1.16%
cases:6.59%
controls:0.93%
cases:4.24%
controls:0.20%
—
—
cases:7.97%
controls:0.16%
cases:9.79%
controls:1.14%
cases:8.86%
controls:2.66%
106
339
2816
28808
193
271
2734
28921
124
57
2803
29135
—
228
46
2632
29059
247
319
2277
27628
168
606
1729
22171
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
5.2e-01
1.3e+00
2.5e+00
4.3e+00
2.8e+00
1.5e+00
8.6e-01
cases:17.11%
controls:10.94%
cases:19.27%
controls:6.07%
cases:10.59%
controls:0.92%
cases:2.60%
controls:0.04%
cases:14.41%
controls:0.98%
cases:21.39%
controls:5.90%
cases:28.15%
controls:14.21%
500
3190
2422
25957
564
1772
2363
27420
310
270
2617
28922
76
11
2851
29181
412
286
2448
28819
540
1650
1984
26297
534
3237
1363
19540
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.0e-01
1.1e+00
2.4e+00
4.9e+00
2.9e+00
1.4e+00
7.0e-01
cases:17.90%
controls:12.73%
cases:19.37%
controls:7.19%
cases:11.58%
controls:1.14%
cases:5.81%
controls:0.05%
cases:16.43%
controls:1.11%
cases:21.83%
controls:6.64%
cases:29.15%
controls:16.92%
523
3709
2399
25438
567
2099
2360
27093
339
334
2588
28858
170
14
2757
29178
470
323
2390
28782
551
1857
1973
26090
553
3853
1344
18924
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
1.1e+00
2.0e+00
3.1e+00
—
3.5e+00
2.3e+00
1.7e+00
cases:1.54%
controls:0.52%
cases:1.61%
controls:0.22%
cases:0.65%
controls:0.03%
—
—
cases:0.77%
controls:0.02%
cases:2.02%
controls:0.20%
cases:3.16%
controls:0.57%
45
151
2877
28996
47
63
2880
29129
19
9
2908
29183
—
22
7
2838
29098
51
57
2473
27890
60
129
1837
22648
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
1.3e+00
2.3e+00
3.2e+00
—
3.3e+00
2.5e+00
1.1e+00
cases:2.33%
controls:0.66%
cases:3.28%
controls:0.34%
cases:1.16%
controls:0.05%
—
—
cases:1.15%
controls:0.04%
cases:3.76%
controls:0.33%
cases:2.90%
controls:0.95%
68
191
2854
28956
96
98
2831
29094
34
14
2893
29178
—
33
13
2827
29092
95
92
2429
27855
55
217
1842
22560
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
1.3e+00
2.0e+00
3.1e+00
—
3.9e+00
2.0e+00
1.2e+00
cases:1.92%
controls:0.52%
cases:2.08%
controls:0.28%
cases:1.40%
controls:0.06%
—
—
cases:2.20%
controls:0.04%
cases:2.22%
controls:0.30%
cases:2.74%
controls:0.81%
56
151
2866
28996
61
82
2866
29110
41
18
2886
29174
—
63
13
2797
29092
56
85
2468
27862
52
185
1845
22592
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
2.7e-01
1.0e+00
2.4e+00
5.4e+00
2.6e+00
1.2e+00
5.7e-01
cases:19.03%
controls:15.16%
cases:19.34%
controls:7.81%
cases:10.18%
controls:1.04%
cases:7.38%
controls:0.03%
cases:11.61%
controls:0.93%
cases:20.72%
controls:7.33%
cases:30.31%
controls:19.70%
556
4420
2366
24727
566
2279
2361
26913
298
304
2629
28888
216
10
2711
29182
332
272
2528
28833
523
2049
2001
25898
575
4486
1322
18291
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
9.8e-01
2.0e+00
3.5e+00
—
3.8e+00
1.9e+00
1.3e+00
cases:1.71%
controls:0.65%
cases:1.78%
controls:0.25%
cases:1.61%
controls:0.05%
—
—
cases:1.85%
controls:0.04%
cases:1.90%
controls:0.29%
cases:3.16%
controls:0.88%
50
190
2872
28957
52
73
2875
29119
47
14
2880
29178
—
53
12
2807
29093
48
80
2476
27867
60
200
1837
22577
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
1.3e+00
2.0e+00
3.1e+00
—
3.8e+00
2.1e+00
1.2e+00
cases:1.98%
controls:0.54%
cases:2.25%
controls:0.32%
cases:1.54%
controls:0.07%
—
—
cases:2.48%
controls:0.05%
cases:2.58%
controls:0.33%
cases:2.95%
controls:0.95%
58
156
2864
28991
66
93
2861
29099
45
20
2882
29172
—
71
16
2789
29089
65
93
2459
27854
56
217
1841
22560
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
8.6e-01
1.8e+00
3.4e+00
—
4.0e+00
2.2e+00
1.2e+00
cases:7.26%
controls:3.20%
cases:9.26%
controls:1.62%
cases:6.39%
controls:0.24%
—
—
cases:10.31%
controls:0.21%
cases:12.92%
controls:1.60%
cases:12.34%
controls:4.00%
212
934
2710
28213
271
473
2656
28719
187
69
2740
29123
—
295
61
2565
29044
326
447
2198
27500
234
912
1663
21865
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
1.3e+00
2.3e+00
—
1.0e+50
5.0e+00
3.2e+00
1.7e+00
cases:1.20%
controls:0.34%
cases:1.26%
controls:0.13%
—
—
cases:0.31%
controls:0.00%
cases:2.45%
controls:0.02%
cases:2.10%
controls:0.09%
cases:1.90%
controls:0.35%
35
98
2887
29049
37
39
2890
29153
—
9
0
2918
29192
70
5
2790
29100
53
24
2471
27923
36
79
1861
22698
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
1.3e+00
2.0e+00
3.1e+00
—
3.8e+00
2.1e+00
1.2e+00
cases:1.92%
controls:0.54%
cases:2.25%
controls:0.32%
cases:1.54%
controls:0.07%
—
—
cases:2.48%
controls:0.05%
cases:2.58%
controls:0.33%
cases:2.95%
controls:0.95%
56
157
2866
28990
66
93
2861
29099
45
20
2882
29172
—
71
16
2789
29089
65
93
2459
27854
56
217
1841
22560
Bone marrow biopsy
XW000 [2001310618]
2.1e+00
3.9e+00
—
1.0e+50
—
4.5e+00
3.0e+00
cases:2.98%
controls:0.36%
cases:5.81%
controls:0.13%
—
—
cases:8.81%
controls:0.00%
—
—
cases:8.12%
controls:0.10%
cases:6.64%
controls:0.37%
87
106
2835
29041
170
38
2757
29154
—
258
0
2669
29192
—
205
28
2319
27919
126
84
1771
22693
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
1.0e+00
2.0e+00
3.4e+00
—
3.7e+00
2.0e+00
1.2e+00
cases:4.24%
controls:1.55%
cases:5.36%
controls:0.73%
cases:3.52%
controls:0.12%
—
—
cases:4.20%
controls:0.10%
cases:4.83%
controls:0.68%
cases:6.91%
controls:2.22%
124
451
2798
28696
157
212
2770
28980
103
36
2824
29156
—
120
30
2740
29075
122
191
2402
27756
131
506
1766
22271
Osmolality of Urine
2695-5 [3026782]
4.6e-01
1.1e+00
2.0e+00
5.1e+00
2.6e+00
1.3e+00
8.1e-01
cases:8.01%
controls:5.22%
cases:6.66%
controls:2.31%
cases:2.66%
controls:0.38%
cases:2.73%
controls:0.02%
cases:3.32%
controls:0.26%
cases:7.01%
controls:1.99%
cases:10.96%
controls:5.19%
234
1521
2688
27626
195
674
2732
28518
78
110
2849
29082
80
5
2847
29187
95
75
2765
29030
177
556
2347
27391
208
1181
1689
21596
Chronic lymphocytic leukaemia of B-cell type
C91.1 [45600564]
1.6e+00
1.9e+00
2.8e+00
1.0e+50
2.6e+00
2.3e+00
2.0e+00
cases:0.82%
controls:0.16%
cases:0.92%
controls:0.13%
cases:0.68%
controls:0.04%
cases:0.61%
controls:0.00%
cases:0.70%
controls:0.05%
cases:1.31%
controls:0.13%
cases:1.21%
controls:0.16%
24
47
2898
29100
27
39
2900
29153
20
12
2907
29180
18
0
2909
29192
20
15
2840
29090
33
37
2491
27910
23
37
1874
22740
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
1.0e+00
1.9e+00
3.3e+00
—
3.9e+00
1.9e+00
1.2e+00
cases:1.88%
controls:0.69%
cases:1.91%
controls:0.28%
cases:1.61%
controls:0.06%
—
—
cases:2.17%
controls:0.04%
cases:2.10%
controls:0.32%
cases:3.58%
controls:1.08%
55
202
2867
28945
56
83
2871
29109
47
17
2880
29175
—
62
13
2798
29092
53
89
2471
27858
68
245
1829
22532
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
1.0e+00
1.9e+00
3.3e+00
—
3.9e+00
1.9e+00
1.2e+00
cases:1.88%
controls:0.70%
cases:1.91%
controls:0.29%
cases:1.61%
controls:0.06%
—
—
cases:2.17%
controls:0.04%
cases:2.14%
controls:0.32%
cases:3.58%
controls:1.08%
55
203
2867
28944
56
84
2871
29108
47
17
2880
29175
—
62
13
2798
29092
54
89
2470
27858
68
246
1829
22531
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
1.0e+00
1.9e+00
3.3e+00
—
3.9e+00
1.9e+00
1.2e+00
cases:1.88%
controls:0.70%
cases:1.91%
controls:0.29%
cases:1.61%
controls:0.06%
—
—
cases:2.17%
controls:0.04%
cases:2.14%
controls:0.32%
cases:3.58%
controls:1.08%
55
203
2867
28944
56
84
2871
29108
47
17
2880
29175
—
62
13
2798
29092
54
89
2470
27858
68
247
1829
22530
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
1.3e+00
1.9e+00
2.8e+00
1.0e+50
3.9e+00
1.9e+00
1.4e+00
cases:1.54%
controls:0.42%
cases:1.47%
controls:0.23%
cases:0.75%
controls:0.04%
cases:0.27%
controls:0.00%
cases:1.50%
controls:0.03%
cases:1.55%
controls:0.23%
cases:2.11%
controls:0.52%
45
122
2877
29025
43
66
2884
29126
22
13
2905
29179
8
0
2919
29192
43
9
2817
29096
39
63
2485
27884
40
119
1857
22658
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
9.0e-01
2.0e+00
3.4e+00
—
3.8e+00
1.9e+00
1.3e+00
cases:1.47%
controls:0.60%
cases:2.19%
controls:0.29%
cases:1.47%
controls:0.05%
—
—
cases:1.89%
controls:0.04%
cases:1.94%
controls:0.30%
cases:3.22%
controls:0.90%
43
176
2879
28971
64
84
2863
29108
43
15
2884
29177
—
54
13
2806
29092
49
85
2475
27862
61
204
1836
22573
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
2.5e+00
3.6e+00
—
1.0e+50
—
4.2e+00
2.9e+00
cases:2.91%
controls:0.24%
cases:4.34%
controls:0.12%
—
—
cases:4.00%
controls:0.00%
—
—
cases:6.77%
controls:0.11%
cases:5.64%
controls:0.32%
85
70
2837
29077
127
35
2800
29157
—
117
0
2810
29192
—
171
31
2353
27916
107
74
1790
22703
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
9.3e-01
1.9e+00
3.3e+00
—
3.9e+00
2.0e+00
1.3e+00
cases:1.64%
controls:0.66%
cases:1.84%
controls:0.27%
cases:1.40%
controls:0.05%
—
—
cases:1.96%
controls:0.04%
cases:2.06%
controls:0.30%
cases:3.43%
controls:0.97%
48
191
2874
28956
54
80
2873
29112
41
16
2886
29176
—
56
12
2804
29093
52
83
2472
27864
65
221
1832
22556
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.8e-01
1.0e+00
2.4e+00
4.7e+00
2.6e+00
1.3e+00
7.5e-01
cases:29.81%
controls:22.53%
cases:31.02%
controls:13.97%
cases:23.98%
controls:2.83%
cases:11.86%
controls:0.12%
cases:26.78%
controls:2.56%
cases:37.36%
controls:13.90%
cases:45.49%
controls:28.28%
871
6566
2051
22581
908
4079
2019
25113
702
826
2225
28366
347
36
2580
29156
766
746
2094
28359
943
3886
1581
24061
863
6442
1034
16335
Base excess in Blood by calculation
11555-0 [3012501]
1.2e+00
1.7e+00
2.8e+00
1.0e+50
3.6e+00
2.3e+00
1.5e+00
cases:1.54%
controls:0.48%
cases:1.40%
controls:0.25%
cases:0.58%
controls:0.03%
cases:0.58%
controls:0.00%
cases:0.98%
controls:0.03%
cases:1.82%
controls:0.18%
cases:1.85%
controls:0.42%
45
141
2877
29006
41
74
2886
29118
17
10
2910
29182
17
0
2910
29192
28
8
2832
29097
46
50
2478
27897
35
96
1862
22681
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
1.2e+00
1.7e+00
2.8e+00
1.0e+50
3.6e+00
2.4e+00
1.5e+00
cases:1.54%
controls:0.48%
cases:1.40%
controls:0.25%
cases:0.58%
controls:0.03%
cases:0.58%
controls:0.00%
cases:0.98%
controls:0.03%
cases:1.86%
controls:0.18%
cases:1.85%
controls:0.43%
45
141
2877
29006
41
74
2886
29118
17
10
2910
29182
17
0
2910
29192
28
8
2832
29097
47
50
2477
27897
35
99
1862
22678
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
1.2e+00
1.7e+00
2.8e+00
1.0e+50
3.6e+00
2.3e+00
1.5e+00
cases:1.54%
controls:0.48%
cases:1.40%
controls:0.25%
cases:0.58%
controls:0.03%
cases:0.58%
controls:0.00%
cases:0.98%
controls:0.03%
cases:1.82%
controls:0.18%
cases:1.85%
controls:0.43%
45
141
2877
29006
41
74
2886
29118
17
10
2910
29182
17
0
2910
29192
28
8
2832
29097
46
50
2478
27897
35
97
1862
22680
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
1.3e+00
1.8e+00
2.7e+00
1.0e+50
3.7e+00
2.2e+00
1.4e+00
cases:1.13%
controls:0.32%
cases:1.16%
controls:0.18%
cases:0.44%
controls:0.03%
cases:0.48%
controls:0.00%
cases:0.66%
controls:0.02%
cases:1.78%
controls:0.19%
cases:2.27%
controls:0.58%
33
93
2889
29054
34
54
2893
29138
13
9
2914
29183
14
0
2913
29192
19
5
2841
29100
45
54
2479
27893
43
131
1854
22646
Intravenous
ZX120 [2001311495]
1.2e+00
2.0e+00
2.9e+00
—
2.6e+00
2.3e+00
1.9e+00
cases:3.59%
controls:1.07%
cases:3.18%
controls:0.45%
cases:1.74%
controls:0.10%
—
—
cases:1.64%
controls:0.12%
cases:3.80%
controls:0.38%
cases:5.22%
controls:0.83%
105
311
2817
28836
93
130
2834
29062
51
28
2876
29164
—
47
35
2813
29070
96
106
2428
27841
99
188
1798
22589
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
6.1e-01
1.6e+00
3.2e+00
—
4.2e+00
2.2e+00
1.1e+00
cases:5.89%
controls:3.28%
cases:6.29%
controls:1.36%
cases:3.45%
controls:0.14%
—
—
cases:7.94%
controls:0.13%
cases:9.79%
controls:1.14%
cases:11.07%
controls:3.80%
172
955
2750
28192
184
396
2743
28796
101
42
2826
29150
—
227
38
2633
29067
247
319
2277
27628
210
865
1687
21912
B-cell lymphoma in marginal zone
C83.80 [2000501237]
2.0e+00
2.3e+00
—
—
2.9e+00
2.7e+00
3.1e+00
cases:0.41%
controls:0.06%
cases:0.41%
controls:0.04%
—
—
—
—
cases:0.31%
controls:0.02%
cases:0.71%
controls:0.05%
cases:0.84%
controls:0.04%
12
17
2910
29130
12
12
2915
29180
—
—
9
5
2851
29100
18
13
2506
27934
16
9
1881
22768
Hemodialysis
TK800 [2001305768]
1.3e+00
1.8e+00
1.8e+00
2.4e+00
1.9e+00
1.9e+00
1.8e+00
cases:0.79%
controls:0.22%
cases:0.75%
controls:0.12%
cases:0.48%
controls:0.08%
cases:0.41%
controls:0.04%
cases:0.52%
controls:0.08%
cases:0.95%
controls:0.14%
cases:1.00%
controls:0.16%
23
63
2899
29084
22
36
2905
29156
14
23
2913
29169
12
11
2915
29181
15
23
2845
29082
24
39
2500
27908
19
37
1878
22740
Acute renal failure, unspecified
N17.9 [45567829]
1.3e+00
2.0e+00
3.0e+00
—
3.6e+00
2.1e+00
1.0e+00
cases:1.06%
controls:0.30%
cases:0.79%
controls:0.11%
cases:0.41%
controls:0.02%
—
—
cases:0.63%
controls:0.02%
cases:1.35%
controls:0.17%
cases:1.53%
controls:0.57%
31
88
2891
29059
23
31
2904
29161
12
6
2915
29186
—
18
5
2842
29100
34
48
2490
27899
29
129
1868
22648
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
5.7e-01
1.7e+00
3.9e+00
1.0e+50
3.9e+00
1.8e+00
1.0e+00
cases:4.28%
controls:2.46%
cases:3.96%
controls:0.75%
cases:3.04%
controls:0.06%
cases:0.72%
controls:0.00%
cases:3.81%
controls:0.08%
cases:4.91%
controls:0.81%
cases:7.75%
controls:2.89%
125
717
2797
28430
116
220
2811
28972
89
18
2838
29174
21
0
2906
29192
109
24
2751
29081
124
227
2400
27720
147
658
1750
22119
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
4.9e-01
1.1e+00
2.3e+00
5.3e+00
2.2e+00
9.9e-01
4.8e-01
cases:10.20%
controls:6.50%
cases:9.09%
controls:3.09%
cases:4.54%
controls:0.45%
cases:3.25%
controls:0.02%
cases:4.02%
controls:0.46%
cases:8.80%
controls:3.46%
cases:13.81%
controls:9.01%
298
1896
2624
27251
266
902
2661
28290
133
132
2794
29060
95
5
2832
29187
115
133
2745
28972
222
968
2302
26979
262
2052
1635
20725
CD19 cells [#/volume] in Blood
8116-6 [3010503]
1.9e+00
3.4e+00
—
—
—
4.3e+00
3.4e+00
cases:0.86%
controls:0.13%
cases:1.13%
controls:0.04%
—
—
—
—
—
—
cases:3.17%
controls:0.05%
cases:2.95%
controls:0.11%
25
37
2897
29110
33
11
2894
29181
—
—
—
80
13
2444
27934
56
24
1841
22753
Granulocytes [#/volume] in Blood
30394-1 [3035715]
1.4e+00
2.5e+00
3.4e+00
—
—
2.9e+00
2.6e+00
cases:1.92%
controls:0.46%
cases:1.64%
controls:0.13%
cases:0.89%
controls:0.03%
—
—
—
—
cases:1.94%
controls:0.11%
cases:2.79%
controls:0.21%
56
134
2866
29013
48
38
2879
29154
26
9
2901
29183
—
—
49
30
2475
27917
53
47
1844
22730
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
4.6e-01
1.0e+00
2.0e+00
5.4e+00
2.3e+00
1.1e+00
6.1e-01
cases:10.20%
controls:6.69%
cases:9.84%
controls:3.78%
cases:3.86%
controls:0.55%
cases:3.66%
controls:0.02%
cases:4.86%
controls:0.53%
cases:10.50%
controls:3.65%
cases:16.08%
controls:9.40%
298
1951
2624
27196
288
1102
2639
28090
113
161
2814
29031
107
5
2820
29187
139
153
2721
28952
265
1020
2259
26927
305
2140
1592
20637
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
4.2e-01
1.0e+00
1.9e+00
5.6e+00
2.2e+00
1.1e+00
6.1e-01
cases:11.26%
controls:7.71%
cases:11.00%
controls:4.31%
cases:4.24%
controls:0.66%
cases:4.34%
controls:0.02%
cases:5.56%
controls:0.62%
cases:12.08%
controls:4.34%
cases:18.61%
controls:11.09%
329
2248
2593
26899
322
1257
2605
27935
124
192
2803
29000
127
5
2800
29187
159
181
2701
28924
305
1212
2219
26735
353
2525
1544
20252
Bacteria [Presence] in Urine
87829-8 [36304419]
4.4e-01
1.0e+00
1.9e+00
5.4e+00
2.3e+00
1.1e+00
6.8e-01
cases:9.62%
controls:6.40%
cases:9.16%
controls:3.49%
cases:3.38%
controls:0.51%
cases:3.48%
controls:0.02%
cases:4.37%
controls:0.47%
cases:9.75%
controls:3.32%
cases:15.71%
controls:8.60%
281
1864
2641
27283
268
1020
2659
28172
99
148
2828
29044
102
5
2825
29187
125
136
2735
28969
246
929
2278
27018
298
1958
1599
20819
Multiple cystostatic therapy of methastized malignancy
WD115 [2001310679]
1.6e+00
3.2e+00
3.5e+00
—
2.7e+00
1.9e+00
9.3e-01
cases:0.38%
controls:0.08%
cases:0.99%
controls:0.04%
cases:0.79%
controls:0.02%
—
—
cases:0.35%
controls:0.02%
cases:0.55%
controls:0.08%
cases:0.42%
controls:0.17%
11
23
2911
29124
29
12
2898
29180
23
7
2904
29185
—
10
7
2850
29098
14
23
2510
27924
8
38
1889
22739
pH of Blood
11558-4 [3010421]
1.1e+00
1.8e+00
2.8e+00
1.0e+50
3.6e+00
2.2e+00
1.4e+00
cases:1.57%
controls:0.54%
cases:1.67%
controls:0.29%
cases:0.75%
controls:0.04%
cases:0.61%
controls:0.00%
cases:1.19%
controls:0.03%
cases:2.30%
controls:0.26%
cases:2.95%
controls:0.76%
46
157
2876
28990
49
86
2878
29106
22
13
2905
29179
18
0
2909
29192
34
10
2826
29095
58
72
2466
27875
56
174
1841
22603
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 [3027831]
1.7e+00
3.1e+00
—
—
—
4.4e+00
3.6e+00
cases:0.72%
controls:0.13%
cases:1.37%
controls:0.06%
—
—
—
—
—
—
cases:3.49%
controls:0.05%
cases:3.85%
controls:0.11%
21
39
2901
29108
40
18
2887
29174
—
—
—
88
13
2436
27934
73
25
1824
22752
Leukocytes [#/volume] in Urine
30405-5 [3018095]
4.1e-01
1.0e+00
1.9e+00
5.5e+00
2.3e+00
1.1e+00
5.7e-01
cases:12.15%
controls:8.39%
cases:12.20%
controls:4.88%
cases:4.71%
controls:0.75%
cases:4.65%
controls:0.02%
cases:6.29%
controls:0.68%
cases:13.23%
controls:4.99%
cases:20.61%
controls:12.81%
355
2445
2567
26702
357
1425
2570
27767
138
218
2789
28974
136
6
2791
29186
180
197
2680
28908
334
1395
2190
26552
391
2917
1506
19860
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.6e-01
9.9e-01
1.9e+00
5.3e+00
2.4e+00
1.1e+00
6.7e-01
cases:12.56%
controls:9.13%
cases:11.68%
controls:4.68%
cases:4.41%
controls:0.71%
cases:4.54%
controls:0.02%
cases:6.12%
controls:0.61%
cases:13.23%
controls:4.64%
cases:20.72%
controls:11.75%
367
2662
2555
26485
342
1365
2585
27827
129
207
2798
28985
133
7
2794
29185
175
178
2685
28927
334
1297
2190
26650
393
2677
1504
20100
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
5.8e-01
1.2e+00
2.4e+00
4.0e+00
2.5e+00
1.2e+00
7.1e-01
cases:9.89%
controls:5.79%
cases:8.99%
controls:2.84%
cases:3.72%
controls:0.34%
cases:1.06%
controls:0.02%
cases:4.62%
controls:0.38%
cases:9.55%
controls:2.97%
cases:15.23%
controls:8.14%
289
1687
2633
27460
263
829
2664
28363
109
100
2818
29092
31
6
2896
29186
132
112
2728
28993
241
829
2283
27118
289
1854
1608
20923
Serous epithelial malignant tumor of the ovary
C56.71 [2000501075]
2.7e+00
2.4e+00
2.7e+00
1.0e+50
2.7e+00
2.2e+00
—
cases:0.51%
controls:0.03%
cases:0.61%
controls:0.06%
cases:0.55%
controls:0.04%
cases:0.34%
controls:0.00%
cases:0.56%
controls:0.04%
cases:0.55%
controls:0.06%
—
—
15
10
2907
29137
18
17
2909
29175
16
11
2911
29181
10
0
2917
29192
16
11
2844
29094
14
18
2510
27929
—
Neutrophil count
30630007 [4148615]
2.0e+00
3.4e+00
—
1.0e+50
—
4.2e+00
3.0e+00
cases:0.62%
controls:0.08%
cases:1.26%
controls:0.04%
—
—
cases:4.34%
controls:0.00%
—
—
cases:2.73%
controls:0.04%
cases:2.06%
controls:0.10%
18
24
2904
29123
37
13
2890
29179
—
127
0
2800
29192
—
69
12
2455
27935
39
23
1858
22754
darbepoetin alfa; parenteral
B03XA02 [21601134]
1.6e+00
1.8e+00
2.5e+00
—
2.0e+00
2.4e+00
2.2e+00
cases:0.99%
controls:0.20%
cases:1.23%
controls:0.20%
cases:0.68%
controls:0.05%
—
—
cases:0.56%
controls:0.08%
cases:2.14%
controls:0.20%
cases:2.16%
controls:0.25%
29
59
2893
29088
36
59
2891
29133
20
16
2907
29176
—
16
22
2844
29083
54
57
2470
27890
41
56
1856
22721
Extracorporeal dialysis
Z49.1 [45537649]
1.4e+00
1.9e+00
1.6e+00
2.6e+00
2.0e+00
1.6e+00
1.5e+00
cases:0.48%
controls:0.12%
cases:0.55%
controls:0.09%
cases:0.38%
controls:0.08%
cases:0.31%
controls:0.02%
cases:0.52%
controls:0.07%
cases:0.55%
controls:0.12%
cases:0.58%
controls:0.13%
14
36
2908
29111
16
25
2911
29167
11
22
2916
29170
9
7
2918
29185
15
21
2845
29084
14
33
2510
27914
11
29
1886
22748
Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
48674-6 [3049539]
2.3e+00
4.4e+00
1.0e+50
—
—
2.8e+00
2.9e+00
cases:1.03%
controls:0.10%
cases:2.53%
controls:0.03%
cases:0.72%
controls:0.00%
—
—
—
—
cases:0.79%
controls:0.05%
cases:1.32%
controls:0.07%
30
30
2892
29117
74
9
2853
29183
21
0
2906
29192
—
—
20
14
2504
27933
25
17
1872
22760
Demanding cystostatic therapy of methastized malignancy
WD135 [2001310681]
2.0e+00
4.5e+00
—
—
1.0e+50
3.9e+00
2.0e+00
cases:0.38%
controls:0.05%
cases:1.54%
controls:0.02%
—
—
—
—
cases:0.45%
controls:0.00%
cases:1.23%
controls:0.03%
cases:0.32%
controls:0.04%
11
15
2911
29132
45
5
2882
29187
—
—
13
0
2847
29105
31
7
2493
27940
6
10
1891
22767
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
1.0e+00
1.8e+00
2.5e+00
—
3.1e+00
2.2e+00
1.8e+00
cases:2.64%
controls:0.98%
cases:2.05%
controls:0.33%
cases:0.44%
controls:0.04%
—
—
cases:0.80%
controls:0.04%
cases:2.69%
controls:0.32%
cases:5.17%
controls:0.89%
77
287
2845
28860
60
97
2867
29095
13
11
2914
29181
—
23
11
2837
29094
68
89
2456
27858
98
203
1799
22574
Gas panel - Central venous blood
97535-9 [1616796]
1.1e+00
1.7e+00
2.6e+00
1.0e+50
3.4e+00
2.1e+00
1.4e+00
cases:1.20%
controls:0.42%
cases:1.40%
controls:0.25%
cases:0.61%
controls:0.04%
cases:0.34%
controls:0.00%
cases:1.12%
controls:0.04%
cases:1.86%
controls:0.24%
cases:2.42%
controls:0.60%
35
122
2887
29025
41
73
2886
29119
18
13
2909
29179
10
0
2917
29192
32
11
2828
29094
47
68
2477
27879
46
136
1851
22641
Short blood count panel - Blood
55429-5 [40758558]
4.0e-01
8.5e-01
2.1e+00
4.6e+00
2.3e+00
1.1e+00
8.5e-01
cases:9.17%
controls:6.33%
cases:7.65%
controls:3.43%
cases:5.60%
controls:0.75%
cases:4.03%
controls:0.04%
cases:7.24%
controls:0.75%
cases:9.55%
controls:3.29%
cases:16.03%
controls:7.56%
268
1845
2654
27302
224
1002
2703
28190
164
218
2763
28974
118
12
2809
29180
207
219
2653
28886
241
920
2283
27027
304
1722
1593
21055
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
5.0e-01
1.1e+00
2.2e+00
4.2e+00
2.4e+00
1.2e+00
6.5e-01
cases:14.13%
controls:9.12%
cases:13.94%
controls:5.10%
cases:6.01%
controls:0.69%
cases:1.98%
controls:0.03%
cases:7.80%
controls:0.77%
cases:15.89%
controls:5.47%
cases:24.35%
controls:14.37%
413
2657
2509
26490
408
1490
2519
27702
176
200
2751
28992
58
9
2869
29183
223
224
2637
28881
401
1529
2123
26418
462
3272
1435
19505
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
8.2e-01
1.8e+00
2.9e+00
—
3.4e+00
1.8e+00
1.3e+00
cases:5.41%
controls:2.45%
cases:6.59%
controls:1.14%
cases:3.83%
controls:0.21%
—
—
cases:4.90%
controls:0.17%
cases:6.54%
controls:1.09%
cases:8.33%
controls:2.45%
158
715
2764
28432
193
332
2734
28860
112
61
2815
29131
—
140
50
2720
29055
165
305
2359
27642
158
559
1739
22218
Abdominal ultrasound examination
JN3AE [2001305555]
8.0e-01
1.8e+00
1.9e+00
1.0e+50
3.6e+00
2.3e+00
1.7e+00
cases:4.04%
controls:1.85%
cases:3.01%
controls:0.50%
cases:0.48%
controls:0.08%
cases:4.71%
controls:0.00%
cases:2.03%
controls:0.05%
cases:4.91%
controls:0.53%
cases:7.96%
controls:1.55%
118
540
2804
28607
88
145
2839
29047
14
22
2913
29170
138
0
2789
29192
58
16
2802
29089
124
148
2400
27799
151
352
1746
22425
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6.6e-01
1.7e+00
2.9e+00
1.0e+50
4.2e+00
1.7e+00
9.1e-01
cases:1.54%
controls:0.80%
cases:1.40%
controls:0.26%
cases:0.55%
controls:0.03%
cases:0.17%
controls:0.00%
cases:1.33%
controls:0.02%
cases:1.58%
controls:0.28%
cases:2.16%
controls:0.88%
45
233
2877
28914
41
77
2886
29115
16
9
2911
29183
5
0
2922
29192
38
6
2822
29099
40
79
2484
27868
41
200
1856
22577
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
3.6e-01
8.8e-01
2.5e+00
4.3e+00
3.0e+00
6.7e-01
3.4e-01
cases:14.03%
controls:10.24%
cases:11.45%
controls:5.10%
cases:6.56%
controls:0.56%
cases:2.22%
controls:0.03%
cases:8.85%
controls:0.49%
cases:10.18%
controls:5.49%
cases:20.61%
controls:15.55%
410
2984
2512
26163
335
1489
2592
27703
192
163
2735
29029
65
9
2862
29183
253
144
2607
28961
257
1533
2267
26414
391
3542
1506
19235
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
4.1e-01
1.1e+00
1.7e+00
4.8e+00
2.4e+00
1.1e+00
5.4e-01
cases:10.10%
controls:6.93%
cases:8.47%
controls:2.95%
cases:2.32%
controls:0.42%
cases:2.90%
controls:0.02%
cases:3.85%
controls:0.38%
cases:8.04%
controls:2.94%
cases:14.50%
controls:8.99%
295
2020
2627
27127
248
860
2679
28332
68
122
2859
29070
85
7
2842
29185
110
110
2750
28995
203
821
2321
27126
275
2048
1622
20729
Diffuse large B-cell lymphoma
C83.3 [45600549]
2.6e+00
4.5e+00
1.0e+50
—
1.0e+50
2.7e+00
2.2e+00
cases:0.62%
controls:0.04%
cases:1.54%
controls:0.02%
cases:0.24%
controls:0.00%
—
—
cases:0.31%
controls:0.00%
cases:0.48%
controls:0.03%
cases:0.32%
controls:0.04%
18
13
2904
29134
45
5
2882
29187
7
0
2920
29192
—
9
0
2851
29105
12
9
2512
27938
6
8
1891
22769
Fever, unspecified
R50.9 [45582716]
8.5e-01
1.8e+00
3.0e+00
—
3.1e+00
2.1e+00
1.2e+00
cases:4.21%
controls:1.84%
cases:3.96%
controls:0.67%
cases:2.02%
controls:0.10%
—
—
cases:2.13%
controls:0.10%
cases:5.15%
controls:0.68%
cases:6.38%
controls:2.07%
123
536
2799
28611
116
196
2811
28996
59
29
2868
29163
—
61
29
2799
29076
130
190
2394
27757
121
472
1776
22305
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
6.8e-01
1.8e+00
2.7e+00
—
3.4e+00
2.0e+00
1.4e+00
cases:1.27%
controls:0.65%
cases:1.26%
controls:0.21%
cases:0.44%
controls:0.03%
—
—
cases:0.70%
controls:0.02%
cases:2.02%
controls:0.26%
cases:3.16%
controls:0.83%
37
189
2885
28958
37
60
2890
29132
13
9
2914
29183
—
20
7
2840
29098
51
74
2473
27873
60
188
1837
22589
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
9.1e-01
1.2e+00
2.6e+00
—
4.1e+00
1.9e+00
1.2e+00
cases:1.57%
controls:0.64%
cases:1.09%
controls:0.32%
cases:0.44%
controls:0.03%
—
—
cases:1.40%
controls:0.02%
cases:1.78%
controls:0.26%
cases:2.95%
controls:0.90%
46
187
2876
28960
32
94
2895
29098
13
10
2914
29182
—
40
7
2820
29098
45
74
2479
27873
56
204
1841
22573
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
4.3e-01
1.8e+00
3.0e+00
—
3.8e+00
2.2e+00
1.1e+00
cases:0.75%
controls:0.49%
cases:0.96%
controls:0.16%
cases:0.55%
controls:0.03%
—
—
cases:0.77%
controls:0.02%
cases:0.99%
controls:0.11%
cases:1.27%
controls:0.41%
22
143
2900
29004
28
47
2899
29145
16
8
2911
29184
—
22
5
2838
29100
25
32
2499
27915
24
93
1873
22684
Emergency Medicine
93 [38004510]
3.2e-01
8.9e-01
2.0e+00
5.7e+00
1.8e+00
8.5e-01
3.8e-01
cases:20.88%
controls:16.15%
cases:18.79%
controls:8.69%
cases:8.95%
controls:1.34%
cases:16.30%
controls:0.07%
cases:7.27%
controls:1.30%
cases:19.37%
controls:9.32%
cases:31.68%
controls:24.12%
610
4706
2312
24441
550
2537
2377
26655
262
392
2665
28800
477
19
2450
29173
208
379
2652
28726
489
2604
2035
25343
601
5494
1296
17283
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
8.5e-01
1.6e+00
2.5e+00
—
3.8e+00
2.2e+00
9.0e-01
cases:3.15%
controls:1.37%
cases:2.94%
controls:0.61%
cases:0.68%
controls:0.05%
—
—
cases:2.94%
controls:0.07%
cases:5.11%
controls:0.59%
cases:4.32%
controls:1.81%
92
398
2830
28749
86
179
2841
29013
20
16
2907
29176
—
84
20
2776
29085
129
166
2395
27781
82
412
1815
22365
Alcoholic cirrhosis of liver
K70.3 [45596343]
1.5e+00
1.9e+00
—
1.0e+50
2.7e+00
2.7e+00
3.0e+00
cases:0.51%
controls:0.11%
cases:0.44%
controls:0.07%
—
—
cases:0.44%
controls:0.00%
cases:0.42%
controls:0.03%
cases:1.23%
controls:0.09%
cases:2.69%
controls:0.14%
15
32
2907
29115
13
20
2914
29172
—
13
0
2914
29192
12
8
2848
29097
31
24
2493
27923
51
31
1846
22746
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
4.3e-01
1.8e+00
3.0e+00
—
3.8e+00
2.1e+00
1.1e+00
cases:0.75%
controls:0.49%
cases:0.92%
controls:0.16%
cases:0.55%
controls:0.03%
—
—
cases:0.77%
controls:0.02%
cases:0.95%
controls:0.11%
cases:1.27%
controls:0.41%
22
143
2900
29004
27
47
2900
29145
16
8
2911
29184
—
22
5
2838
29100
24
32
2500
27915
24
93
1873
22684
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.2e-01
8.2e-01
2.1e+00
4.8e+00
2.5e+00
9.4e-01
4.2e-01
cases:38.30%
controls:33.36%
cases:38.26%
controls:21.51%
cases:28.94%
controls:4.55%
cases:27.64%
controls:0.30%
cases:34.06%
controls:4.23%
cases:41.60%
controls:21.72%
cases:52.98%
controls:42.65%
1119
9722
1803
19425
1120
6279
1807
22913
847
1328
2080
27864
809
89
2118
29103
974
1232
1886
27873
1050
6070
1474
21877
1005
9714
892
13063
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
2.5e-01
9.3e-01
1.9e+00
5.3e+00
2.1e+00
8.9e-01
4.6e-01
cases:11.74%
controls:9.36%
cases:10.90%
controls:4.58%
cases:4.71%
controls:0.72%
cases:5.81%
controls:0.03%
cases:4.93%
controls:0.65%
cases:10.50%
controls:4.59%
cases:18.40%
controls:12.48%
343
2728
2579
26419
319
1338
2608
27854
138
211
2789
28981
170
9
2757
29183
141
190
2719
28915
265
1282
2259
26665
349
2842
1548
19935
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
4.0e-01
9.6e-01
2.0e+00
5.0e+00
2.2e+00
9.1e-01
3.9e-01
cases:10.27%
controls:7.11%
cases:9.43%
controls:3.83%
cases:4.48%
controls:0.65%
cases:3.79%
controls:0.03%
cases:4.62%
controls:0.53%
cases:10.06%
controls:4.30%
cases:14.50%
controls:10.28%
300
2073
2622
27074
276
1118
2651
28074
131
191
2796
29001
111
8
2816
29184
132
155
2728
28950
254
1202
2270
26745
275
2342
1622
20435
Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
61366-1 [40764127]
1.8e+00
3.3e+00
—
1.0e+50
—
3.7e+00
3.0e+00
cases:0.55%
controls:0.09%
cases:0.99%
controls:0.04%
—
—
cases:0.20%
controls:0.00%
—
—
cases:1.58%
controls:0.04%
cases:1.58%
controls:0.08%
16
26
2906
29121
29
11
2898
29181
—
6
0
2921
29192
—
40
11
2484
27936
30
19
1867
22758
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
1.3e+00
2.2e+00
3.4e+00
1.0e+50
—
3.2e+00
1.7e+00
cases:1.13%
controls:0.32%
cases:1.20%
controls:0.13%
cases:0.51%
controls:0.02%
cases:0.27%
controls:0.00%
—
—
cases:1.70%
controls:0.07%
cases:1.79%
controls:0.33%
33
94
2889
29053
35
39
2892
29153
15
5
2912
29187
8
0
2919
29192
—
43
20
2481
27927
34
75
1863
22702
Immunofixation for Serum or Plasma
25700-6 [3037756]
1.5e+00
2.5e+00
—
—
4.3e+00
2.3e+00
1.2e+00
cases:1.54%
controls:0.35%
cases:1.74%
controls:0.14%
—
—
—
—
cases:1.43%
controls:0.02%
cases:1.07%
controls:0.11%
cases:1.85%
controls:0.57%
45
102
2877
29045
51
41
2876
29151
—
—
41
6
2819
29099
27
31
2497
27916
35
129
1862
22648
High resolution CT examination of lungs
GD1DD [2001303632]
6.1e-01
1.6e+00
2.6e+00
—
3.8e+00
2.2e+00
1.5e+00
cases:1.06%
controls:0.58%
cases:1.16%
controls:0.23%
cases:0.38%
controls:0.03%
—
—
cases:0.77%
controls:0.02%
cases:1.94%
controls:0.21%
cases:2.53%
controls:0.59%
31
169
2891
28978
34
68
2893
29124
11
8
2916
29184
—
22
5
2838
29100
49
60
2475
27887
48
134
1849
22643
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
6.8e-01
1.4e+00
3.2e+00
1.0e+50
3.2e+00
2.0e+00
1.1e+00
cases:1.71%
controls:0.87%
cases:1.16%
controls:0.29%
cases:0.61%
controls:0.02%
cases:0.55%
controls:0.00%
cases:0.59%
controls:0.02%
cases:1.58%
controls:0.21%
cases:2.21%
controls:0.76%
50
255
2872
28892
34
84
2893
29108
18
7
2909
29185
16
0
2911
29192
17
7
2843
29098
40
58
2484
27889
42
172
1855
22605
CT of torso and neck
JN6AD [2001310938]
2.2e+00
3.5e+00
—
1.0e+50
1.0e+50
2.8e+00
3.2e+00
cases:0.68%
controls:0.08%
cases:1.50%
controls:0.05%
—
—
cases:0.44%
controls:0.00%
cases:0.94%
controls:0.00%
cases:1.74%
controls:0.10%
cases:2.74%
controls:0.11%
20
23
2902
29124
44
14
2883
29178
—
13
0
2914
29192
27
0
2833
29105
44
29
2480
27918
52
26
1845
22751
Microorganisms panel - Urine sediment
58435-9 [40761536]
8.9e-01
1.7e+00
3.0e+00
—
3.1e+00
1.7e+00
1.2e+00
cases:5.17%
controls:2.20%
cases:5.47%
controls:1.02%
cases:3.01%
controls:0.15%
—
—
cases:2.52%
controls:0.12%
cases:5.27%
controls:1.06%
cases:6.75%
controls:2.05%
151
640
2771
28507
160
298
2767
28894
88
43
2839
29149
—
72
35
2788
29070
133
295
2391
27652
128
467
1769
22310
palonosetron, combinations
A04AA55 [45893275]
1.4e+00
2.8e+00
3.4e+00
—
2.6e+00
1.5e+00
3.1e-01
cases:0.99%
controls:0.26%
cases:1.74%
controls:0.11%
cases:0.82%
controls:0.03%
—
—
cases:0.42%
controls:0.03%
cases:0.48%
controls:0.11%
cases:0.26%
controls:0.19%
29
75
2893
29072
51
33
2876
29159
24
8
2903
29184
—
12
9
2848
29096
12
31
2512
27916
5
44
1892
22733
Karyotype in Bone marrow
81861-7 [21494434]
1.9e+00
3.1e+00
—
1.0e+50
1.0e+50
3.9e+00
2.7e+00
cases:0.89%
controls:0.14%
cases:1.09%
controls:0.05%
—
—
cases:1.98%
controls:0.00%
cases:4.13%
controls:0.00%
cases:2.93%
controls:0.06%
cases:2.37%
controls:0.17%
26
40
2896
29107
32
14
2895
29178
—
58
0
2869
29192
118
0
2742
29105
74
17
2450
27930
45
39
1852
22738
Body CT examination
JN4AD [2001310897]
1.1e+00
2.0e+00
2.1e+00
1.0e+50
2.9e+00
2.0e+00
1.4e+00
cases:3.32%
controls:1.09%
cases:5.02%
controls:0.72%
cases:1.02%
controls:0.12%
cases:1.98%
controls:0.00%
cases:1.61%
controls:0.09%
cases:5.15%
controls:0.74%
cases:7.38%
controls:1.91%
97
318
2825
28829
147
209
2780
28983
30
36
2897
29156
58
0
2869
29192
46
27
2814
29078
130
207
2394
27740
140
436
1757
22341
tinzaparin; parenteral
B01AB10 [21600981]
9.9e-01
1.7e+00
2.9e+00
—
3.2e+00
1.9e+00
8.3e-01
cases:2.26%
controls:0.85%
cases:2.80%
controls:0.55%
cases:1.61%
controls:0.09%
—
—
cases:2.17%
controls:0.09%
cases:4.16%
controls:0.64%
cases:3.58%
controls:1.60%
66
248
2856
28899
82
160
2845
29032
47
25
2880
29167
—
62
27
2798
29078
105
178
2419
27769
68
364
1829
22413
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.0e-01
8.3e-01
1.8e+00
5.3e+00
2.0e+00
8.9e-01
4.4e-01
cases:21.70%
controls:18.46%
cases:18.96%
controls:9.27%
cases:8.30%
controls:1.53%
cases:7.72%
controls:0.04%
cases:10.07%
controls:1.42%
cases:19.89%
controls:9.29%
cases:31.00%
controls:22.37%
634
5381
2288
23766
555
2705
2372
26487
243
447
2684
28745
226
12
2701
29180
288
414
2572
28691
502
2596
2022
25351
588
5095
1309
17682
Lymph node Pathology biopsy report
66112-4 [40768795]
2.3e+00
3.9e+00
1.0e+50
—
—
2.4e+00
2.8e+00
cases:1.37%
controls:0.14%
cases:2.32%
controls:0.05%
cases:0.55%
controls:0.00%
—
—
—
—
cases:0.83%
controls:0.08%
cases:1.48%
controls:0.09%
40
40
2882
29107
68
14
2859
29178
16
0
2911
29192
—
—
21
21
2503
27926
28
20
1869
22757
Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
29723-4 [3037875]
1.8e+00
3.2e+00
—
1.0e+50
—
3.6e+00
2.8e+00
cases:0.55%
controls:0.09%
cases:0.96%
controls:0.04%
—
—
cases:0.20%
controls:0.00%
—
—
cases:1.58%
controls:0.04%
cases:1.58%
controls:0.10%
16
26
2906
29121
28
11
2899
29181
—
6
0
2921
29192
—
40
12
2484
27935
30
23
1867
22754
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
4.2e-01
1.4e+00
3.0e+00
—
3.9e+00
2.0e+00
1.1e+00
cases:0.68%
controls:0.45%
cases:0.72%
controls:0.17%
cases:0.55%
controls:0.03%
—
—
cases:0.80%
controls:0.02%
cases:0.99%
controls:0.13%
cases:1.16%
controls:0.38%
20
131
2902
29016
21
51
2906
29141
16
8
2911
29184
—
23
5
2837
29100
25
36
2499
27911
22
87
1875
22690
General Practice
1 [38004446]
3.3e-01
6.1e-01
1.5e+00
5.4e+00
2.1e+00
9.5e-01
4.9e-01
cases:19.82%
controls:15.09%
cases:11.10%
controls:6.35%
cases:4.30%
controls:0.98%
cases:4.51%
controls:0.02%
cases:7.31%
controls:1.00%
cases:15.61%
controls:6.69%
cases:25.46%
controls:17.36%
579
4397
2343
24750
325
1853
2602
27339
126
286
2801
28906
132
6
2795
29186
209
292
2651
28813
394
1871
2130
26076
483
3954
1414
18823
Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49672-9 [3032699]
1.8e+00
3.3e+00
—
1.0e+50
—
3.6e+00
2.6e+00
cases:0.58%
controls:0.09%
cases:1.02%
controls:0.04%
—
—
cases:0.20%
controls:0.00%
—
—
cases:1.58%
controls:0.04%
cases:1.79%
controls:0.14%
17
27
2905
29120
30
11
2897
29181
—
6
0
2921
29192
—
40
12
2484
27935
34
31
1863
22746
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.5e-01
9.3e-01
1.8e+00
5.0e+00
2.2e+00
8.4e-01
2.7e-01
cases:16.02%
controls:11.85%
cases:15.61%
controls:6.80%
cases:6.53%
controls:1.09%
cases:5.06%
controls:0.04%
cases:7.69%
controls:0.93%
cases:15.69%
controls:7.45%
cases:23.99%
controls:19.41%
468
3453
2454
25694
457
1984
2470
27208
191
318
2736
28874
148
11
2779
29181
220
271
2640
28834
396
2082
2128
25865
455
4422
1442
18355
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.3e-01
9.3e-01
1.8e+00
5.0e+00
2.2e+00
8.5e-01
2.7e-01
cases:15.33%
controls:11.48%
cases:15.24%
controls:6.64%
cases:6.39%
controls:1.08%
cases:5.06%
controls:0.04%
cases:7.62%
controls:0.91%
cases:15.53%
controls:7.26%
cases:23.67%
controls:19.08%
448
3345
2474
25802
446
1937
2481
27255
187
315
2740
28877
148
11
2779
29181
218
266
2642
28839
392
2029
2132
25918
449
4345
1448
18432
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
9.0e-01
1.6e+00
2.5e+00
—
3.0e+00
1.8e+00
1.4e+00
cases:4.76%
controls:1.99%
cases:4.44%
controls:0.93%
cases:1.54%
controls:0.12%
—
—
cases:1.92%
controls:0.10%
cases:5.31%
controls:0.89%
cases:8.80%
controls:2.23%
139
579
2783
28568
130
272
2797
28920
45
36
2882
29156
—
55
28
2805
29077
134
248
2390
27699
167
509
1730
22268
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.4e-01
9.1e-01
1.8e+00
5.0e+00
2.2e+00
8.4e-01
2.6e-01
cases:15.74%
controls:11.70%
cases:15.27%
controls:6.73%
cases:6.46%
controls:1.11%
cases:5.12%
controls:0.04%
cases:7.62%
controls:0.93%
cases:15.69%
controls:7.44%
cases:23.83%
controls:19.40%
460
3410
2462
25737
447
1966
2480
27226
189
325
2738
28867
150
11
2777
29181
218
270
2642
28835
396
2080
2128
25867
452
4419
1445
18358
Other and unspecified cirrhosis of liver
K74.6 [45538546]
2.2e+00
2.5e+00
—
1.0e+50
—
3.3e+00
3.3e+00
cases:0.75%
controls:0.09%
cases:0.75%
controls:0.06%
—
—
cases:0.41%
controls:0.00%
—
—
cases:1.82%
controls:0.07%
cases:3.58%
controls:0.14%
22
25
2900
29122
22
18
2905
29174
—
12
0
2915
29192
—
46
20
2478
27927
68
31
1829
22746
Oesophageal varices without bleeding
I85.9 [45581834]
1.9e+00
2.9e+00
—
—
—
3.1e+00
3.4e+00
cases:0.48%
controls:0.08%
cases:0.38%
controls:0.02%
—
—
—
—
—
—
cases:1.23%
controls:0.06%
cases:2.58%
controls:0.09%
14
22
2908
29125
11
6
2916
29186
—
—
—
31
16
2493
27931
49
20
1848
22757
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
9.4e-01
2.1e+00
3.1e+00
1.0e+50
—
3.1e+00
1.9e+00
cases:0.86%
controls:0.34%
cases:1.16%
controls:0.14%
cases:0.55%
controls:0.02%
cases:0.17%
controls:0.00%
—
—
cases:2.14%
controls:0.10%
cases:1.90%
controls:0.28%
25
98
2897
29049
34
40
2893
29152
16
7
2911
29185
5
0
2922
29192
—
54
28
2470
27919
36
63
1861
22714
Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
71668-8 [43055361]
2.3e+00
3.6e+00
—
1.0e+50
1.0e+50
3.7e+00
1.6e+00
cases:0.62%
controls:0.06%
cases:1.13%
controls:0.03%
—
—
cases:0.31%
controls:0.00%
cases:1.05%
controls:0.00%
cases:1.23%
controls:0.03%
cases:0.95%
controls:0.18%
18
18
2904
29129
33
9
2894
29183
—
9
0
2918
29192
30
0
2830
29105
31
9
2493
27938
18
42
1879
22735
INR in Blood by Coagulation assay
34714-6 [3032080]
4.6e-01
1.1e+00
1.5e+00
4.3e+00
1.8e+00
1.2e+00
7.8e-01
cases:19.44%
controls:13.25%
cases:20.26%
controls:7.73%
cases:10.86%
controls:2.65%
cases:9.33%
controls:0.13%
cases:14.02%
controls:2.52%
cases:20.56%
controls:7.37%
cases:28.57%
controls:15.53%
568
3861
2354
25286
593
2256
2334
26936
318
773
2609
28419
273
39
2654
29153
401
733
2459
28372
519
2060
2005
25887
542
3538
1355
19239
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
2.9e-01
9.0e-01
1.9e+00
5.0e+00
2.0e+00
8.0e-01
3.0e-01
cases:12.94%
controls:9.98%
cases:11.65%
controls:5.09%
cases:5.43%
controls:0.84%
cases:3.79%
controls:0.03%
cases:5.07%
controls:0.70%
cases:11.29%
controls:5.40%
cases:18.19%
controls:14.08%
378
2908
2544
26239
341
1487
2586
27705
159
245
2768
28947
111
8
2816
29184
145
205
2715
28900
285
1509
2239
26438
345
3207
1552
19570
prednisolone; oral, parenteral
H02AB06 [21602734]
4.2e-01
1.0e+00
1.6e+00
3.0e+00
2.6e+00
1.6e+00
8.4e-01
cases:16.77%
controls:11.68%
cases:13.39%
controls:5.18%
cases:4.65%
controls:0.95%
cases:0.55%
controls:0.03%
cases:12.41%
controls:1.00%
cases:21.35%
controls:5.03%
cases:23.83%
controls:11.95%
490
3404
2432
25743
392
1513
2535
27679
136
276
2791
28916
16
8
2911
29184
355
292
2505
28813
539
1407
1985
26540
452
2721
1445
20056
prednisolone
A07EA01 [21600653]
4.2e-01
1.0e+00
1.6e+00
3.0e+00
2.6e+00
1.6e+00
8.3e-01
cases:16.84%
controls:11.71%
cases:13.43%
controls:5.23%
cases:4.65%
controls:0.95%
cases:0.55%
controls:0.03%
cases:12.41%
controls:1.01%
cases:21.47%
controls:5.05%
cases:23.88%
controls:11.99%
492
3414
2430
25733
393
1526
2534
27666
136
277
2791
28915
16
8
2911
29184
355
293
2505
28812
542
1411
1982
26536
453
2731
1444
20046
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
3.9e-01
1.5e+00
3.0e+00
—
3.7e+00
1.9e+00
1.0e+00
cases:0.82%
controls:0.56%
cases:0.89%
controls:0.20%
cases:0.55%
controls:0.03%
—
—
cases:0.84%
controls:0.02%
cases:0.99%
controls:0.15%
cases:1.27%
controls:0.45%
24
163
2898
28984
26
59
2901
29133
16
8
2911
29184
—
24
6
2836
29099
25
41
2499
27906
24
102
1873
22675
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
6.7e-01
1.4e+00
2.6e+00
—
3.4e+00
2.0e+00
1.1e+00
cases:4.72%
controls:2.46%
cases:4.20%
controls:1.02%
cases:1.61%
controls:0.13%
—
—
cases:3.01%
controls:0.10%
cases:6.22%
controls:0.91%
cases:7.59%
controls:2.76%
138
718
2784
28429
123
298
2804
28894
47
37
2880
29155
—
86
29
2774
29076
157
255
2367
27692
144
628
1753
22149
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
8.4e-01
1.3e+00
3.1e+00
—
3.4e+00
1.7e+00
8.0e-01
cases:3.97%
controls:1.75%
cases:3.86%
controls:1.07%
cases:2.15%
controls:0.10%
—
—
cases:3.32%
controls:0.11%
cases:5.78%
controls:1.13%
cases:7.80%
controls:3.67%
116
511
2806
28636
113
312
2814
28880
63
29
2864
29163
—
95
33
2765
29072
146
315
2378
27632
148
835
1749
21942
dexamethasone; oral, parenteral
H02AB02 [21602730]
8.4e-01
2.0e+00
3.0e+00
—
2.7e+00
1.8e+00
7.4e-01
cases:5.41%
controls:2.40%
cases:7.21%
controls:1.00%
cases:3.07%
controls:0.16%
—
—
cases:2.55%
controls:0.17%
cases:6.26%
controls:1.07%
cases:6.22%
controls:3.08%
158
700
2764
28447
211
291
2716
28901
90
48
2837
29144
—
73
50
2787
29055
158
300
2366
27647
118
701
1779
22076
cyclophosphamide
L01AA01 [21601390]
2.4e+00
3.3e+00
—
—
1.0e+50
3.4e+00
2.1e+00
cases:0.62%
controls:0.06%
cases:0.44%
controls:0.02%
—
—
—
—
cases:0.21%
controls:0.00%
cases:0.63%
controls:0.02%
cases:0.32%
controls:0.04%
18
17
2904
29130
13
5
2914
29187
—
—
6
0
2854
29105
16
6
2508
27941
6
9
1891
22768
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
8.2e-01
1.3e+00
3.0e+00
—
3.4e+00
1.7e+00
8.0e-01
cases:3.83%
controls:1.72%
cases:3.93%
controls:1.06%
cases:2.32%
controls:0.11%
—
—
cases:3.60%
controls:0.13%
cases:6.10%
controls:1.17%
cases:8.22%
controls:3.86%
112
502
2810
28645
115
309
2812
28883
68
33
2859
29159
—
103
37
2757
29068
154
326
2370
27621
156
880
1741
21897
Other transplanted organ and tissue status
Z94.8 [45600381]
—
2.2e+00
2.1e+00
—
—
3.2e+00
3.5e+00
—
—
cases:0.34%
controls:0.04%
cases:0.20%
controls:0.02%
—
—
—
—
cases:1.31%
controls:0.05%
cases:1.42%
controls:0.04%
—
10
11
2917
29181
6
7
2921
29185
—
—
33
15
2491
27932
27
10
1870
22767
Chronic kidney disease, unspecified
N18.9 [45553438]
6.3e-01
8.2e-01
1.5e+00
3.8e+00
2.0e+00
1.3e+00
9.2e-01
cases:1.92%
controls:1.03%
cases:1.61%
controls:0.72%
cases:0.85%
controls:0.18%
cases:1.30%
controls:0.03%
cases:1.36%
controls:0.18%
cases:2.65%
controls:0.75%
cases:3.69%
controls:1.51%
56
299
2866
28848
47
209
2880
28983
25
54
2902
29138
38
9
2889
29183
39
52
2821
29053
67
210
2457
27737
70
343
1827
22434
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
7.1e-01
1.4e+00
2.4e+00
—
3.6e+00
1.9e+00
1.0e+00
cases:1.13%
controls:0.56%
cases:0.92%
controls:0.24%
cases:0.34%
controls:0.03%
—
—
cases:0.77%
controls:0.02%
cases:1.35%
controls:0.21%
cases:1.48%
controls:0.55%
33
163
2889
28984
27
69
2900
29123
10
9
2917
29183
—
22
6
2838
29099
34
59
2490
27888
28
125
1869
22652
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
2.4e-01
7.8e-01
1.8e+00
4.8e+00
2.1e+00
8.1e-01
4.1e-01
cases:23.44%
controls:19.48%
cases:19.27%
controls:9.83%
cases:8.75%
controls:1.51%
cases:6.46%
controls:0.06%
cases:10.17%
controls:1.33%
cases:19.93%
controls:9.93%
cases:31.63%
controls:23.52%
685
5677
2237
23470
564
2871
2363
26321
256
441
2671
28751
189
17
2738
29175
291
388
2569
28717
503
2776
2021
25171
600
5358
1297
17419
Epistaxis
R04.0 [45606791]
7.2e-01
1.4e+00
2.5e+00
1.0e+50
3.6e+00
1.6e+00
1.0e+00
cases:2.09%
controls:1.03%
cases:1.26%
controls:0.31%
cases:0.38%
controls:0.03%
cases:0.79%
controls:0.00%
cases:0.77%
controls:0.02%
cases:1.58%
controls:0.31%
cases:2.95%
controls:1.05%
61
299
2861
28848
37
90
2890
29102
11
9
2916
29183
23
0
2904
29192
22
6
2838
29099
40
88
2484
27859
56
240
1841
22537
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
2.0e+00
3.7e+00
—
—
1.0e+50
3.1e+00
2.1e+00
cases:2.94%
controls:0.41%
cases:5.47%
controls:0.14%
—
—
—
—
cases:2.52%
controls:0.00%
cases:2.38%
controls:0.11%
cases:2.53%
controls:0.31%
86
120
2836
29027
160
42
2767
29150
—
—
72
0
2788
29105
60
30
2464
27917
48
71
1849
22706
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
7.9e-01
1.3e+00
2.7e+00
—
3.4e+00
1.7e+00
8.7e-01
cases:5.41%
controls:2.53%
cases:5.36%
controls:1.48%
cases:3.01%
controls:0.20%
—
—
cases:4.72%
controls:0.17%
cases:8.08%
controls:1.57%
cases:11.12%
controls:5.01%
158
738
2764
28409
157
431
2770
28761
88
58
2839
29134
—
135
49
2725
29056
204
438
2320
27509
211
1140
1686
21637
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
1.3e+00
2.2e+00
3.0e+00
—
—
2.4e+00
1.9e+00
cases:1.33%
controls:0.37%
cases:1.33%
controls:0.15%
cases:0.34%
controls:0.02%
—
—
—
—
cases:1.58%
controls:0.14%
cases:3.06%
controls:0.46%
39
109
2883
29038
39
44
2888
29148
10
5
2917
29187
—
—
40
40
2484
27907
58
105
1839
22672
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
8.1e-01
1.5e+00
2.8e+00
—
2.8e+00
1.7e+00
1.1e+00
cases:6.19%
controls:2.84%
cases:6.73%
controls:1.56%
cases:3.25%
controls:0.20%
—
—
cases:3.99%
controls:0.24%
cases:9.19%
controls:1.73%
cases:12.02%
controls:4.55%
181
829
2741
28318
197
454
2730
28738
95
58
2832
29134
—
114
70
2746
29035
232
484
2292
27463
228
1036
1669
21741
Bacteria identified in Urine by Culture
630-4 [3026008]
3.1e-01
8.1e-01
1.7e+00
4.6e+00
1.9e+00
8.9e-01
5.3e-01
cases:9.00%
controls:6.75%
cases:7.28%
controls:3.37%
cases:2.70%
controls:0.52%
cases:1.95%
controls:0.02%
cases:3.46%
controls:0.51%
cases:8.48%
controls:3.66%
cases:15.34%
controls:9.66%
263
1966
2659
27181
213
985
2714
28207
79
152
2848
29040
57
6
2870
29186
99
148
2761
28957
214
1022
2310
26925
291
2200
1606
20577
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
6.5e-01
1.4e+00
2.2e+00
1.0e+50
3.5e+00
2.1e+00
9.0e-01
cases:4.38%
controls:2.34%
cases:3.45%
controls:0.90%
cases:1.02%
controls:0.11%
cases:2.87%
controls:0.00%
cases:1.96%
controls:0.06%
cases:5.07%
controls:0.66%
cases:5.80%
controls:2.44%
128
681
2794
28466
101
263
2826
28929
30
32
2897
29160
84
0
2843
29192
56
18
2804
29087
128
184
2396
27763
110
556
1787
22221
Biopsy of lymphnode with ultrasound guidance
PJ2AT [2001309679]
2.3e+00
3.1e+00
—
—
—
2.7e+00
2.6e+00
cases:0.24%
controls:0.02%
cases:0.68%
controls:0.03%
—
—
—
—
—
—
cases:0.32%
controls:0.02%
cases:0.42%
controls:0.03%
7
7
2915
29140
20
9
2907
29183
—
—
—
8
6
2516
27941
8
7
1889
22770
Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
55774-4 [40758895]
2.2e+00
2.9e+00
—
1.0e+50
—
3.3e+00
2.3e+00
cases:0.48%
controls:0.05%
cases:0.61%
controls:0.03%
—
—
cases:0.44%
controls:0.00%
—
—
cases:1.19%
controls:0.05%
cases:1.21%
controls:0.12%
14
15
2908
29132
18
10
2909
29182
—
13
0
2914
29192
—
30
13
2494
27934
23
27
1874
22750
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
55776-9 [40758897]
2.2e+00
2.9e+00
—
1.0e+50
—
3.3e+00
2.3e+00
cases:0.48%
controls:0.05%
cases:0.61%
controls:0.03%
—
—
cases:0.44%
controls:0.00%
—
—
cases:1.19%
controls:0.05%
cases:1.21%
controls:0.12%
14
15
2908
29132
18
10
2909
29182
—
13
0
2914
29192
—
30
13
2494
27934
23
27
1874
22750
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
6.6e-01
1.4e+00
2.6e+00
—
3.1e+00
2.0e+00
1.0e+00
cases:4.62%
controls:2.44%
cases:3.18%
controls:0.82%
cases:1.23%
controls:0.10%
—
—
cases:2.31%
controls:0.11%
cases:5.67%
controls:0.83%
cases:7.38%
controls:2.80%
135
710
2787
28437
93
240
2834
28952
36
28
2891
29164
—
66
31
2794
29074
143
232
2381
27715
140
637
1757
22140
Morphology [Interpretation] in Blood Narrative
18314-5 [3000093]
1.7e+00
3.3e+00
—
1.0e+50
—
3.2e+00
2.4e+00
cases:1.13%
controls:0.20%
cases:1.67%
controls:0.06%
—
—
cases:0.79%
controls:0.00%
—
—
cases:1.78%
controls:0.08%
cases:1.90%
controls:0.17%
33
59
2889
29088
49
18
2878
29174
—
23
0
2904
29192
—
45
21
2479
27926
36
38
1861
22739
Bacteria identified in Blood by Culture
600-7 [3023368]
6.1e-01
1.4e+00
2.8e+00
—
3.3e+00
1.7e+00
7.9e-01
cases:9.89%
controls:5.64%
cases:10.32%
controls:2.72%
cases:6.05%
controls:0.39%
—
—
cases:9.65%
controls:0.38%
cases:13.79%
controls:2.73%
cases:16.55%
controls:8.28%
289
1645
2633
27502
302
793
2625
28399
177
114
2750
29078
—
276
111
2584
28994
348
763
2176
27184
314
1886
1583
20891
tranexamic acid; oral, parenteral
B02AA02 [21601036]
6.7e-01
1.3e+00
2.5e+00
—
2.9e+00
1.9e+00
1.4e+00
cases:1.78%
controls:0.92%
cases:1.06%
controls:0.30%
cases:0.51%
controls:0.04%
—
—
cases:0.66%
controls:0.04%
cases:1.82%
controls:0.27%
cases:4.01%
controls:1.00%
52
267
2870
28880
31
88
2896
29104
15
12
2912
29180
—
19
11
2841
29094
46
76
2478
27871
76
228
1821
22549
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.6e-01
6.1e-01
2.0e+00
4.7e+00
2.1e+00
7.2e-01
3.2e-01
cases:30.80%
controls:27.45%
cases:35.05%
controls:22.75%
cases:29.55%
controls:5.33%
cases:25.59%
controls:0.31%
cases:31.54%
controls:5.17%
cases:38.35%
controls:23.30%
cases:45.97%
controls:38.24%
900
8002
2022
21145
1026
6640
1901
22552
865
1557
2062
27635
749
91
2178
29101
902
1505
1958
27600
968
6511
1556
21436
872
8710
1025
14067
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
7.9e-01
1.5e+00
2.8e+00
—
2.9e+00
1.7e+00
9.7e-01
cases:6.33%
controls:2.97%
cases:6.90%
controls:1.68%
cases:3.45%
controls:0.22%
—
—
cases:4.27%
controls:0.24%
cases:9.23%
controls:1.89%
cases:12.23%
controls:5.01%
185
866
2737
28281
202
491
2725
28701
101
64
2826
29128
—
122
71
2738
29034
233
528
2291
27419
232
1141
1665
21636
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
9.2e-01
2.2e+00
2.9e+00
—
2.2e+00
1.5e+00
7.8e-01
cases:7.70%
controls:3.21%
cases:10.73%
controls:1.29%
cases:2.90%
controls:0.16%
—
—
cases:1.57%
controls:0.18%
cases:5.47%
controls:1.24%
cases:7.12%
controls:3.40%
225
935
2697
28212
314
377
2613
28815
85
47
2842
29145
—
45
51
2815
29054
138
347
2386
27600
135
774
1762
22003
B-cell lymphoma, unspecified
C85.1 [45586056]
2.2e+00
3.3e+00
—
—
—
2.6e+00
2.5e+00
cases:0.27%
controls:0.03%
cases:0.44%
controls:0.02%
—
—
—
—
—
—
cases:0.24%
controls:0.02%
cases:0.32%
controls:0.03%
8
9
2914
29138
13
5
2914
29187
—
—
—
6
5
2518
27942
6
6
1891
22771
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
7.7e-01
1.4e+00
2.7e+00
—
3.0e+00
1.6e+00
9.5e-01
cases:6.81%
controls:3.27%
cases:7.11%
controls:1.80%
cases:3.52%
controls:0.23%
—
—
cases:4.65%
controls:0.25%
cases:9.43%
controls:2.03%
cases:12.81%
controls:5.35%
199
953
2723
28194
208
525
2719
28667
103
68
2824
29124
—
133
74
2727
29031
238
567
2286
27380
243
1219
1654
21558
Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61365-3 [40764126]
1.8e+00
2.9e+00
—
1.0e+50
—
3.4e+00
2.3e+00
cases:0.72%
controls:0.12%
cases:1.09%
controls:0.06%
—
—
cases:0.31%
controls:0.00%
—
—
cases:2.02%
controls:0.07%
cases:1.58%
controls:0.15%
21
36
2901
29111
32
17
2895
29175
—
9
0
2918
29192
—
51
19
2473
27928
30
35
1867
22742
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
8.6e-01
1.4e+00
2.5e+00
—
3.2e+00
1.6e+00
9.6e-01
cases:0.68%
controls:0.29%
cases:0.51%
controls:0.13%
cases:0.20%
controls:0.02%
—
—
cases:0.42%
controls:0.02%
cases:0.59%
controls:0.13%
cases:1.00%
controls:0.39%
20
85
2902
29062
15
37
2912
29155
6
5
2921
29187
—
12
5
2848
29100
15
35
2509
27912
19
88
1878
22689
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
1.7e+00
1.4e+00
1.7e+00
—
2.0e+00
1.9e+00
1.8e+00
cases:0.44%
controls:0.08%
cases:0.44%
controls:0.11%
cases:0.31%
controls:0.05%
—
—
cases:0.42%
controls:0.06%
cases:0.79%
controls:0.12%
cases:0.90%
controls:0.15%
13
24
2909
29123
13
32
2914
29160
9
16
2918
29176
—
12
17
2848
29088
20
34
2504
27913
17
35
1880
22742
CD3+CD4+ (T4 helper) cells/cells in Blood
8123-2 [3014037]
1.7e+00
3.3e+00
—
—
—
2.9e+00
2.5e+00
cases:0.48%
controls:0.09%
cases:0.89%
controls:0.03%
—
—
—
—
—
—
cases:1.19%
controls:0.06%
cases:1.11%
controls:0.09%
14
26
2908
29121
26
10
2901
29182
—
—
—
30
18
2494
27929
21
20
1876
22757
Radiotherapy of metastasis
WF049 [2001310705]
1.7e+00
2.0e+00
3.3e+00
—
—
2.4e+00
1.1e+00
cases:0.65%
controls:0.12%
cases:0.75%
controls:0.11%
cases:0.48%
controls:0.02%
—
—
—
—
cases:1.43%
controls:0.14%
cases:1.11%
controls:0.39%
19
35
2903
29112
22
31
2905
29161
14
5
2913
29187
—
—
36
38
2488
27909
21
88
1876
22689
moxifloxacin; oral, parenteral
J01MA14 [21603021]
5.0e-01
1.7e+00
2.2e+00
—
3.5e+00
2.1e+00
9.3e-01
cases:1.44%
controls:0.88%
cases:1.09%
controls:0.20%
cases:0.24%
controls:0.03%
—
—
cases:0.91%
controls:0.03%
cases:2.22%
controls:0.29%
cases:2.32%
controls:0.93%
42
256
2880
28891
32
59
2895
29133
7
8
2920
29184
—
26
8
2834
29097
56
81
2468
27866
44
211
1853
22566
Ascites
R18 [45548949]
1.7e+00
2.6e+00
—
1.0e+50
—
3.5e+00
2.5e+00
cases:0.44%
controls:0.08%
cases:0.48%
controls:0.03%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.67%
controls:0.02%
cases:1.63%
controls:0.13%
13
23
2909
29124
14
10
2913
29182
—
9
0
2918
29192
—
17
6
2507
27941
31
30
1866
22747
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
8.9e-01
1.2e+00
2.5e+00
—
2.9e+00
1.9e+00
9.4e-01
cases:0.79%
controls:0.33%
cases:1.06%
controls:0.32%
cases:0.51%
controls:0.04%
—
—
cases:0.56%
controls:0.03%
cases:1.62%
controls:0.26%
cases:2.58%
controls:1.02%
23
95
2899
29052
31
93
2896
29099
15
12
2912
29180
—
16
9
2844
29096
41
72
2483
27875
49
233
1848
22544
Outpatient Visit
OP [9202]
2.1e-01
6.1e-01
1.1e+00
4.6e+00
1.8e+00
1.3e+00
7.6e-01
cases:78.41%
controls:74.65%
cases:69.32%
controls:55.18%
cases:27.88%
controls:11.61%
cases:32.59%
controls:0.48%
cases:43.11%
controls:11.41%
cases:80.59%
controls:53.80%
cases:89.56%
controls:79.98%
2291
21758
631
7389
2029
16107
898
13085
816
3388
2111
25804
954
141
1973
29051
1233
3320
1627
25785
2034
15035
490
12912
1699
18216
198
4561
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
2.6e-01
1.9e+00
2.5e+00
1.0e+50
2.9e+00
1.8e+00
1.3e+00
cases:1.37%
controls:1.06%
cases:1.84%
controls:0.28%
cases:0.48%
controls:0.04%
cases:0.27%
controls:0.00%
cases:0.49%
controls:0.03%
cases:1.62%
controls:0.28%
cases:2.58%
controls:0.73%
40
310
2882
28837
54
82
2873
29110
14
12
2913
29180
8
0
2919
29192
14
8
2846
29097
41
78
2483
27869
49
167
1848
22610
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
1.2e+00
2.4e+00
—
—
—
3.3e+00
3.4e+00
cases:0.55%
controls:0.17%
cases:0.61%
controls:0.06%
—
—
—
—
—
—
cases:1.39%
controls:0.05%
cases:2.21%
controls:0.08%
16
49
2906
29098
18
17
2909
29175
—
—
—
35
14
2489
27933
42
18
1855
22759
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.9e-01
7.1e-01
1.9e+00
4.1e+00
2.1e+00
8.3e-01
3.0e-01
cases:20.40%
controls:16.03%
cases:14.21%
controls:7.52%
cases:6.49%
controls:1.02%
cases:3.11%
controls:0.05%
cases:6.50%
controls:0.84%
cases:15.37%
controls:7.34%
cases:25.30%
controls:20.08%
596
4671
2326
24476
416
2195
2511
26997
190
298
2737
28894
91
16
2836
29176
186
244
2674
28861
388
2050
2136
25897
480
4574
1417
18203
Oxygen saturation in Capillary blood
2709-4 [3021901]
7.7e-01
1.3e+00
2.8e+00
1.0e+50
3.2e+00
1.8e+00
1.1e+00
cases:0.58%
controls:0.27%
cases:0.72%
controls:0.19%
cases:0.41%
controls:0.02%
cases:0.20%
controls:0.00%
cases:0.66%
controls:0.03%
cases:1.39%
controls:0.24%
cases:2.16%
controls:0.72%
17
79
2905
29068
21
56
2906
29136
12
7
2915
29185
6
0
2921
29192
19
8
2841
29097
35
68
2489
27879
41
165
1856
22612
pH of Urine
2756-5 [3015736]
2.7e-01
7.4e-01
1.4e+00
4.8e+00
2.1e+00
7.9e-01
2.0e-01
cases:11.77%
controls:9.23%
cases:9.84%
controls:4.94%
cases:3.25%
controls:0.81%
cases:2.94%
controls:0.02%
cases:5.07%
controls:0.63%
cases:10.66%
controls:5.12%
cases:17.29%
controls:14.59%
344
2690
2578
26457
288
1443
2639
27749
95
237
2832
28955
86
7
2841
29185
145
182
2715
28923
269
1430
2255
26517
328
3324
1569
19453
Metastasis
OMOP4998856 [36769180]
1.3e+00
2.2e+00
2.5e+00
—
2.6e+00
1.6e+00
8.5e-01
cases:0.72%
controls:0.20%
cases:1.84%
controls:0.21%
cases:1.61%
controls:0.14%
—
—
cases:1.61%
controls:0.12%
cases:1.31%
controls:0.27%
cases:0.79%
controls:0.34%
21
57
2901
29090
54
62
2873
29130
47
41
2880
29151
—
46
35
2814
29070
33
75
2491
27872
15
77
1882
22700
Secondary malignant neoplasm of other specified sites
C79.8 [45547524]
1.3e+00
2.2e+00
2.5e+00
—
2.6e+00
1.6e+00
8.5e-01
cases:0.72%
controls:0.20%
cases:1.84%
controls:0.21%
cases:1.61%
controls:0.14%
—
—
cases:1.57%
controls:0.12%
cases:1.31%
controls:0.26%
cases:0.79%
controls:0.34%
21
57
2901
29090
54
62
2873
29130
47
41
2880
29151
—
45
35
2815
29070
33
74
2491
27873
15
77
1882
22700
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
2.3e-01
8.5e-01
2.0e+00
3.7e+00
2.1e+00
7.9e-01
4.5e-01
cases:25.50%
controls:21.44%
cases:22.14%
controls:10.88%
cases:9.70%
controls:1.44%
cases:3.25%
controls:0.09%
cases:10.38%
controls:1.34%
cases:20.52%
controls:10.48%
cases:35.32%
controls:25.78%
745
6250
2177
22897
648
3175
2279
26017
284
421
2643
28771
95
25
2832
29167
297
390
2563
28715
518
2928
2006
25019
670
5873
1227
16904
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
-5.0e-03
1.6e+00
3.2e+00
—
3.1e+00
1.7e+00
5.3e-01
cases:1.44%
controls:1.44%
cases:2.56%
controls:0.55%
cases:0.92%
controls:0.04%
—
—
cases:1.01%
controls:0.04%
cases:2.42%
controls:0.47%
cases:2.79%
controls:1.66%
42
421
2880
28726
75
162
2852
29030
27
11
2900
29181
—
29
13
2831
29092
61
131
2463
27816
53
378
1844
22399
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
1.2e+00
2.2e+00
—
—
—
3.4e+00
3.3e+00
cases:0.55%
controls:0.16%
cases:0.51%
controls:0.05%
—
—
—
—
—
—
cases:1.55%
controls:0.05%
cases:2.00%
controls:0.08%
16
48
2906
29099
15
16
2912
29176
—
—
—
39
15
2485
27932
38
18
1859
22759
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 [3016921]
6.1e-01
1.4e+00
2.5e+00
—
3.7e+00
1.8e+00
7.7e-01
cases:0.79%
controls:0.43%
cases:0.75%
controls:0.19%
cases:0.20%
controls:0.02%
—
—
cases:0.80%
controls:0.02%
cases:1.03%
controls:0.18%
cases:1.48%
controls:0.69%
23
125
2899
29022
22
56
2905
29136
6
5
2921
29187
—
23
6
2837
29099
26
50
2498
27897
28
157
1869
22620
Infectious Disease
44 [38004484]
6.5e-01
1.2e+00
2.2e+00
—
2.9e+00
1.8e+00
1.3e+00
cases:3.35%
controls:1.78%
cases:2.25%
controls:0.67%
cases:0.99%
controls:0.11%
—
—
cases:1.89%
controls:0.11%
cases:3.96%
controls:0.68%
cases:6.80%
controls:1.95%
98
520
2824
28627
66
197
2861
28995
29
33
2898
29159
—
54
31
2806
29074
100
189
2424
27758
129
444
1768
22333
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
3.8e-01
1.1e+00
2.6e+00
—
3.5e+00
1.7e+00
8.2e-01
cases:10.10%
controls:7.14%
cases:8.78%
controls:3.12%
cases:4.82%
controls:0.38%
—
—
cases:9.37%
controls:0.33%
cases:12.32%
controls:2.55%
cases:15.81%
controls:7.64%
295
2082
2627
27065
257
910
2670
28282
141
111
2786
29081
—
268
95
2592
29010
311
713
2213
27234
300
1741
1597
21036
prednisone; oral
H02AB07 [21602735]
6.8e-01
1.6e+00
1.5e+00
—
2.8e+00
2.0e+00
1.4e+00
cases:2.81%
controls:1.45%
cases:2.60%
controls:0.55%
cases:0.55%
controls:0.12%
—
—
cases:2.20%
controls:0.14%
cases:4.20%
controls:0.59%
cases:4.90%
controls:1.23%
82
422
2840
28725
76
161
2851
29031
16
35
2911
29157
—
63
40
2797
29065
106
164
2418
27783
93
280
1804
22497
prednisone
A07EA03 [21600655]
6.8e-01
1.6e+00
1.5e+00
—
2.8e+00
2.0e+00
1.4e+00
cases:2.81%
controls:1.45%
cases:2.60%
controls:0.55%
cases:0.55%
controls:0.12%
—
—
cases:2.20%
controls:0.14%
cases:4.20%
controls:0.59%
cases:4.90%
controls:1.23%
82
422
2840
28725
76
161
2851
29031
16
35
2911
29157
—
63
40
2797
29065
106
164
2418
27783
93
280
1804
22497
Sepsis, unspecified
A41.9 [45585911]
9.8e-01
2.2e+00
2.3e+00
—
3.3e+00
2.2e+00
1.3e+00
cases:0.75%
controls:0.28%
cases:0.61%
controls:0.07%
cases:0.17%
controls:0.02%
—
—
cases:0.56%
controls:0.02%
cases:0.87%
controls:0.09%
cases:1.58%
controls:0.43%
22
83
2900
29064
18
21
2909
29171
5
5
2922
29187
—
16
6
2844
29099
22
26
2502
27921
30
99
1867
22678
Oncology Clinic/Center
261QX0200X [38004268]
6.3e-01
1.9e+00
2.8e+00
—
3.2e+00
1.1e+00
4.1e-01
cases:12.01%
controls:6.75%
cases:11.45%
controls:1.97%
cases:2.12%
controls:0.14%
—
—
cases:4.27%
controls:0.18%
cases:4.44%
controls:1.59%
cases:8.17%
controls:5.59%
351
1968
2571
27179
335
575
2592
28617
62
40
2865
29152
—
122
51
2738
29054
112
444
2412
27503
155
1274
1742
21503
Melaena
K92.1 [45533624]
7.0e-01
1.6e+00
2.6e+00
—
2.6e+00
1.4e+00
1.1e+00
cases:1.23%
controls:0.62%
cases:0.89%
controls:0.18%
cases:0.27%
controls:0.02%
—
—
cases:0.28%
controls:0.02%
cases:0.83%
controls:0.21%
cases:1.95%
controls:0.68%
36
180
2886
28967
26
53
2901
29139
8
6
2919
29186
—
8
6
2852
29099
21
59
2503
27888
37
154
1860
22623
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 [3028167]
1.5e+00
2.8e+00
—
—
—
2.8e+00
2.9e+00
cases:0.72%
controls:0.16%
cases:0.92%
controls:0.06%
—
—
—
—
—
—
cases:1.07%
controls:0.07%
cases:1.63%
controls:0.09%
21
47
2901
29100
27
17
2900
29175
—
—
—
27
19
2497
27928
31
21
1866
22756
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
6.4e-01
1.3e+00
2.7e+00
—
3.5e+00
1.7e+00
4.1e-01
cases:1.61%
controls:0.85%
cases:1.54%
controls:0.42%
cases:0.68%
controls:0.04%
—
—
cases:1.12%
controls:0.03%
cases:2.50%
controls:0.45%
cases:2.42%
controls:1.62%
47
248
2875
28899
45
122
2882
29070
20
13
2907
29179
—
32
10
2828
29095
63
126
2461
27821
46
368
1851
22409
Multiple myeloma
C90.0 [45600562]
1.2e+00
1.6e+00
2.4e+00
1.0e+50
2.5e+00
2.1e+00
1.4e+00
cases:0.34%
controls:0.11%
cases:0.55%
controls:0.12%
cases:0.61%
controls:0.05%
cases:0.48%
controls:0.00%
cases:0.66%
controls:0.05%
cases:0.91%
controls:0.11%
cases:0.69%
controls:0.18%
10
31
2912
29116
16
34
2911
29158
18
16
2909
29176
14
0
2913
29192
19
16
2841
29089
23
32
2501
27915
13
40
1884
22737
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 [3006999]
6.0e-01
1.3e+00
2.5e+00
—
3.6e+00
1.8e+00
7.7e-01
cases:0.79%
controls:0.43%
cases:0.68%
controls:0.19%
cases:0.20%
controls:0.02%
—
—
cases:0.77%
controls:0.02%
cases:1.03%
controls:0.18%
cases:1.48%
controls:0.69%
23
126
2899
29021
20
56
2907
29136
6
5
2921
29187
—
22
6
2838
29099
26
50
2498
27897
28
157
1869
22620
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
6.3e-01
1.2e+00
2.5e+00
—
3.7e+00
1.7e+00
8.0e-01
cases:0.86%
controls:0.46%
cases:0.68%
controls:0.20%
cases:0.20%
controls:0.02%
—
—
cases:0.80%
controls:0.02%
cases:1.03%
controls:0.19%
cases:1.63%
controls:0.74%
25
134
2897
29013
20
58
2907
29134
6
5
2921
29187
—
23
6
2837
29099
26
53
2498
27894
31
169
1866
22608
Platelets [#/volume] in Blood
26515-7 [3007461]
5.9e-02
4.8e-01
2.0e+00
4.8e+00
2.1e+00
5.5e-01
7.6e-02
cases:44.73%
controls:43.27%
cases:48.31%
controls:36.74%
cases:39.67%
controls:8.54%
cases:35.02%
controls:0.46%
cases:42.10%
controls:8.06%
cases:50.79%
controls:37.28%
cases:58.72%
controls:56.86%
1307
12613
1615
16534
1414
10726
1513
18466
1161
2493
1766
26699
1025
133
1902
29059
1204
2346
1656
26759
1282
10419
1242
17528
1114
12951
783
9826
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
9.3e-01
1.6e+00
2.1e+00
—
2.5e+00
1.4e+00
1.4e+00
cases:0.79%
controls:0.31%
cases:1.09%
controls:0.23%
cases:0.31%
controls:0.04%
—
—
cases:0.49%
controls:0.04%
cases:0.99%
controls:0.24%
cases:1.48%
controls:0.39%
23
91
2899
29056
32
66
2895
29126
9
11
2918
29181
—
14
12
2846
29093
25
68
2499
27879
28
88
1869
22689
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
8.5e-01
1.2e+00
2.0e+00
—
3.1e+00
1.7e+00
1.0e+00
cases:2.60%
controls:1.13%
cases:2.66%
controls:0.79%
cases:0.92%
controls:0.13%
—
—
cases:1.68%
controls:0.08%
cases:3.45%
controls:0.64%
cases:4.59%
controls:1.72%
76
329
2846
28818
78
230
2849
28962
27
38
2900
29154
—
48
23
2812
29082
87
178
2437
27769
87
391
1810
22386
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
5.7e-02
4.7e-01
1.9e+00
4.8e+00
2.1e+00
5.5e-01
6.9e-02
cases:44.80%
controls:43.39%
cases:48.31%
controls:36.80%
cases:39.63%
controls:8.58%
cases:35.05%
controls:0.46%
cases:42.10%
controls:8.07%
cases:50.79%
controls:37.35%
cases:58.67%
controls:56.98%
1309
12646
1613
16501
1414
10742
1513
18450
1160
2504
1767
26688
1026
134
1901
29058
1204
2350
1656
26755
1282
10439
1242
17508
1113
12979
784
9798
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
5.8e-02
4.7e-01
1.9e+00
4.8e+00
2.1e+00
5.5e-01
7.2e-02
cases:44.80%
controls:43.38%
cases:48.27%
controls:36.78%
cases:39.60%
controls:8.57%
cases:35.05%
controls:0.46%
cases:42.10%
controls:8.07%
cases:50.75%
controls:37.32%
cases:58.72%
controls:56.97%
1309
12644
1613
16503
1413
10736
1514
18456
1159
2502
1768
26690
1026
134
1901
29058
1204
2348
1656
26757
1281
10429
1243
17518
1114
12976
783
9801
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
5.8e-02
4.7e-01
1.9e+00
4.8e+00
2.1e+00
5.5e-01
6.9e-02
cases:44.87%
controls:43.43%
cases:48.34%
controls:36.83%
cases:39.70%
controls:8.59%
cases:35.09%
controls:0.46%
cases:42.10%
controls:8.10%
cases:50.79%
controls:37.41%
cases:58.72%
controls:57.04%
1311
12658
1611
16489
1415
10751
1512
18441
1162
2509
1765
26683
1027
134
1900
29058
1204
2358
1656
26747
1282
10455
1242
17492
1114
12991
783
9786
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
5.8e-02
4.7e-01
1.9e+00
4.8e+00
2.1e+00
5.5e-01
7.2e-02
cases:44.80%
controls:43.37%
cases:48.21%
controls:36.80%
cases:39.67%
controls:8.59%
cases:35.05%
controls:0.46%
cases:42.10%
controls:8.08%
cases:50.75%
controls:37.34%
cases:58.72%
controls:56.97%
1309
12642
1613
16505
1411
10744
1516
18448
1161
2507
1766
26685
1026
134
1901
29058
1204
2351
1656
26754
1281
10435
1243
17512
1114
12975
783
9802
MCH [Entitic mass]
28539-5 [3035941]
5.8e-02
4.7e-01
1.9e+00
4.8e+00
2.1e+00
5.5e-01
6.9e-02
cases:44.76%
controls:43.34%
cases:48.21%
controls:36.75%
cases:39.56%
controls:8.56%
cases:35.02%
controls:0.46%
cases:42.03%
controls:8.06%
cases:50.71%
controls:37.29%
cases:58.62%
controls:56.94%
1308
12631
1614
16516
1411
10727
1516
18465
1158
2499
1769
26693
1025
134
1902
29058
1202
2347
1658
26758
1280
10422
1244
17525
1112
12969
785
9808
Multiple adjuvant cytostatic therapy
WB113 [2001310629]
7.0e-01
1.9e+00
3.7e+00
—
2.7e+00
1.6e+00
—
cases:0.96%
controls:0.48%
cases:1.09%
controls:0.17%
cases:0.92%
controls:0.02%
—
—
cases:0.45%
controls:0.03%
cases:0.48%
controls:0.10%
—
—
28
140
2894
29007
32
49
2895
29143
27
7
2900
29185
—
13
9
2847
29096
12
27
2512
27920
—
Leukocytes [#/volume] in Blood
26464-8 [3010813]
5.7e-02
4.7e-01
1.9e+00
4.8e+00
2.1e+00
5.5e-01
7.5e-02
cases:44.83%
controls:43.44%
cases:48.24%
controls:36.84%
cases:39.60%
controls:8.60%
cases:35.09%
controls:0.46%
cases:41.99%
controls:8.08%
cases:50.79%
controls:37.38%
cases:58.83%
controls:57.00%
1310
12661
1612
16486
1412
10754
1515
18438
1159
2510
1768
26682
1027
134
1900
29058
1201
2351
1659
26754
1282
10446
1242
17501
1116
12982
781
9795
Interstitial pulmonary disease, unspecified
J84.9 [45543277]
1.1e+00
1.4e+00
1.7e+00
1.0e+50
2.1e+00
1.8e+00
1.6e+00
cases:0.68%
controls:0.22%
cases:0.61%
controls:0.15%
cases:0.27%
controls:0.05%
cases:0.24%
controls:0.00%
cases:0.24%
controls:0.03%
cases:0.91%
controls:0.15%
cases:1.16%
controls:0.24%
20
65
2902
29082
18
44
2909
29148
8
14
2919
29178
7
0
2920
29192
7
9
2853
29096
23
41
2501
27906
22
55
1875
22722
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
6.2e-01
1.2e+00
2.1e+00
—
2.9e+00
1.7e+00
1.2e+00
cases:5.61%
controls:3.09%
cases:5.98%
controls:1.82%
cases:3.25%
controls:0.39%
—
—
cases:6.19%
controls:0.38%
cases:9.55%
controls:1.83%
cases:10.81%
controls:3.64%
164
902
2758
28245
175
530
2752
28662
95
114
2832
29078
—
177
110
2683
28995
241
511
2283
27436
205
830
1692
21947
CBC panel - Blood by Automated count
58410-2 [40761511]
5.9e-02
4.9e-01
1.8e+00
4.7e+00
2.0e+00
5.6e-01
1.7e-01
cases:38.36%
controls:36.98%
cases:34.92%
controls:24.74%
cases:22.89%
controls:4.77%
cases:20.02%
controls:0.23%
cases:26.19%
controls:4.45%
cases:35.74%
controls:24.06%
cases:48.55%
controls:44.32%
1121
10778
1801
18369
1022
7223
1905
21969
670
1393
2257
27799
586
66
2341
29126
749
1295
2111
27810
902
6723
1622
21224
921
10094
976
12683
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.7e-01
5.5e-01
1.8e+00
4.5e+00
1.9e+00
5.6e-01
2.3e-01
cases:32.20%
controls:28.67%
cases:36.25%
controls:24.70%
cases:25.76%
controls:5.42%
cases:19.78%
controls:0.27%
cases:27.80%
controls:5.32%
cases:37.56%
controls:25.61%
cases:46.44%
controls:40.68%
941
8356
1981
20791
1061
7209
1866
21983
754
1582
2173
27610
579
80
2348
29112
795
1547
2065
27558
948
7156
1576
20791
881
9266
1016
13511
Atrial fibrillation and flutter
I48 [45596206]
4.0e-01
5.6e-01
1.2e+00
4.8e+00
1.6e+00
7.7e-01
4.0e-01
cases:11.02%
controls:7.70%
cases:7.28%
controls:4.29%
cases:2.60%
controls:0.82%
cases:3.93%
controls:0.03%
cases:3.46%
controls:0.75%
cases:8.40%
controls:4.09%
cases:11.70%
controls:8.13%
322
2243
2600
26904
213
1252
2714
27940
76
240
2851
28952
115
10
2812
29182
99
217
2761
28888
212
1142
2312
26805
222
1851
1675
20926
Extensive abdominal CT
JN3BD [2001305556]
4.9e-01
1.4e+00
1.9e+00
—
3.0e+00
1.6e+00
1.2e+00
cases:2.02%
controls:1.25%
cases:1.33%
controls:0.33%
cases:0.31%
controls:0.04%
—
—
cases:0.42%
controls:0.02%
cases:1.27%
controls:0.26%
cases:2.58%
controls:0.82%
59
363
2863
28784
39
95
2888
29097
9
13
2918
29179
—
12
6
2848
29099
32
72
2492
27875
49
186
1848
22591
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
7.1e-01
1.2e+00
2.9e+00
1.0e+50
3.1e+00
1.6e+00
7.9e-01
cases:0.79%
controls:0.39%
cases:0.92%
controls:0.29%
cases:0.55%
controls:0.03%
cases:0.27%
controls:0.00%
cases:0.87%
controls:0.04%
cases:1.74%
controls:0.34%
cases:2.64%
controls:1.21%
23
113
2899
29034
27
85
2900
29107
16
9
2911
29183
8
0
2919
29192
25
11
2835
29094
44
95
2480
27852
50
276
1847
22501
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
7.4e-02
5.0e-01
1.8e+00
4.6e+00
2.1e+00
5.5e-01
1.3e-01
cases:40.28%
controls:38.52%
cases:42.30%
controls:30.69%
cases:28.87%
controls:6.29%
cases:24.74%
controls:0.33%
cases:33.74%
controls:5.78%
cases:44.02%
controls:31.16%
cases:53.66%
controls:50.30%
1177
11226
1745
17921
1238
8959
1689
20233
845
1836
2082
27356
724
95
2203
29097
965
1681
1895
27424
1111
8707
1413
19240
1018
11457
879
11320
Metastasis to liver
OMOP5000224 [36770544]
1.6e+00
2.0e+00
2.1e+00
—
2.2e+00
1.6e+00
7.6e-01
cases:0.62%
controls:0.13%
cases:1.13%
controls:0.15%
cases:0.65%
controls:0.08%
—
—
cases:0.73%
controls:0.08%
cases:0.79%
controls:0.15%
cases:0.58%
controls:0.27%
18
38
2904
29109
33
44
2894
29148
19
23
2908
29169
—
21
23
2839
29082
20
43
2504
27904
11
62
1886
22715
Secondary malignant neoplasm of liver and intrahepatic bile duct
C78.7 [45595688]
1.6e+00
2.0e+00
2.1e+00
—
2.2e+00
1.6e+00
7.6e-01
cases:0.62%
controls:0.13%
cases:1.13%
controls:0.15%
cases:0.65%
controls:0.08%
—
—
cases:0.73%
controls:0.08%
cases:0.79%
controls:0.15%
cases:0.58%
controls:0.27%
18
38
2904
29109
33
44
2894
29148
19
23
2908
29169
—
21
23
2839
29082
20
43
2504
27904
11
62
1886
22715
Metastasis to intrahepatic bile ducts
OMOP5031661 [35226180]
1.6e+00
2.0e+00
2.1e+00
—
2.2e+00
1.6e+00
7.6e-01
cases:0.62%
controls:0.13%
cases:1.13%
controls:0.15%
cases:0.65%
controls:0.08%
—
—
cases:0.73%
controls:0.08%
cases:0.79%
controls:0.15%
cases:0.58%
controls:0.27%
18
38
2904
29109
33
44
2894
29148
19
23
2908
29169
—
21
23
2839
29082
20
43
2504
27904
11
62
1886
22715
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2.1e-01
7.0e-01
1.3e+00
4.4e+00
2.1e+00
7.3e-01
3.0e-01
cases:8.04%
controls:6.60%
cases:5.77%
controls:2.95%
cases:1.13%
controls:0.31%
cases:1.40%
controls:0.02%
cases:2.24%
controls:0.27%
cases:5.67%
controls:2.81%
cases:11.49%
controls:8.76%
235
1925
2687
27222
169
861
2758
28331
33
91
2894
29101
41
5
2886
29187
64
79
2796
29026
143
786
2381
27161
218
1996
1679
20781
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
4.2e-01
1.2e+00
2.5e+00
1.0e+50
3.2e+00
1.6e+00
1.1e+00
cases:0.58%
controls:0.38%
cases:0.68%
controls:0.21%
cases:0.34%
controls:0.03%
cases:0.17%
controls:0.00%
cases:0.49%
controls:0.02%
cases:1.07%
controls:0.21%
cases:2.06%
controls:0.73%
17
112
2905
29035
20
60
2907
29132
10
8
2917
29184
5
0
2922
29192
14
6
2846
29099
27
60
2497
27887
39
166
1858
22611
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
4.1e-01
1.0e+00
3.0e+00
—
3.2e+00
1.1e+00
8.4e-01
cases:7.63%
controls:5.18%
cases:4.34%
controls:1.57%
cases:2.63%
controls:0.13%
—
—
cases:2.69%
controls:0.12%
cases:3.84%
controls:1.36%
cases:8.17%
controls:3.70%
223
1510
2699
27637
127
458
2800
28734
77
38
2850
29154
—
77
34
2783
29071
97
381
2427
27566
155
843
1742
21934
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
6.9e-02
5.0e-01
1.8e+00
4.6e+00
2.1e+00
5.5e-01
1.4e-01
cases:40.35%
controls:38.71%
cases:42.47%
controls:30.97%
cases:29.21%
controls:6.42%
cases:24.84%
controls:0.33%
cases:34.09%
controls:5.91%
cases:44.41%
controls:31.63%
cases:53.98%
controls:50.56%
1179
11282
1743
17865
1243
9042
1684
20150
855
1874
2072
27318
727
97
2200
29095
975
1721
1885
27384
1121
8840
1403
19107
1024
11515
873
11262
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
8.6e-01
1.4e+00
1.8e+00
—
2.2e+00
1.9e+00
1.3e+00
cases:1.40%
controls:0.60%
cases:1.78%
controls:0.45%
cases:0.65%
controls:0.10%
—
—
cases:0.73%
controls:0.08%
cases:2.61%
controls:0.39%
cases:3.37%
controls:0.95%
41
174
2881
28973
52
131
2875
29061
19
30
2908
29162
—
21
23
2839
29082
66
110
2458
27837
64
217
1833
22560
lenalidomide; oral
L04AX04 [21603930]
2.3e+00
2.3e+00
2.6e+00
—
—
2.3e+00
—
cases:0.27%
controls:0.03%
cases:0.31%
controls:0.03%
cases:0.24%
controls:0.02%
—
—
—
—
cases:0.32%
controls:0.03%
—
—
8
8
2914
29139
9
9
2918
29183
7
5
2920
29187
—
—
8
9
2516
27938
—
Helicobacter pylori Ag [Presence] in Stool
31843-6 [3013139]
2.5e-01
4.5e-01
3.5e+00
1.0e+50
4.1e+00
1.9e+00
1.4e-01
cases:1.71%
controls:1.33%
cases:0.68%
controls:0.44%
cases:1.33%
controls:0.04%
cases:0.17%
controls:0.00%
cases:1.71%
controls:0.03%
cases:2.34%
controls:0.36%
cases:1.63%
controls:1.43%
50
389
2872
28758
20
127
2907
29065
39
12
2888
29180
5
0
2922
29192
49
8
2811
29097
59
101
2465
27846
31
325
1866
22452
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
1952-1 [3013201]
1.7e+00
2.7e+00
—
—
—
3.0e+00
2.2e+00
cases:0.65%
controls:0.12%
cases:1.02%
controls:0.07%
—
—
—
—
—
—
cases:0.63%
controls:0.03%
cases:1.16%
controls:0.14%
19
34
2903
29113
30
21
2897
29171
—
—
—
16
9
2508
27938
22
31
1875
22746
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
2.9e-01
8.2e-01
2.6e+00
—
3.7e+00
1.4e+00
6.3e-01
cases:5.51%
controls:4.18%
cases:3.69%
controls:1.66%
cases:1.91%
controls:0.14%
—
—
cases:5.35%
controls:0.13%
cases:5.86%
controls:1.50%
cases:9.80%
controls:5.45%
161
1219
2761
27928
108
486
2819
28706
56
41
2871
29151
—
153
39
2707
29066
148
420
2376
27527
186
1241
1711
21536
Nephrology
39 [38004479]
7.1e-01
8.3e-01
1.1e+00
2.8e+00
1.6e+00
1.2e+00
1.2e+00
cases:2.33%
controls:1.16%
cases:1.98%
controls:0.87%
cases:0.99%
controls:0.33%
cases:0.92%
controls:0.06%
cases:1.71%
controls:0.34%
cases:2.93%
controls:0.87%
cases:4.01%
controls:1.22%
68
337
2854
28810
58
254
2869
28938
29
97
2898
29095
27
17
2900
29175
49
98
2811
29007
74
244
2450
27703
76
277
1821
22500
Treatment plan or consultation
WZC00 [2001310885]
4.9e-01
1.6e+00
2.6e+00
—
2.5e+00
1.5e+00
7.9e-01
cases:9.21%
controls:5.86%
cases:10.93%
controls:2.33%
cases:3.89%
controls:0.30%
—
—
cases:3.01%
controls:0.26%
cases:9.47%
controls:2.25%
cases:13.92%
controls:6.84%
269
1708
2653
27439
320
681
2607
28511
114
88
2813
29104
—
86
77
2774
29028
239
630
2285
27317
264
1558
1633
21219
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
6.7e-01
1.3e+00
2.8e+00
—
3.2e+00
1.1e+00
4.0e-01
cases:7.46%
controls:3.98%
cases:8.27%
controls:2.47%
cases:4.75%
controls:0.29%
—
—
cases:7.69%
controls:0.32%
cases:8.12%
controls:2.98%
cases:13.76%
controls:9.62%
218
1160
2704
27987
242
722
2685
28470
139
86
2788
29106
—
220
94
2640
29011
205
832
2319
27115
261
2191
1636
20586
Implantation of vascular injection port
TPX10 [2001309608]
1.8e+00
3.2e+00
—
1.0e+50
1.0e+50
2.9e+00
1.6e+00
cases:0.92%
controls:0.16%
cases:1.61%
controls:0.07%
—
—
cases:0.20%
controls:0.00%
cases:0.52%
controls:0.00%
cases:1.35%
controls:0.07%
cases:1.11%
controls:0.23%
27
46
2895
29101
47
20
2880
29172
—
6
0
2921
29192
15
0
2845
29105
34
20
2490
27927
21
53
1876
22724
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
8.7e-02
5.1e-01
1.9e+00
4.3e+00
2.1e+00
6.1e-01
1.2e-01
cases:40.69%
controls:38.60%
cases:41.54%
controls:29.85%
cases:28.25%
controls:5.50%
cases:14.55%
controls:0.23%
cases:29.93%
controls:5.04%
cases:44.18%
controls:29.99%
cases:54.24%
controls:51.33%
1189
11252
1733
17895
1216
8715
1711
20477
827
1606
2100
27586
426
66
2501
29126
856
1466
2004
27639
1115
8382
1409
19565
1029
11691
868
11086
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
4.7e-01
1.3e+00
2.4e+00
—
3.1e+00
1.4e+00
7.4e-01
cases:10.34%
controls:6.71%
cases:9.67%
controls:2.77%
cases:4.10%
controls:0.39%
—
—
cases:6.01%
controls:0.28%
cases:10.42%
controls:2.87%
cases:14.71%
controls:7.63%
302
1955
2620
27192
283
809
2644
28383
120
113
2807
29079
—
172
82
2688
29023
263
802
2261
27145
279
1739
1618
21038
Liver transplant status
Z94.4 [45566478]
1.7e+00
1.8e+00
2.0e+00
—
—
1.8e+00
2.1e+00
cases:0.27%
controls:0.05%
cases:0.27%
controls:0.04%
cases:0.20%
controls:0.03%
—
—
—
—
cases:0.32%
controls:0.05%
cases:0.69%
controls:0.08%
8
15
2914
29132
8
13
2919
29179
6
8
2921
29184
—
—
8
15
2516
27932
13
19
1884
22758
Blood chemistry outside reference range
166318006 [436230]
1.7e+00
2.8e+00
—
—
—
3.0e+00
1.9e+00
cases:0.34%
controls:0.07%
cases:0.44%
controls:0.03%
—
—
—
—
—
—
cases:0.79%
controls:0.04%
cases:0.63%
controls:0.10%
10
19
2912
29128
13
8
2914
29184
—
—
—
20
11
2504
27936
12
22
1885
22755
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 [3020565]
1.2e+00
2.9e+00
—
1.0e+50
—
3.1e+00
2.0e+00
cases:0.75%
controls:0.22%
cases:1.30%
controls:0.07%
—
—
cases:0.24%
controls:0.00%
—
—
cases:2.10%
controls:0.09%
cases:2.79%
controls:0.37%
22
64
2900
29083
38
21
2889
29171
—
7
0
2920
29192
—
53
26
2471
27921
53
85
1844
22692
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
7.5e-01
1.2e+00
1.9e+00
—
2.7e+00
1.6e+00
1.1e+00
cases:4.45%
controls:2.15%
cases:4.24%
controls:1.27%
cases:1.81%
controls:0.28%
—
—
cases:3.64%
controls:0.25%
cases:5.86%
controls:1.26%
cases:7.22%
controls:2.47%
130
626
2792
28521
124
370
2803
28822
53
82
2874
29110
—
104
72
2756
29033
148
353
2376
27594
137
563
1760
22214

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
548
795
8.17
307.65
3.5
2.6
3.33
3.61
g/l
3.37
527
756
1017
2874
4.79
307.65
1.7
1.6
—
—
—
0
0
791
438
23.97
307.65
2.0
1.5
—
—
—
0
0
1252
2669
7.23
307.65
5.2
2.6
76.43
68.96
e9/l
3.90
949
1963
981
2106
6.37
307.65
3.9
2.8
10.10
10.66
g/l
2.37
931
1935
429
259
19.09
307.65
1.2
1.1
—
—
—
0
0
802
1911
5.33
307.65
1.5
1.5
—
—
—
0
0
510
298
20.32
307.65
1.7
1.3
—
—
—
0
0
1480
3435
7.38
307.65
5.1
2.6
1.96
1.78
%
5.82
1397
3063
433
230
21.75
307.65
1.3
1.2
—
—
—
0
0
730
1378
6.64
307.65
2.5
1.8
1.19
1.53
g/l
14.83
625
1199
850
1661
6.69
307.65
2.2
1.9
1.22
1.36
g/l
0.93
806
1523
1972
9438
4.04
305.05
13.7
6.2
—
—
—
0
0
1122
3777
4.10
288.35
1.8
1.7
—
—
—
0
0
2307
12867
4.19
271.69
15.0
6.5
9.85
8.96
%
16.92
2242
12052
1193
4365
3.83
268.79
3.5
2.0
30.27
29.65
s
2.46
1164
4243
2298
12846
4.13
268.15
14.8
6.4
2.36
2.84
%
23.19
2237
12021
2320
13120
4.14
264.43
14.9
6.5
27.60
27.27
%
0.57
2269
12435
2283
12852
4.02
260.02
15.0
6.5
0.61
0.67
%
4.45
2226
12025
264
246
11.65
248.21
3.4
2.3
1005.94
1209.38
e6/l
2.05
228
213
835
2507
4.20
247.28
8.3
4.3
0.98
0.88
%
0.53
564
753
234
181
13.91
247.26
2.8
2.4
14.88
15.12
%
0.09
228
175
238
193
13.28
244.44
2.9
2.3
74.33
73.47
%
0.26
230
179
2252
12872
3.81
243.22
13.9
6.3
56.21
57.61
%
4.90
2207
12289
328
424
8.54
241.54
3.6
2.1
1.00
0.91
%
1.34
272
293
2355
13911
3.97
240.45
13.8
6.2
0.58
0.60
e9/l
1.76
2136
11840
1214
4776
3.55
240.14
7.9
3.5
0.79
0.82
mmol/l
8.57
1168
4510
2355
13943
3.95
238.83
13.7
6.2
0.03
0.04
e9/l
26.70
2133
11865
2394
14366
4.02
236.92
14.8
6.4
0.15
0.19
e9/l
40.38
2185
12426
2373
14207
3.95
234.48
14.0
6.3
1.62
1.91
e9/l
13.48
2188
12399
796
2397
4.13
233.52
8.2
4.1
0.85
0.71
%
1.06
534
722
1156
4498
3.52
231.21
1.9
1.9
—
—
—
0
0
806
2478
4.05
229.31
2.9
2.7
65.30
66.39
g/l
2.78
763
2285
326
473
7.59
216.91
6.4
3.4
1.51
1.55
%
0.06
300
421
775
2408
3.97
216.02
8.4
4.3
0.18
0.11
%
1.99
500
655
1086
4272
3.39
210.22
3.4
2.7
26.37
22.59
%
6.98
1046
3984
2448
15582
3.81
205.72
25.9
9.3
3.54
4.19
e9/l
26.68
2260
13444
2322
14426
3.50
200.08
16.2
6.6
14.50
12.14
umol/l
6.53
2267
13784
1120
4612
3.25
199.20
3.4
2.7
2.20
2.29
g/l
5.33
1064
4264
752
2433
3.77
195.89
8.9
4.5
0.93
0.09
%
2.29
476
618
1162
4942
3.17
194.82
3.4
2.7
13.90
12.87
umol/l
3.12
1121
4612
161
97
17.46
194.28
2.6
2.1
40.09
28.71
%
7.74
161
97
326
533
6.72
193.65
1.4
1.5
—
—
—
0
0
1592
8110
3.00
192.74
9.1
4.4
—
—
—
0
0
296
480
6.72
176.89
1.4
1.5
139.31
144.38
au/ml
0.23
88
153
974
3945
3.15
174.67
9.8
6.3
1.06
1.05
mmol/l
0.75
930
3682
2043
12446
2.92
168.50
9.7
5.2
33.80
35.44
g/l
27.22
1962
11678
1164
5334
2.90
165.72
2.2
1.5
2.63
2.49
g/l
0.91
919
3245
679
2328
3.46
158.91
1.8
1.4
—
—
—
0
0
289
513
6.11
157.47
1.3
1.3
284.76
251.87
u/ml
0.79
187
292
1536
8350
2.68
153.80
8.9
4.2
7.40
7.40
ph
7.58
1202
6038
875
3563
3.04
152.70
1.6
1.3
673.93
491.63
titre
1.59
224
777
745
2775
3.22
151.62
3.3
2.3
0.19
0.21
g/l
10.36
698
2585
401
994
4.49
148.63
3.3
2.2
21.81
21.20
s
1.05
379
893
363
840
4.77
146.60
1.3
1.3
—
—
—
0
0
1339
6973
2.63
143.88
8.2
4.2
81.89
87.61
%
12.23
1302
6827
1993
12609
2.65
141.59
13.2
7.1
1.20
1.21
mmol/l
5.24
1899
11639
1187
5912
2.64
138.66
10.9
4.6
—
—
—
0
0
2130
14044
2.69
136.82
14.6
7.7
1.20
1.21
mmol/l
4.52
1782
12125
389
1013
4.25
134.70
3.0
3.5
35.58
73.75
mg/l
1.66
311
862
389
1014
4.25
134.51
3.0
3.5
180.60
55.38
mg/l
0.47
311
862
1373
7613
2.45
124.38
3.0
2.3
3.22
2.81
mg/l
5.61
1254
6554
760
3173
2.85
123.59
5.8
2.8
12.68
8.52
umol/l
3.23
684
2809
352
907
4.25
123.25
2.8
3.3
11.03
3.02
ratio
0.63
171
526
1985
13034
2.48
122.13
22.1
16.1
1.31
1.28
inr
1.30
1730
10901
1313
7215
2.43
120.36
5.3
2.9
339.52
349.86
umol/l
2.52
1224
6332
277
604
4.94
119.57
5.6
3.1
56.08
58.01
%
1.27
277
604
285
638
4.82
119.19
5.5
2.7
41.16
36.47
umol/l
1.24
267
573
1866
12027
2.40
118.00
30.2
11.7
0.01
0.00
e9/l
2.14
1577
9747
1425
8188
2.38
117.22
2.1
1.7
18.64
20.09
nmol/l
3.63
1302
6927
414
1258
3.65
114.48
2.4
1.9
2.13
1.99
ug/l
0.08
384
1113
171
245
7.33
114.01
1.6
1.2
—
—
—
0
0
275
621
4.76
113.69
1.6
1.6
—
—
—
0
0
225
432
5.54
112.16
1.1
1.1
—
—
—
0
0
1501
8972
2.32
110.74
6.0
2.5
—
—
—
0
0
672
2778
2.82
110.04
11.5
7.4
11.04
10.27
mmol/l
1.53
646
2660
219
418
5.56
109.84
1.1
1.1
—
—
—
0
0
397
1206
3.63
109.63
2.1
2.4
6.60
7.43
g/l
16.95
370
1110
397
1206
3.63
109.63
2.1
2.4
4.07
4.18
g/l
1.36
370
1111
396
1205
3.62
109.05
2.1
2.4
3.62
3.76
g/l
0.55
369
1110
1895
12550
2.33
108.76
4.6
3.1
331.89
130.69
ug/l
14.11
1808
11676
298
770
4.18
103.44
2.7
1.6
0.20
0.24
g/l
8.25
273
739
175
287
6.40
102.64
7.5
3.7
—
—
—
0
0
137
175
8.15
100.80
3.8
2.3
559.86
526.35
e6/l
0.17
90
139
300
795
4.07
100.55
2.7
1.6
1.10
1.19
g/l
4.32
281
761
369
1129
3.58
100.46
2.1
2.5
2.87
2.95
g/l
0.76
342
1034
95
77
12.70
96.90
1.0
1.0
—
—
—
0
0
170
289
6.17
96.14
2.5
2.5
12.30
40.44
iu/ml
2.18
26
36
150
225
6.96
95.77
1.5
1.9
4.51
4.65
mg/l
0.09
142
217
245
586
4.46
93.92
1.2
1.3
—
—
—
0
0
1339
8019
2.19
93.76
4.4
3.5
0.47
0.41
e6/l
0.53
1069
5948
228
520
4.66
92.77
1.5
1.2
109.66
34.04
u/l
5.20
214
449
131
175
7.77
92.75
4.2
2.4
209.40
230.55
e6/l
0.32
94
150
1485
9295
2.16
92.46
4.6
3.6
108.97
82.59
e6/l
0.38
1219
7152
340
1045
3.53
91.63
2.0
2.5
10.69
10.35
g/l
0.56
312
943
1614
10476
2.14
90.91
5.5
4.2
109.24
101.39
e6/l
0.09
1256
7481
1858
12728
2.16
90.89
6.2
2.8
—
—
estimate
—
0
0
543
2211
2.77
90.02
10.8
3.8
1.22
1.23
mmol/l
3.16
505
1909
274
737
3.98
89.72
1.3
1.2
89.29
97.38
titre
0.18
28
65
2594
20511
2.70
88.78
20.5
8.3
88.78
80.71
u/l
9.05
2542
19490
1276
7623
2.15
88.58
4.2
3.4
1.40
79.69
estimate
—
5
32
61
24
25.91
87.69
1.3
1.2
0.13
0.05
u/ml
—
8
6
1054
5873
2.21
87.04
2.7
1.7
1.93
1.30
mg/l
5.75
892
4552
1005
5542
2.21
84.75
3.8
3.0
505.91
538.39
mosm/kgh2o
5.42
931
4866
167
315
5.55
84.60
6.7
3.4
52.45
59.45
%
2.87
151
272
910
4823
2.26
84.58
2.1
1.8
1234.41
1166.25
nmol/l
1.26
734
3652
265
736
3.85
82.79
1.3
1.2
990.00
1179.00
titre
—
8
20
793
4057
2.29
79.54
2.6
2.1
—
—
—
0
0
120
173
7.18
79.37
3.9
2.1
0.50
0.71
e9/l
2.32
110
163
578
2598
2.51
77.49
2.3
2.3
358.61
377.92
nmol/l
1.52
552
2402
168
357
4.92
74.27
1.5
1.2
5.08
3.48
u/ml
0.99
101
164
80
76
10.78
73.54
1.2
1.1
—
—
—
0
0
2159
16307
2.09
73.53
10.4
5.4
6.68
6.77
mmol/l
1.07
2102
15515
1087
6454
2.06
73.43
3.6
2.8
5.80
5.25
e6/l
0.66
1026
5896
78
72
11.09
73.11
2.8
2.5
0.19
0.22
e9/l
0.15
32
30
1755
12344
1.98
72.79
2.7
2.2
91.99
94.73
pmol/l
1.64
1142
6630
88
97
9.31
72.69
1.1
1.1
—
—
—
0
0
282
892
3.38
72.16
7.0
4.8
1.66
1.57
mg/l
0.85
263
808
84
92
9.36
69.71
3.0
2.5
34.69
28.51
%
2.22
78
86
2274
17662
2.11
69.66
6.3
4.9
133.04
1401.58
e6/l
2.98
52
257
1377
9016
1.96
69.35
6.2
3.2
41.09
36.84
u/l
0.90
1309
8522
1339
8700
1.96
68.84
3.8
2.7
56.72
69.59
u/l
0.77
1254
8072
77
79
9.97
67.04
1.0
1.2
904.17
820.00
titre
0.16
24
15
83
97
8.77
65.51
3.0
2.6
10.36
9.40
%
0.24
74
88
82
97
8.66
64.10
1.1
1.1
—
—
—
0
0
226
669
3.57
63.96
4.9
3.9
—
—
—
0
0
485
2184
2.45
63.83
5.9
4.1
—
—
—
0
0
468
2077
2.48
63.56
10.5
9.7
24.13
24.87
mmol/l
4.23
461
2068
301
1069
3.01
63.19
2.7
1.7
9.18
7.46
iu/ml
0.42
75
250
59
45
13.35
62.27
1.4
1.3
—
—
—
0
0
128
257
5.15
60.37
2.6
2.2
—
—
—
0
0
1401
9536
1.86
59.89
5.3
3.5
2.33
2.35
mmol/l
9.02
1307
8673
270
935
3.07
59.15
5.4
3.9
7.42
7.41
ph
3.32
264
927
204
602
3.56
57.93
5.8
4.6
8.70
8.43
kpa
1.31
197
593
203
599
3.56
57.65
5.8
4.6
2.21
2.58
mmol/l
1.11
141
413
203
600
3.55
57.50
5.8
4.6
4.73
5.05
kpa
7.35
196
592
268
940
3.03
57.37
1.5
1.6
27.01
17.72
u/ml
0.69
37
200
1255
8390
1.84
55.64
3.9
3.3
—
—
—
0
0
2391
19517
2.02
55.51
6.8
4.4
16.52
12.43
mm/h
21.57
2281
18217
59
57
10.53
53.55
3.1
1.6
—
—
—
0
0
156
405
4.00
53.28
2.3
2.7
—
—
—
0
0
627
3382
2.07
52.32
5.0
3.3
7.17
4.54
e9/l
2.73
561
2914
93
159
6.00
52.15
3.2
2.7
34.53
40.79
%
1.67
49
89
1860
14162
1.79
51.88
5.3
4.0
0.00
0.00
estimate
0.50
588
3059
1873
14345
1.78
50.62
5.3
4.0
4.20
3.07
estimate
0.14
598
3109
79
118
6.84
50.52
35.0
30.5
137.34
125.61
ug/l
0.62
70
96
436
2072
2.29
49.98
6.3
4.5
5.00
5.14
kpa
2.88
422
1989
1878
14424
1.78
49.95
5.4
4.0
0.01
0.12
estimate
0.52
565
2899
199
641
3.25
49.11
4.5
2.9
89.22
89.65
%
0.32
192
624
1261
8688
1.77
48.69
4.2
3.2
1990.62
1488.14
ng/l
3.33
1140
7517
424
2015
2.28
48.52
6.4
4.6
7.42
7.41
ph
1.05
366
1674
162
461
3.65
48.50
2.7
1.9
1.99
1.71
mmol/l
1.86
156
449
239
873
2.88
47.38
6.1
4.8
8.15
8.31
kpa
0.77
230
855
291
1181
2.62
47.06
1.4
1.5
6.32
18.10
iu/ml
—
6
32
38
22
17.47
46.30
1.1
1.1
—
—
—
0
0
203
686
3.10
46.19
2.0
2.0
11.49
12.04
mg/l
0.36
191
631
149
426
3.62
44.28
7.2
6.4
11.83
12.08
mg/l
0.26
140
400
393
1898
2.23
42.98
7.2
4.2
23.89
24.04
mmol/l
0.40
382
1876
141
397
3.67
42.86
2.0
1.5
—
—
—
0
0
141
397
3.67
42.86
2.0
1.5
—
—
—
0
0
141
397
3.67
42.86
2.0
1.5
—
—
—
0
0
141
397
3.67
42.86
2.0
1.5
—
—
—
0
0
1182
8209
1.71
42.84
14.5
6.2
—
—
—
0
0
577
3234
1.97
42.34
6.8
4.1
7.38
7.38
ph
0.01
358
1883
895
5774
1.78
41.99
1.9
1.8
473.37
29243739.01
pmol/l
4.59
768
4784
570
3202
1.96
41.47
6.7
4.0
5.68
5.82
kpa
3.00
551
3114
71
117
6.19
41.31
2.8
2.4
165.13
60.83
mg/l
0.52
64
87
754
4643
1.83
41.24
4.1
3.3
2.30
1.96
e6/l
0.46
405
2323
555
3105
1.96
40.81
6.8
4.0
1.32
1.77
mmol/l
1.98
486
2667
147
442
3.44
40.45
2.0
1.6
0.68
0.87
g/l
1.08
111
345
57
77
7.52
39.88
1.1
1.1
—
—
—
0
0
245
990
2.60
39.82
1.3
1.2
—
—
—
0
0
498
2717
1.99
39.24
12.2
9.6
—
—
—
0
0
37
28
13.36
39.11
4.1
2.2
—
—
—
0
0
306
1388
2.34
38.68
1.4
1.2
—
—
—
0
0
1099
7642
1.68
38.63
1.8
1.4
—
—
—
0
0
499
2748
1.97
38.20
10.2
8.4
1.53
1.36
mmol/l
1.79
489
2700
111
289
3.95
37.74
1.2
1.1
—
—
—
0
0
1418
10578
1.63
37.48
5.8
4.0
43.09
111.27
ng/l
0.97
1171
7738
235
961
2.56
37.22
1.4
1.2
0.97
0.82
u/ml
—
7
72
1503
11397
1.62
37.00
4.5
3.5
6.21
6.24
ph
0.60
831
6339
571
3322
1.88
36.97
2.0
1.8
—
—
—
0
0
251
1071
2.46
36.32
5.2
3.1
23.98
24.71
mmol/l
1.92
243
1058
563
3299
1.86
35.51
2.1
1.5
—
—
—
0
0
196
762
2.68
34.35
1.4
1.3
21.30
15.15
iu/ml
—
7
13
473
2648
1.93
34.23
3.0
2.5
32.59
57.96
u/l
0.77
393
2221
83
188
4.51
33.91
1.1
1.0
—
—
—
0
0
1116
7993
1.62
33.78
5.6
4.1
0.00
0.00
estimate
1.54
529
2790
101
267
3.88
33.63
1.6
1.3
—
—
—
0
0
615
3761
1.79
33.55
1.3
1.3
—
—
—
0
0
250
1105
2.37
33.41
2.0
1.6
0.37
0.33
mg/l
0.34
110
516
123
373
3.39
33.39
1.2
1.1
1.58
1.51
g/l
0.70
117
343
100
269
3.81
32.49
1.7
1.3
0.46
0.41
g/l
0.41
65
192
100
269
3.81
32.49
1.7
1.3
6.47
6.79
g/l
0.34
66
193
100
269
3.81
32.49
1.7
1.3
2.69
2.94
g/l
0.68
67
193
63
118
5.43
32.11
35.7
38.9
7.10
6.95
ug/l
0.23
58
107
569
3442
1.80
32.05
10.1
8.3
0.66
0.90
mmol/l
0.67
465
2825
81
189
4.37
31.88
2.1
1.4
—
—
—
0
0
825
5541
1.67
31.87
3.8
3.0
2.46
2.45
mmol/l
0.95
750
4982
765
5043
1.69
31.71
3.9
3.2
1.22
1.02
e6/l
0.44
418
2735
570
3473
1.79
31.26
10.3
8.3
7.42
7.41
ph
2.25
311
1897
569
3475
1.78
30.93
10.2
8.3
4.93
5.10
kpa
3.93
546
3337
568
3476
1.78
30.63
10.2
8.3
12.44
12.17
kpa
0.55
544
3341
52
85
6.20
30.52
2.9
1.8
3929.57
22546.88
e6/l
0.45
37
52
180
714
2.62
30.28
3.2
2.3
115.90
129.26
g/l
8.87
155
563
1541
12102
1.55
30.25
3.1
2.5
75.56
77.21
nmol/l
1.51
1419
10872
399
2194
1.94
30.23
1.6
1.8
—
—
—
0
0
464
2686
1.86
30.01
6.0
3.5
4.72
4.59
kpa
0.67
445
2612
338
1759
2.04
29.96
1.2
1.3
—
—
—
0
0
56
101
5.63
29.73
3.1
2.1
436.00
759.89
e6/l
1.08
48
79
1046
7568
1.58
29.32
5.3
3.4
0.01
0.14
estimate
0.67
491
2398
52
89
5.93
29.15
1.9
1.4
9.58
12.64
g/l
1.35
33
68
494
2947
1.81
28.89
4.0
4.3
17.77
22.68
ug/l
0.25
400
2420
1164
8660
1.55
28.70
2.9
2.2
314.51
226.46
u/l
0.53
1106
8211
48
79
6.16
27.99
3.3
1.7
—
—
—
0
0
119
401
3.05
27.17
2.1
2.6
—
—
—
0
0
63
137
4.67
27.09
1.3
1.2
1.14
1.07
ratio
0.95
55
116
81
217
3.81
26.50
1.3
1.2
300.00
185.41
titre
0.36
12
37
507
3121
1.75
26.45
10.6
8.6
95.28
95.54
%
0.35
487
3010
2783
25521
1.96
26.17
42.8
17.0
24.71
25.35
mg/l
0.53
2581
21220
52
100
5.27
25.78
2.9
2.5
0.59
0.61
mmol/l
0.94
52
100
156
630
2.55
25.29
2.7
1.5
335.58
766.19
e6/l
0.83
130
494
2019
17155
1.52
25.12
5.8
3.4
71.85
51.08
u/l
11.48
1917
16068
154
623
2.55
24.88
2.7
1.5
53.04
36.60
e6/l
0.14
120
461
223
1066
2.18
24.61
2.6
2.1
432.89
661.58
ug/l
0.53
212
1012
2393
21157
1.59
24.38
52.3
20.8
14.59
13.68
%
101.97
2383
20874
1349
10653
1.47
23.58
5.5
3.9
0.01
0.09
estimate
1.12
518
2545
169
732
2.38
23.56
1.5
1.2
3.31
3.33
u/ml
0.01
22
57
51
105
4.92
23.42
1.3
1.1
78.60
9.63
u/ml
—
5
8
175
778
2.32
23.00
1.5
1.2
35.12
39.90
u/ml
0.09
16
33
461
2881
1.71
22.50
11.7
9.1
112.50
121.63
g/l
15.74
451
2807
371
2188
1.79
22.20
5.7
4.3
99.43
92.56
ng/l
0.65
322
1907
39
66
5.97
22.14
1.5
1.3
14.25
24.89
g/l
4.10
31
51
166
735
2.33
22.02
1.5
1.2
16.51
7.79
u/ml
0.47
31
99
94
314
3.06
21.83
1.5
1.8
—
1505.45
—
0
11
141
583
2.49
21.77
2.9
1.4
—
—
—
0
0
94
318
3.02
21.36
2.7
1.4
—
—
—
0
0
97
336
2.95
21.15
2.3
2.3
1.61
1.40
g/24h
0.16
66
197
137
572
2.46
20.72
1.5
1.2
56.57
48.58
u/ml
0.22
26
50
160
719
2.29
20.51
2.6
1.4
611.50
577.85
mg/l
0.27
153
683
43
86
5.06
20.43
3.2
4.8
—
—
—
0
0
476
3083
1.64
20.11
1.4
1.4
—
—
—
0
0
73
220
3.37
20.10
1.6
1.3
2.46
2.18
mmol/l
0.39
68
206
94
330
2.91
20.02
1.1
1.2
—
—
—
0
0
161
737
2.25
19.76
3.9
3.4
3.45
2.02
index
0.94
101
382
91
321
2.89
19.22
4.8
6.1
8.34
7.35
mmol/l
0.31
81
273
313
1829
1.79
19.22
12.0
10.6
23.88
24.20
mmol/l
1.02
307
1790
144
640
2.31
18.95
2.6
1.3
3.74
3.78
mmol/l
0.12
133
602
816
6035
1.48
18.90
1.4
1.3
2.98
1.48
u/ml
1.31
197
1600
75
243
3.14
18.39
1.4
1.1
—
—
—
0
0
71
224
3.22
18.19
1.1
1.0
286.25
285.97
mg/l
0.01
65
203
258
1447
1.85
18.09
7.4
4.8
—
—
—
0
0
30
48
6.30
18.00
1.2
1.3
60.33
159.14
titre
—
6
7
128
553
2.37
17.98
1.8
1.4
63.50
61.34
mmol/l
0.19
94
442
1300
10544
1.40
17.98
2.4
2.2
—
—
—
0
0
203
1055
1.99
17.89
3.6
3.4
611.08
4040.92
u/ml
0.73
170
916
140
632
2.27
17.78
3.8
3.4
295.33
795.90
u/ml
0.58
123
588
749
5508
1.48
17.67
4.7
4.1
427.75
630.57
ng/l
0.50
621
4435
104
412
2.58
17.60
1.5
1.5
31.01
32.18
g/l
0.46
96
371
39
82
4.80
17.52
1.5
1.2
30.55
20.79
%
0.36
11
14
174
863
2.08
17.44
1.5
1.4
263.48
275.87
ug/g
0.33
99
521
163
794
2.11
17.14
5.7
3.2
63.68
61.43
%
0.63
154
770
85
310
2.79
16.92
1.5
1.2
51.37
69.34
u/ml
—
6
14
66
209
3.20
16.83
1.1
1.1
—
—
—
0
0
20
5
40.29
16.32
1.1
1.0
—
—
—
0
0
20
5
40.29
16.32
1.1
1.0
—
—
—
0
0
20
5
40.29
16.32
1.1
1.0
—
—
—
0
0
20
5
40.29
16.32
1.1
1.0
—
—
—
0
0
20
5
40.29
16.32
1.1
1.0
—
—
—
0
0
62
195
3.22
16.00
1.1
1.1
—
—
—
0
0
962
7525
1.41
15.92
3.7
3.1
0.21
0.04
0.58
19
192
2780
26120
1.68
15.53
44.2
20.4
139.16
139.65
mmol/l
17.52
2750
25617
84
320
2.67
15.41
1.5
1.5
—
—
—
0
0
2780
26157
1.66
14.98
45.4
20.6
3.99
3.99
mmol/l
0.03
2745
25610
94
388
2.47
14.65
1.2
1.2
—
—
—
0
0
483
3364
1.52
14.58
2.6
2.5
154.64
138.08
ug/g
0.47
401
2690
841
6586
1.38
13.36
4.3
3.8
0.00
0.11
—
5
73
45
130
3.50
13.32
1.7
1.4
66.40
69.20
%
—
10
20
260
1598
1.68
13.25
5.5
3.0
0.65
0.61
%
1.48
260
1589
299
1907
1.63
13.20
5.8
3.3
115.22
129.03
g/l
17.63
291
1848
201
1150
1.80
13.20
8.0
5.2
24.86
24.68
mmol/l
0.45
190
1073
27
53
5.13
13.15
2.0
2.0
—
—
—
0
0
144
741
1.99
13.09
1.3
1.3
184.23
228.91
miu/ml
0.66
47
322
262
1621
1.67
13.02
5.7
3.0
1.28
1.20
%
0.86
262
1610
80
324
2.51
13.02
1.5
1.4
5.99
6.48
mmol/l
0.89
74
306
75
295
2.58
12.96
1.9
2.1
—
—
—
0
0
23
20
11.58
12.79
3.4
1.7
58.91
58.07
%
0.02
11
15
30
67
4.51
12.59
1.2
1.2
31.47
28.01
s
1.11
30
67
299
1929
1.61
12.59
13.4
10.7
0.65
0.63
%
0.60
293
1918
77
315
2.48
12.28
1.6
1.6
—
—
—
0
0
305
1999
1.58
12.01
12.8
10.4
1.44
1.30
%
1.29
299
1988
49
163
3.04
11.60
2.3
2.1
522.09
502.05
min
0.51
35
116
51
174
2.96
11.56
1.9
1.6
—
—
—
0
0
279
1808
1.60
11.52
9.3
6.7
24.48
24.45
mmol/l
0.04
263
1726
34
90
3.81
11.45
1.7
1.6
1991.11
3261.54
titre
—
9
13
80
345
2.35
11.40
1.1
1.2
104.66
113.91
%
1.29
71
314
22
41
5.40
11.34
2.8
3.2
48.57
22.61
mg/l
—
6
14
132
694
1.94
11.32
1.3
1.1
—
—
—
0
0
43
137
3.17
10.96
1.4
1.7
—
—
—
0
0
32
85
3.79
10.74
1.3
1.2
—
—
—
0
0
267
1743
1.58
10.68
15.1
11.0
14.83
15.98
%
8.39
258
1674
76
332
2.32
10.54
1.2
1.2
—
—
—
0
0
23
30
7.71
10.37
1.6
1.5
—
—
—
0
0
2170
19871
1.31
10.32
4.7
4.3
14.94
14.84
pmol/l
1.04
2012
18142
19
18
10.61
10.26
3.7
1.6
13.00
21.91
%
—
7
11
165
963
1.75
10.17
4.4
3.7
1.43
1.38
mmol/l
0.25
155
953
190
1155
1.69
10.11
2.3
2.7
—
—
—
0
0
223
1414
1.62
10.07
2.4
2.4
—
—
—
0
0
343
2397
1.48
10.02
3.4
2.5
0.63
0.45
e6/l
0.73
336
2303
28
72
3.91
9.84
1.4
1.3
—
—
—
0
0
115
609
1.92
9.70
3.1
3.4
0.79
0.82
nmol/l
0.34
80
495
26
64
4.09
9.69
3.8
2.8
424.58
538.59
ug/l
0.07
26
64
80
372
2.18
9.60
1.5
1.4
1177.67
4014.91
e6/l
0.61
60
250
258
1720
1.55
9.41
1.4
1.3
409.88
224.63
u/ml
1.08
223
1599
597
4680
1.34
8.93
1.3
1.3
44.10
33.24
iu/ml
0.58
186
1408
54
219
2.49
8.87
2.3
2.3
756.46
630.41
ml
1.17
39
141
484
3688
1.37
8.68
1.4
1.3
—
—
—
0
0
167
1027
1.66
8.54
3.6
3.7
367.92
384.06
mg/l
0.07
99
462
50
200
2.52
8.47
1.5
1.5
1805.04
1910.86
ml
0.38
50
195
187
1189
1.61
8.38
1.2
1.2
—
—
—
0
0
129
747
1.76
8.22
1.3
1.2
—
—
—
0
0
45
174
2.61
8.17
2.2
2.5
13.69
16.37
%
5.77
45
174
69
325
2.15
8.07
1.4
1.4
57568.10
91172.34
e6/l
0.41
41
177
34
114
3.00
8.03
1.8
1.8
—
—
—
0
0
44
170
2.61
8.01
1.5
1.3
7.41
7.40
ph
0.10
33
119
2785
26741
1.44
7.93
27.1
12.3
27.45
26.17
u/l
1.81
2745
25943
70
335
2.11
7.88
1.7
1.4
279.88
277.52
mosm/kgh2o
0.30
56
246
360
2660
1.40
7.75
2.5
2.1
0.00
0.01
estimate
0.78
74
552
36
128
2.83
7.68
1.1
1.1
—
5.29
iu/ml
—
0
7
66
313
2.13
7.61
1.5
1.4
—
—
—
0
0
57
256
2.25
7.52
4.1
3.5
11.27
11.44
index
0.04
44
151
35
125
2.82
7.42
1.1
1.1
1172.50
1444.23
miu/ml
0.87
35
125
38
142
2.70
7.41
1.6
1.6
1.86
2.52
u/field
0.29
29
103
15
18
8.37
7.31
1.3
1.4
1.38
1.03
iu/ml
—
8
6
204
1374
1.52
7.14
5.3
3.3
24.64
25.23
mmol/l
1.73
198
1321
33
117
2.84
7.10
1.1
1.1
361.00
197.35
iu/ml
0.74
33
117
121
719
1.71
7.09
1.6
1.5
12.84
8.83
u/l
1.83
95
581
14
16
8.78
7.04
1.0
1.0
—
—
—
0
0
2803
27023
1.43
7.03
49.5
22.2
86.13
79.97
umol/l
9.16
2782
26706
42
170
2.49
7.00
1.4
1.3
—
—
—
0
0
207
1405
1.51
6.99
4.2
3.4
1.02
1.02
ratio
0.41
197
1281
290
2107
1.42
6.88
1.2
1.2
—
—
—
0
0
355
2675
1.37
6.78
8.6
4.4
7.37
7.36
ph
0.94
300
1918
48
211
2.29
6.69
2.0
1.4
1.15
1.17
promille
0.04
42
166
49
220
2.25
6.51
1.2
1.1
—
—
—
0
0
2490
23650
1.28
6.48
5.9
5.3
2.00
1.95
mu/l
1.10
2339
21802
46
202
2.30
6.44
2.3
1.3
31.40
34.95
mmol/l
0.47
41
180
195
1341
1.48
6.20
7.8
5.1
1.63
1.59
%
0.28
182
1259
166
2437
0.66
6.20
2.1
2.0
3.57
3.48
ratio
0.35
127
1905
59
293
2.03
6.10
2.1
2.5
10.85
9.63
umol/l
0.16
46
206
60
301
2.01
6.04
4.5
1.6
—
—
—
0
0
179
1220
1.50
5.96
8.7
5.4
0.85
0.87
%
0.35
169
1145
30
112
2.69
5.91
3.2
1.7
37.44
40.03
g/l
1.04
30
112
61
317
1.94
5.59
3.8
2.5
1.20
1.19
mmol/l
0.15
61
312
1072
9450
1.21
5.57
4.7
3.8
—
0.68
—
0
31
194
1363
1.45
5.56
2.7
2.2
0.02
0.62
estimate
0.49
57
408
16
42
3.82
5.53
1.8
1.5
—
—
—
0
0
305
2318
1.35
5.52
3.5
3.0
287.67
209.38
ng/l
2.15
284
2127
17
47
3.63
5.48
1.1
1.1
—
—
—
0
0
40
179
2.25
5.41
2.5
2.2
7.92
8.25
mmol/l
0.20
40
179
61
325
1.89
5.22
3.8
2.4
105.95
105.51
mmol/l
0.35
61
320
61
325
1.89
5.22
3.8
2.4
4.05
4.08
mmol/l
0.25
61
320
318
2453
1.33
5.21
2.3
2.4
10.28
7.55
ug/l
0.90
277
2167
32
132
2.44
5.20
1.1
1.2
—
—
—
0
0
37
165
2.26
5.07
1.3
1.1
—
—
—
0
0
10
12
8.35
5.05
3.0
4.4
—
—
—
0
0
175
1231
1.45
5.01
1.2
1.1
177.50
135.84
titre
—
8
25
106
670
1.60
4.99
4.9
4.3
—
—
—
0
0
57
302
1.90
4.97
1.2
1.2
—
—
—
0
0
60
325
1.86
4.90
1.5
1.2
—
—
—
0
0
32
136
2.37
4.90
3.3
2.9
—
—
—
0
0
960
10786
0.84
4.71
2.2
1.9
1.43
1.35
mmol/l
1.61
792
9061
526
4384
1.24
4.66
1.3
1.3
16.99
11.33
u/ml
0.65
164
1651
1048
9335
1.19
4.66
5.1
4.2
12.21
10.43
mg/mmol
0.33
709
5970
1086
9728
1.18
4.48
4.3
3.5
7.13
7.66
mmol/l
3.60
932
8222
16
49
3.28
4.46
1.8
1.6
4.09
9.48
%
1.39
11
25
75
448
1.69
4.44
1.8
1.9
4.37
4.83
mmol/24h
0.57
68
395
124
1791
0.68
4.31
1.8
1.8
3.38
3.45
mmol/l
0.31
80
1258
114
764
1.51
4.21
2.5
2.3
6678.24
5642.88
u/l
0.11
44
316
117
790
1.50
4.17
4.9
3.9
3.87
3.93
mmol/l
0.54
111
784
63
366
1.74
4.14
1.5
1.6
23.23
27.97
ng/l
0.60
63
366
45
236
1.92
4.10
1.7
1.5
29.14
27.93
%
0.08
29
141
161
1160
1.41
4.09
7.7
3.4
74.00
70.99
u/ml
0.05
156
1120
1020
9151
1.17
4.03
4.0
3.6
66.32
47.87
mg/l
1.81
724
6022
27
117
2.32
4.01
1.3
1.1
1721.42
215.40
ng/l
0.62
12
30
125
866
1.46
3.94
9.7
6.1
1.37
1.34
mmol/l
0.15
99
756
8
11
7.29
3.86
1.8
1.4
—
—
—
0
0
205
1553
1.34
3.85
3.5
3.5
4.24
4.48
pmol/l
2.46
188
1376
54
309
1.76
3.77
1.7
1.6
62.31
61.36
%
0.06
35
191
2829
27634
1.30
3.73
64.3
25.7
6.42
6.82
e9/l
5.39
2788
26959
2828
27625
1.30
3.71
64.2
25.6
92.39
91.20
fl
25.17
2808
27312
2828
27627
1.30
3.69
64.1
25.5
30.66
30.36
pg
11.56
2808
27312
2828
27628
1.30
3.68
65.6
26.2
37.52
40.38
%
45.36
2808
27301
2828
27628
1.30
3.68
64.3
25.6
4.14
4.48
e12/l
132.43
2785
26957
2827
27619
1.29
3.67
64.5
25.7
162.85
247.68
e9/l
307.65
2786
27038
2828
27634
1.29
3.63
64.9
25.8
124.70
134.85
g/l
153.83
2809
27326
21
85
2.48
3.62
1.2
1.3
357.04
112.93
ug/l
0.29
11
38
29
136
2.14
3.60
2.7
2.0
29.28
27.08
umol/l
0.38
29
125
141
1022
1.40
3.51
1.5
1.4
30.01
25.81
iu/l
0.65
111
858
21
87
2.42
3.46
1.0
1.0
—
—
—
0
0
21
87
2.42
3.46
1.0
1.0
—
—
—
0
0
21
87
2.42
3.46
1.0
1.0
—
—
—
0
0
39
208
1.89
3.44
1.2
1.1
61.11
41.50
mg/l
1.13
27
171
143
1929
0.73
3.40
1.3
1.4
—
—
—
0
0
9
18
5.01
3.37
1.0
1.0
—
—
—
0
0
9
18
5.01
3.37
1.0
1.0
—
—
—
0
0
103
714
1.46
3.29
1.8
1.6
18326.65
14211.70
e6/l
0.40
77
489
13
43
3.03
3.25
1.9
2.9
—
—
—
0
0
11
29
3.80
3.18
1.1
1.0
—
—
—
0
0
30
153
1.97
3.04
1.5
1.2
0.46
0.54
ratio
1.19
13
88
7
12
5.84
3.02
1.9
1.1
—
—
—
0
0
46
751
0.61
2.92
1.1
1.1
0.57
0.64
ratio
—
8
97
213
1694
1.28
2.87
1.2
1.2
147.55
144.66
u/ml
0.04
74
615
36
201
1.80
2.81
1.1
1.1
361.90
280.80
mg/l
0.70
29
174
43
254
1.70
2.77
1.4
1.6
3.42
4.31
ug/l
0.38
36
225
41
239
1.72
2.77
2.7
2.1
1.77
1.66
u/field
0.05
26
129
36
202
1.79
2.77
1.3
1.2
335.26
363.20
nmol/l
0.33
31
174
8
19
4.22
2.67
1.1
1.0
—
—
—
0
0
8
19
4.22
2.67
1.4
1.2
—
—
—
0
0
9
24
3.76
2.67
1.1
1.0
—
—
—
0
0
20
92
2.18
2.67
1.1
1.1
—
—
—
0
0
38
220
1.74
2.64
1.2
1.2
104.66
104.17
pmol/l
0.02
38
220
17
74
2.30
2.57
1.0
1.0
—
—
—
0
0
25
131
1.92
2.40
2.7
3.4
—
—
—
0
0
11
40
2.76
2.27
1.4
1.5
—
—
—
0
0
58
392
1.49
2.21
6.5
5.4
405.46
353.99
umol/l
1.67
48
353
258
2164
1.21
2.21
2.7
2.7
6.07
6.07
ph
0.00
196
1489
7
19
3.69
2.15
1.4
1.2
—
—
—
0
0
13
55
2.37
2.12
1.3
1.5
—
—
—
0
0
198
1629
1.23
2.06
1.4
1.3
64.85
56.36
au/ml
0.19
11
111
89
661
1.36
2.04
2.8
2.3
173.25
104.65
ug/min
0.80
57
406
81
593
1.38
2.03
12.5
7.1
11.03
11.29
mmol/l
0.32
70
523
81
594
1.37
2.01
12.5
7.1
105.29
105.28
mmol/l
0.00
70
524
11
44
2.50
2.01
2.4
1.1
—
—
—
0
0
11
44
2.50
2.01
2.3
1.1
—
—
—
0
0
11
44
2.50
2.01
2.4
1.1
—
—
—
0
0
19
97
1.96
2.00
2.7
2.5
171.09
103.39
ug/l
0.15
19
87
56
386
1.46
1.97
1.3
1.3
—
—
—
0
0
80
1066
0.74
1.88
1.8
1.7
—
—
—
0
0
22
121
1.82
1.88
2.9
3.5
—
—
—
0
0
56
391
1.44
1.86
8.8
2.5
—
—
—
0
0
6
17
3.53
1.83
1.2
2.2
—
—
—
0
0
18
94
1.92
1.80
2.1
2.0
—
—
—
0
0
7
23
3.05
1.80
1.3
1.1
—
—
—
0
0
18
95
1.90
1.75
1.3
1.8
0.00
0.06
estimate
0.80
18
95
13
61
2.14
1.71
1.3
1.2
—
—
—
0
0
33
210
1.58
1.70
2.8
2.7
21.35
32.30
mg/l
1.54
23
153
687
6321
1.11
1.67
5.4
4.1
1.02
1.25
kg/l
0.50
503
4249
6
20
3.00
1.58
1.0
1.1
—
—
—
0
0
10
44
2.28
1.55
10.4
11.9
9.27
5.87
mmol/l
—
10
44
76
579
1.32
1.54
4.6
3.6
30.64
29.17
mg/l
0.13
64
405
209
1786
1.18
1.53
2.7
2.4
33.23
20.14
au/ml
0.47
14
166
24
146
1.65
1.50
1.0
1.3
127.21
138.23
nmol/l
0.39
24
146
5
16
3.13
1.44
2.0
1.6
—
—
—
0
0
15
81
1.86
1.40
1.2
1.2
9.11
8.97
pmol/l
—
6
30
36
515
0.70
1.37
1.8
1.7
—
—
—
0
0
6
23
2.61
1.36
1.0
1.1
—
23.57
—
0
7
6
23
2.61
1.36
1.3
1.2
—
—
—
0
0
6
24
2.50
1.30
1.7
1.1
—
—
—
0
0
60
456
1.32
1.28
1.2
1.1
3.52
18.09
au/ml
—
5
100
5
18
2.78
1.28
1.0
1.0
—
—
—
0
0
13
69
1.89
1.28
9.2
6.2
6.53
5.35
kpa
0.69
13
69
17
99
1.72
1.27
1.4
2.8
1.19
1.41
ug/l
0.27
17
91
66
516
1.28
1.17
1.7
2.0
—
—
—
0
0
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
51
386
1.33
1.15
1.4
1.5
—
—
—
0
0
52
395
1.32
1.14
1.5
1.6
—
—
—
0
0
22
142
1.55
1.14
2.4
2.7
47.60
48.75
umol/l
—
5
13
65
510
1.28
1.13
1.4
1.5
70.80
63.12
ug/l
0.32
50
436
50
379
1.32
1.12
1.4
1.5
1.20
1.29
mm
0.76
34
278
5
21
2.38
1.09
1.0
1.2
334.20
353.57
umol/24h
—
5
21
47
355
1.33
1.08
1.7
1.4
0.95
0.34
nmol/l
0.60
34
275
15
89
1.69
1.07
2.7
3.9
9.15
8.19
mg/l
—
8
77
11
59
1.87
1.07
3.3
2.3
7.90
7.92
mmol/l
—
5
32
106
892
1.19
1.00
1.5
1.6
1078.49
1019.09
mu/l
0.23
86
754
9
48
1.88
1.00
1.4
1.1
—
—
—
0
0
1076
10303
1.07
0.99
5.4
5.8
3.36
3.48
ug/l
0.06
942
9296
79
648
1.22
0.98
1.1
1.1
1.00
6.92
eliau/ml
—
6
73
72
585
1.24
0.97
1.8
1.8
1.00
0.86
nmol/l
0.86
63
480
57
452
1.27
0.95
1.4
1.1
—
—
—
0
0
6
27
2.22
0.93
2.3
2.9
0.00
0.67
u/field
—
6
27
47
365
1.29
0.92
1.2
1.2
—
—
—
0
0
36
476
0.75
0.92
1.1
1.1
0.81
1.44
u/ml
0.56
15
228
6
29
2.07
0.89
2.0
1.5
—
—
—
0
0
34
255
1.34
0.86
1.2
1.1
—
—
—
0
0
8
44
1.82
0.85
5.5
5.8
10.00
8.20
%
—
8
44
8
44
1.82
0.85
2.8
2.9
47.75
41.86
%
—
8
44
56
451
1.25
0.84
1.4
1.1
—
—
—
0
0
300
3263
0.91
0.83
4.6
5.0
31.57
32.48
%
0.70
217
2135
11
65
1.69
0.82
1.3
1.6
0.38
0.48
e9/l
0.76
11
65
25
180
1.39
0.81
1.0
1.1
13.76
16.27
u/ml
—
7
64
98
844
1.17
0.76
1.7
1.7
375.04
297.84
mu/l
0.78
91
772
42
332
1.27
0.76
1.0
1.1
9.31
2.64
eliau/ml
0.40
13
131
18
124
1.45
0.75
1.4
3.1
66.18
122.29
umol/l
1.27
11
76
5
25
2.00
0.72
2.4
3.2
0.84
0.61
ug/l
—
5
25
26
343
0.76
0.70
1.0
1.0
0.16
0.28
u/ml
—
10
130
2441
24705
0.94
0.69
5.2
5.1
1.35
1.44
mmol/l
18.61
2225
22852
2498
25263
0.94
0.69
5.9
5.9
2.47
2.64
mmol/l
17.98
2292
23429
39
486
0.80
0.68
1.1
1.1
1.89
4.66
u/ml
2.53
20
278
58
691
0.84
0.66
1.1
1.2
—
—
—
0
0
29
223
1.30
0.66
1.4
1.4
0.94
3.13
u/ml
1.24
15
127
16
111
1.44
0.65
1.3
1.3
148.88
170.28
mmol/24h
0.49
16
111
5
29
1.72
0.64
1.0
1.2
1.62
1.94
umol/24h
—
5
29
76
880
0.86
0.63
1.9
1.9
49.41
41.91
nmol/l
1.51
76
847
72
618
1.17
0.62
13.3
2.5
—
—
—
0
0
20
147
1.36
0.61
2.0
1.6
—
—
—
0
0
47
564
0.83
0.60
1.2
1.1
0.78
2.79
u/ml
3.33
29
322
8
53
1.51
0.58
1.8
1.5
—
—
—
0
0
16
115
1.39
0.56
1.2
1.2
13.81
9.47
mm/h
0.45
16
115
95
842
1.13
0.55
5.7
2.0
—
—
—
0
0
229
2456
0.93
0.51
1.6
1.5
—
—
—
0
0
71
810
0.87
0.51
22.4
10.7
—
—
—
0
0
2468
24444
1.05
0.48
5.9
5.3
6.08
5.98
mmol/l
2.29
2272
22337
63
554
1.14
0.44
1.4
1.3
—
—
—
0
0
8
58
1.38
0.41
1.0
1.1
26.26
38.32
iu/ml
—
8
58
99
900
1.10
0.41
5.5
2.0
—
—
—
0
0
102
1115
0.91
0.39
1.1
1.1
—
—
—
0
0
10
71
1.41
0.39
2.5
2.3
—
—
—
0
0
40
463
0.86
0.38
1.1
1.1
0.73
1.78
u/ml
1.50
17
254
28
235
1.19
0.36
5.0
5.2
33.57
34.36
u/ml
—
7
68
14
179
0.78
0.35
1.6
1.4
132.36
213.87
pmol/l
0.76
14
179
99
909
1.09
0.35
5.6
2.0
—
—
—
0
0
33
384
0.86
0.35
1.0
1.1
6.13
3.91
u/ml
0.16
16
205
18
146
1.23
0.32
7.1
7.0
4.04
141.90
ug/l
—
10
94
98
905
1.09
0.32
5.6
2.0
—
—
—
0
0
23
193
1.19
0.30
1.0
1.1
8.72
8.98
iu/ml
—
9
48
22
184
1.20
0.30
1.7
2.1
6.43
6.85
mmol/l
0.31
16
122
76
825
0.92
0.28
1.1
1.1
—
—
—
0
0
10
76
1.32
0.28
1.9
1.4
9.33
8.67
mmol/l
—
10
76
96
894
1.08
0.27
5.6
1.9
—
—
—
0
0
37
328
1.13
0.26
1.6
1.3
0.21
0.19
nmol/l
0.53
27
262
42
376
1.12
0.26
1.6
1.4
0.65
5.38
nmol/l
0.50
42
359
49
443
1.11
0.26
1.1
1.1
1.60
122.71
iu/ml
—
5
90
2377
23616
1.03
0.26
4.7
4.4
1.32
1.28
mmol/l
1.84
2173
21620
2474
24872
0.97
0.25
5.4
5.2
4.28
4.53
mmol/l
25.87
2273
23171
13
157
0.83
0.22
1.0
1.1
11.43
1.42
u/ml
—
7
67
0
12
0.00
0.21
0.0
1.1
—
0.04
—
0
12
0
12
0.00
0.21
0.0
1.2
—
0.16
—
0
12
133
1272
1.05
0.19
2.3
2.0
—
—
—
0
0
10
82
1.22
0.17
1.7
1.5
81.50
490.44
nmol/24h
—
10
82
7
63
1.11
0.17
1.4
1.4
103.64
55.46
mu/l
—
7
50
33
360
0.92
0.16
1.0
1.1
3.20
5.00
u/ml
0.46
14
174
29
264
1.10
0.15
2.1
1.6
389.83
324.82
mu/l
0.34
24
213
604
6123
0.98
0.13
3.2
3.4
0.89
0.78
ug/l
0.61
422
4162
2103
21121
0.99
0.13
50.2
21.8
331.41
332.36
g/l
4.29
2090
20989
34
317
1.07
0.12
1.6
1.3
—
—
nmol/l
—
0
0
19
173
1.10
0.10
1.1
1.0
—
—
—
0
0
21
193
1.09
0.09
2.0
1.5
98.71
84.73
umol/l
0.85
21
193
5
48
1.04
0.09
1.2
1.5
0.02
1.60
u/ml
—
5
48
33
311
1.06
0.09
1.8
1.8
—
—
—
0
0
74
716
1.03
0.08
2.2
2.0
15.28
11.88
iu/l
0.09
33
291
6
70
0.86
0.07
1.0
1.0
10.55
9.24
mu/l
—
6
63
24
225
1.07
0.07
3.3
3.2
13.28
35.39
mg/l
1.59
16
169
20
186
1.08
0.07
1.2
1.2
—
—
—
0
0
927
9318
0.99
0.06
3.5
3.2
—
—
—
0
0
2406
24012
1.01
0.06
7.2
6.6
39.17
39.57
mmol/mol
1.33
2235
22391
14
152
0.92
0.06
1.0
1.2
3.45
2.22
u/ml
—
6
53
19
203
0.94
0.06
1.0
1.0
702.43
692.05
ng/l
0.03
14
131
19
202
0.94
0.05
1.0
1.0
253.64
308.64
ng/l
0.51
14
133
29
279
1.04
0.04
2.1
2.4
—
—
—
0
0
30
311
0.96
0.03
3.0
2.6
—
—
—
0
0
36
351
1.03
0.02
2.1
2.2
15.18
20.73
mg/l
0.51
11
126
17
164
1.04
0.00
2.7
1.9
119.18
123.05
ng/l
0.06
17
164
12
116
1.03
0.00
1.2
1.1
—
—
—
0
0
30
295
1.02
0.00
1.5
1.3
7.65
7.49
mmol/l
0.09
25
259
251
2510
1.00
0.00
2.3
2.3
12.60
13.01
nmol/l
0.28
222
2256
5
56
0.89
0.00
1.0
1.1
0.38
5.93
u/ml
—
5
50
0
6
0.00
-0.00
0.0
1.5
—
46.92
—
0
6
6
59
1.02
-0.00
1.0
1.2
—
—
—
0
0
5
52
0.96
-0.00
1.6
2.2
9.98
16.71
umol/l
—
5
52
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
8.45
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
3220.00
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_THROMBOCYTOPENIANAS and mortality.

Females

Parameter HR [95% CI] p-value
D3_THROMBOCYTOPENIANAS 2.959 [2.61, 3.36] < 0.001
Birth year 0.995 [0.99, 1.0] 0.239

During the follow-up period (1.1.1998 — 31.12.2019), 2428 out of 7148 females with D3_THROMBOCYTOPENIANAS died.

Males

Parameter HR [95% CI] p-value
D3_THROMBOCYTOPENIANAS 3.095 [2.72, 3.52] < 0.001
Birth year 0.997 [0.99, 1.01] 0.474

During the follow-up period (1.1.1998 — 31.12.2019), 3444 out of 8372 males with D3_THROMBOCYTOPENIANAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_THROMBOCYTOPENIANAS.

N-year risk Females Males
1 0.242% 0.6%
5 1.655% 4.353%
10 4.4% 10.977%
15 8.294% 19.863%
20 14.628% 32.578%

Relationships between endpoints

↥

Index endpoint: D3_THROMBOCYTOPENIANAS – Thrombocytopenia, unspecified

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data